10-Q

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________________________________________ 

Form 10-Q

_______________________________________________ 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

For the Quarter Ended August 31, 2019

Commission File Number 1-15147

______________________________________________ 

OMNOVA SOLUTIONS INC

(Exact name of registrant as specified in its charter)

_______________________________________________ 

Ohio	34-1897652
(State of Incorporation)	(I.R.S. Employer Identification No.)

25435 Harvard Road, Beachwood, Ohio 44122-6201

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code (216) 682-7000

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock	OMN	The New York Stock Exchange

______________________________________________ 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, interactive data file required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ☒    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company (as defined in Rule 12b-2 of the Exchange Act).

 

Large accelerated filer	¨	Accelerated filer	ý	Emerging growth company	¨
Non-accelerated filer	¨	Smaller reporting company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Yes  ☐    No  ý

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   Yes  ☐    No  ý

At August 31, 2019, there were 44,853,732 outstanding shares of OMNOVA Solutions’ Common Stock, par value $0.10.

OMNOVA SOLUTIONS INC.

Table of Contents

		Page No.
Part I. Financial Information
Item 1.	Financial Statements (Unaudited)
	Consolidated Statements of Operations – Three and Nine Months Ended August 31, 2019 and 2018	3
	Consolidated Statements of Comprehensive Income (Loss) – Three and Nine Months Ended August 31, 2019 and 2018	4
	Consolidated Balance Sheets – August 31, 2019 and November 30, 2018	5
	Consolidated Statements of Cash Flows – Nine Months Ended August 31, 2019 and 2018	6
	Notes to Unaudited Interim Consolidated Financial Statements as of August 31, 2019	7
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	21
Item 3.	Quantitative and Qualitative Disclosure About Market Risk	38
Item 4.	Controls and Procedures	38
Part II. Other Information
Item 1.	Legal Proceedings	38
Item 1A.	Risk Factors	38
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	39
Item 6.	Exhibits	41
Signatures		42
Index to Exhibits		43

2

Part I. Financial Information

Item 1. Financial Statements

OMNOVA SOLUTIONS INC.

Consolidated Statements of Operations

(Unaudited)

	Three Months Ended August 31,						Nine Months Ended August 31,
	2019			2018			2019			2018
	(Dollars and shares in millions, except per share data)
Net sales	$	192.4		$	193.6		$	567.0		$	578.5
Cost of goods sold (exclusive of depreciation)	146.1			144.5			434.7			431.3
Gross profit	46.3			49.1			132.3			147.2
Other costs and expenses:
Selling, general and administrative	26.6			26.3			85.6			83.4
Depreciation and amortization	7.5			7.8			23.4			22.3
Asset impairments	1.0			9.2			1.0			9.6
(Gain) loss on asset sales	(.1		)	—			(4.2		)	—
Restructuring and severance	.8			.4			4.9			1.8
Interest expense	5.1			4.7			15.3			14.4
Debt issuance costs write-off	.2			—			.2			.8
Merger, acquisition, and integration related expense	5.9			(.3		)	6.1			.7
Other (income) expense, net	(1.6		)	.6			(2.7		)	.8
Total other costs and expenses	45.4			48.7			129.6			133.8
Income (loss) before income taxes	.9			.4			2.7			13.4
Income tax (benefit) expense	.6			2.3			1.4			(.3		)
Net income (loss)	$	.3		$	(1.9	)	$	1.3		$	13.7
Net income (loss) per share - Basic and Diluted	$	.01		$	(.04	)	$	.03		$	.31
Weighted average shares outstanding - Basic	44.8			44.5			44.8			44.6
Weighted average shares outstanding - Diluted	45.7			44.5			45.6			44.8

See notes to unaudited interim consolidated financial statements.

3

OMNOVA SOLUTIONS INC.

Consolidated Statements of Comprehensive Income (Loss)

(Unaudited)

	Three Months Ended August 31,						Nine Months Ended August 31,
	2019			2018			2019			2018
	(Dollars in millions)
Net income (loss)	$	.3		$	(1.9	)	$	1.3		$	13.7
Components of other comprehensive income (loss):
Foreign currency translations:
Unrealized net change during the period	(2.3		)	(5.4		)	(3.6		)	(4.4		)
Unrealized net change on intercompany foreign debt during the period	(.2		)	(.1		)	(.6		)	(.4		)
Tax effect	—			—			—			(.1		)
Foreign currency translations, net of tax	(2.5		)	(5.5		)	(4.2		)	(4.9		)
Post retirement benefit plans:
Actuarial net (gain) loss:
Amortization of net loss included in net periodic benefit cost	.8			1.2			2.5			3.4
Tax effect	(.2		)	—			(.4		)	—
Post-retirement benefit plans, net of tax	.6			1.2			2.1			3.4
Other comprehensive income (loss), net of tax	(1.9		)	(4.3		)	(2.1		)	(1.5		)
Comprehensive income (loss)	$	(1.6	)	$	(6.2	)	$	(.8	)	$	12.2

See notes to unaudited interim consolidated financial statements.

4

OMNOVA SOLUTIONS INC.

Consolidated Balance Sheets

	August 31, 2019			November 30, 2018
	(Unaudited)			(Audited)
	(Dollars in millions, except share amounts)
ASSETS:
Current Assets
Cash and cash equivalents	$	36.8		$	54.1
Accounts receivable, net	113.4			112.1
Inventories, net	78.6			78.8
Prepaid expenses and other	8.6			8.0
Total Current Assets	237.4			253.0
Property, plant and equipment, net	208.7			205.8
Intangible assets, net	48.9			53.5
Goodwill	69.5			70.9
Other non-current assets	5.7			6.0
Total Assets	$	570.2		$	589.2
LIABILITIES AND SHAREHOLDERS’ EQUITY:
Current Liabilities
Short-term debt	$	4.3		$	4.2
Accounts payable	88.8			101.1
Accrued payroll and personal property taxes	17.9			15.5
Employee benefits	3.3			2.9
Other current liabilities	5.4			10.1
Total Current Liabilities	119.7			133.8
Long-term debt	322.8			318.7
Post-retirement benefits other than pensions	5.0			5.3
Pension liabilities	46.0			51.6
Deferred income taxes	10.7			13.4
Other non-current liabilities	7.3			8.8
Total Liabilities	511.5			531.6
Shareholders’ Equity
Preferred stock - $1.00 par value; 15.0 million shares authorized; none outstanding	—			—
Common stock - $0.10 par value; 135.0 million shares authorized; 48.3 million shares issued; 44.9 million shares outstanding as of August 31, 2019 and November 30, 2018, respectively	4.8			4.8
Additional contributed capital	348.5			345.9
Retained deficit	(144.6		)	(145.4		)
Treasury stock at cost - 3.4 million shares as of August 31, 2019 and November 30, 2018, respectively	(25.5		)	(25.3		)
Accumulated other comprehensive loss	(124.5		)	(122.4		)
Total Shareholders’ Equity	58.7			57.6
Total Liabilities and Shareholders’ Equity	$	570.2		$	589.2

See notes to unaudited interim consolidated financial statements.

5

OMNOVA SOLUTIONS INC.

Consolidated Statements of Cash Flows

(Unaudited)

	Nine Months Ended August 31,
	2019			2018
	(Dollars in millions)
Operating Activities:
Net income (loss)	$	1.3		$	13.7
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
(Gain) loss on asset sales	(4.2		)	—
Depreciation and amortization	23.4			22.3
Impairment of long-lived assets	1.0			9.6
Amortization and write-off of deferred financing fees	1.1			1.8
Non-cash stock compensation expense	2.8			2.1
Provision for uncollectible accounts	.5			.4
Provision for obsolete inventories	(.1		)	1.3
Deferred income taxes	(.9		)	(6.6		)
Changes in operating assets and liabilities:
Accounts receivable	(4.7		)	(3.8		)
Inventories	(.8		)	(3.1		)
Other current assets	2.4			5.3
Current liabilities	(3.8		)	1.4
Other non-current assets	(5.9		)	1.2
Other non-current liabilities	(5.6		)	(2.5		)
Contributions to defined benefit plan	(3.0		)	(6.0		)
Net Cash Provided By (Used In) Operating Activities	3.5			37.1
Investing Activities:
Capital expenditures	(25.9		)	(12.8		)
Proceeds from asset sales	5.5			—
Business acquisitions	(2.8		)	(.5		)
Net Cash Provided By (Used In) Investing Activities	(23.2		)	(13.3		)
Financing Activities:
Proceeds from borrowings	267.6			2.3
Repayment of debt obligations	(264.5		)	(45.4		)
Payments for debt refinancing	—			(1.0		)
Employee tax withholdings related to redemption of common shares	(.5		)	(.5		)
Net Cash Provided By (Used In) Financing Activities	2.6			(44.6		)
Effect of exchange rate changes on cash and cash equivalents	(.2		)	(1.0		)
Net Increase (Decrease) In Cash And Cash Equivalents	(17.3		)	(21.8		)
Cash and cash equivalents at beginning of period	54.1			88.0
Cash and Cash Equivalents at End of Period	$	36.8		$	66.2
Supplemental Cash Flow Information:
Cash paid for:
Interest	$	14.2		$	13.2
Income taxes	$	6.2		$	5.7

See notes to unaudited interim consolidated financial statements.

6

OMNOVA SOLUTIONS INC.

NOTES TO UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

As of August 31, 2019

(Dollars In Millions, Except Share Data)

Note A – Pending Merger, Basis of Presentation, Description of Business, and Accounting Standards

Pending Merger

On July 3, 2019, OMNOVA Solutions Inc. (the "Company") announced that it entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Synthomer plc ("Synthomer"), Spirit USA Holdings Inc. ("Merger Sub"), and Synthomer USA LLC, pursuant to which Merger Sub, a wholly-owned subsidiary of Synthomer, would merge with and into the Company, subject to shareholder and regulatory approvals and other customary conditions (the "Merger").

Upon consummation of the Merger (the “Effective Time”), each common share, par value $0.10 per share, of the Company (“Company Common Shares”) issued and outstanding immediately prior to the Effective Time (other than dissenting shares, shares held in the treasury of the Company and shares held by Synthomer or any of its wholly owned subsidiaries) will be canceled and automatically converted into the right to receive $10.15 in cash, without interest and subject to any applicable withholding taxes (the “Per-Share Amount”).

Pursuant to the Merger Agreement, each unvested Company restricted share, restricted share unit, and performance share that is outstanding immediately prior to the Effective Time, will be canceled and converted into the right to receive an amount in cash equal to the Per-Share Amount. Each Company performance share will be considered to have vested at target achievement levels.

The Merger Agreement contains customary representations, warranties, and covenants, including, among others, covenants: (a) that each of the Company, Synthomer, and Merger Sub uses its reasonable best efforts to cause the proposed transactions to be consummated; (b) that require the Company, Synthomer and Merger Sub to take certain actions that may be necessary to obtain required antitrust approvals; (c) that require the Company (i) subject to certain restrictions, to operate in the ordinary course of business consistent with past practice until the Effective Time, (ii) not to initiate, solicit or knowingly facilitate or encourage the making of any inquiries or proposals relating to alternate transactions or, subject to certain exceptions, engage in any discussions or negotiations with respect thereto, and (iii) to convene a meeting of the Company’s shareholders and solicit proxies from its shareholders in favor of the adoption of the Merger Agreement; and (d) that require Synthomer (y) not to initiate, solicit or knowingly facilitate or encourage the making of any offers or proposals relating to certain acquisitions of Synthomer’s equity or assets or, subject to certain exceptions, engage or participate in any discussions or negotiations with respect thereto, and (z) to convene a meeting of Synthomer’s shareholders and solicit proxies from its shareholders in favor of approving the transactions and certain matters related thereto.

Subject to certain exceptions and limitations, either party may terminate the Merger Agreement if the proposed transactions are not consummated by nine (9) months after the date of the Merger Agreement, subject to an automatic extension for an additional period of three (3) months if necessary to obtain regulatory clearances. Consummation of the proposed transactions is not subject to any financing condition.

The Merger Agreement contains certain termination rights and provides that, upon termination of the Merger Agreement under specified circumstances, including, without limitation, (i) a change in the recommendation of the Company’s Board of Directors or a termination of the Merger Agreement by the Company to enter into an agreement for a “superior proposal,” the Company will pay Synthomer a cash termination fee equal to $15.8 million, and (ii) a change in recommendation of Synthomer’s Board of Directors or a termination of the Merger Agreement by the Company or Synthomer due to a failure in certain circumstances to obtain certain antitrust approvals with respect to the transactions, Synthomer will pay the Company a cash termination fee equal to $15.8 million.

The proposed Merger has been unanimously approved by the respective Boards of Synthomer and the Company, and at a special meeting of Synthomer’s shareholders on July 31, 2019, Synthomer received shareholder approval to, among other things, consummate the Merger. The closing of the Merger remains subject to the satisfaction of customary closing conditions, including approval of the Merger Agreement by the Company’s shareholders and receiving regulatory clearance for the transaction in certain non-U.S. jurisdictions. The Company's shareholders will have the opportunity to vote on a proposal to adopt the Merger Agreement at a special meeting of Company shareholders scheduled to occur on October 10, 2019. The Company and Synthomer continue to target closing the transaction in late 2019 or early 2020.

Basis of Presentation

The accompanying unaudited interim consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial statements and with the instructions to Form 10-Q and Article 10

7

of Regulation S-X and, therefore, do not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements. These interim consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the OMNOVA Solutions Inc. (“OMNOVA Solutions”, "OMNOVA", the “Company”, "we", "us" or "our") Annual Report on Form 10-K for the year ended November 30, 2018, previously filed with the Securities and Exchange Commission (“SEC”).

The consolidated financial statements as of August 31, 2019 have been derived from the unaudited interim consolidated financial statements at that date and do not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.

These interim consolidated financial statements reflect all adjustments that are, in the opinion of Management, necessary for a fair presentation of the results for the interim period and all such adjustments are of a normal recurring nature except as disclosed herein. The results of operations for the interim period are not necessarily indicative, if annualized, of those to be expected for the full year.

The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires Management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.

The consolidation method is followed to report investments in subsidiaries. The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Inter-company accounts and transactions are eliminated during the consolidation process of these accounts.

A detailed description of the Company’s significant accounting policies and Management judgments is located in the audited consolidated financial statements for the year ended November 30, 2018, included in the Company’s Form 10-K filed with the SEC.

Description of Business

The Company is an innovator of emulsion polymers, specialty chemicals, and engineered surfaces for a variety of commercial, industrial, and residential end uses. The Company's products provide a variety of important functional and aesthetic benefits to hundreds of products that people use daily. The Company holds leading positions in key market categories, which have been built through innovative products, customized product solutions, strong technical expertise, well-established distribution channels, recognized brands, and long-standing customer relationships. The Company utilizes strategically-located manufacturing, technical, and other facilities in North America, Europe, China, and Thailand to service a broad customer base. The Company has two business segments: Specialty Solutions, which is focused on the Company's higher growth specialty businesses, and Performance Materials, which is focused on the Company’s more mature businesses.

Specialty Solutions – The Specialty Solutions segment develops, designs, produces, and markets a broad line of specialty polymers for use in coatings, adhesives, sealants, elastomers, nonwovens, and oil & gas products, as well as laminates and films. These products are used in numerous applications, including architectural and industrial coatings; nonwovens used in hygiene products, filtration, and construction; drilling additives for oil and gas exploration and production; elastomeric modification of plastic casings and hoses used in household and industrial products and automobiles; tapes and adhesives; sports surfaces; textile finishes; commercial building refurbishment; new construction; residential cabinets; flooring; ceiling tile; furnishings; manufactured housing; health care patient and common area furniture; and a variety of industrial films applications. The segment's products enhance our customers’ products performance, including stain, rust and aging resistance; surface modification; gloss; softness or hardness; dimensional stability; high heat and pressure tolerance; and binding and barrier (e.g. moisture, oil) properties.

The Specialty Solutions segment consists of Specialty Coatings & Ingredients, Oil & Gas, and Laminates & Films. The Specialty Coatings & Ingredients business line encompasses products that have applications for specialty coatings, nonwovens (such as disposable hygiene products, engine filters, roofing mat, and scrub pads), construction, adhesives, sealants, tape, floor care, textiles, graphic arts, and various other specialty applications. Oil & Gas applications include drilling fluid additives, which provide fluid loss control and sealing to enhance wellbore integrity, as well as cement additives for gas migration and fluid loss. The Laminates & Films product line applications include kitchen and bath cabinets, wall surfacing, manufactured housing and recreational vehicle interiors, flooring, commercial and residential furniture, retail display fixtures, home furnishings, commercial appliances, and a variety of industrial film applications.

Performance Materials – The Performance Materials segment serves mature markets with a broad range of emulsion polymers based primarily on styrene butadiene (SB), styrene butadiene acrylonitrile (SBA), styrene butadiene vinyl pyridine, high styrene pigments, polyvinyl acetate, acrylic, styrene acrylic, calcium stearate, glyoxal, and bio-based chemistries. Performance Materials' custom-formulated products are tailored latexes, resins, binders, antioxidants, hollow plastic pigment, coated fabrics, and rubber reinforcing which are used in tire cord, polymer stabilization, industrial rubbers, carpet binders, paper coatings, and various other applications. Its products provide a variety of functional properties to enhance the Company’s

8

customers’ products, including greater strength, adhesion, dimensional stability, ultraviolet resistance, improved processibility, and enhanced appearance.

The Performance Materials segment encompasses performance additives, paper coatings, carpet binders, and coated fabrics. This segment includes products that have applications in the paper coatings, paperboard, carpet binders, polymer stabilization, industrial rubbers, and tire cord industries. Paper and paperboard coatings are used in magazines, catalogs, direct mail advertising, brochures, printed reports, food cartons, household, and other consumer and industrial packaging. Carpet binders are used to secure carpet fibers to carpet backing and meet stringent manufacturing, environmental, odor, flammability, and flexible installation requirements. Tire cord is used in automotive tires. The Coated Fabrics product line applications include upholstery used in refurbishment and new construction for the commercial office, hospitality, health care, retail, education and restaurant markets, marine and transportation seating, commercial and residential furniture, automotive soft tops, and automotive after-market applications.

Accounting Standards

Accounting Standards Adopted in 2019

In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-09, Revenue from Contracts with Customers Accounting Standards Codification ("ASC") Topic 606, which clarified existing accounting literature relating to how and when a company recognizes revenue. This standard prescribes a five-step model for recognizing revenue, the application of which will require a certain amount of judgment. The provisions of this ASU may be applied retroactively or on a modified retrospective (cumulative effect) basis. The standard requires additional disclosures in the notes to the consolidated financial statements, including qualitative and quantitative disclosures identifying the nature, amount, timing and significant judgments impacting revenue from contracts with customers. The Company adopted ASU 2014-09 during the first quarter of fiscal year 2019 and utilized the modified retrospective approach and recorded a cumulative effect adjustment to retained earnings of $0.5 million for the accounting impact of certain previously capitalized contract costs as of December 1, 2018.

In March 2017, the FASB issued ASU 2017-07, Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost, which requires that an employer report the service cost component in the same line item or items as other compensation costs arising from services rendered by the pertinent employees during the period. The amendments in this ASU also allow only the service cost component to be eligible for capitalization when applicable. ASU 2017-07 must be applied retrospectively for the presentation of the service cost component and the other components of net periodic benefit cost in the income statement and prospectively, on and after the effective date, for the capitalization of the service cost component of net periodic benefit cost in assets. The Company adopted ASU 2017-17 during the first quarter of fiscal year 2019. The Company elected to use the practical expedient to use amounts disclosed in the 2018 consolidated financial statements as an estimate for applying the retrospective presentation requirements. As a result, selling, general, and administrative expense ("SG&A") increased with an offsetting increase to other (income) expense of $0.7 million and $0.4 million in the three months ended August 31, 2019 and 2018, respectively, and $1.6 million and $1.4 million in the nine months ended August 31, 2019 and 2018, respectively. Other than this reclassification, the adoption of ASU 2017-07 did not have an impact on the Company’s consolidated financial statements as of and for the periods ended August 31, 2019 and 2018.

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows - Classification of Certain Cash Receipts and Cash Payments, which clarifies existing guidance related to accounting for cash receipts and cash payments and classification on the statement of cash flows. The amendments in this ASU should be applied using a retrospective transition method to each period presented. The Company adopted the amendments of this ASU effective December 1, 2018, and this ASU did not have an impact on the Company's consolidated financial statements.

In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows - Restricted Cash, which requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash would be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The amendments in this ASU should be applied using a retrospective transition method to each period presented. The Company adopted the amendments of this ASU effective December 1, 2018, and this ASU did not have an impact on the Company's consolidated financial statements.

In January 2017, the FASB issued ASU No. 2017-01, Clarifying the Definition of a Business, which clarified existing guidance on the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The Company adopted the amendments of this ASU effective December 1, 2018, and this ASU did not have an impact on the Company's consolidated financial statements.

Accounting Standards Not Yet Adopted

9

In February 2018, the FASB issued ASU 2018-02, Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (Loss), which allows a reclassification from accumulated other comprehensive income (loss) to retained earnings for standard tax effects resulting from the Tax Cuts and Jobs Act. ASU 2018-02 must be applied either in the period of adoption or retrospectively to each period in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act is recognized. This guidance is effective for annual periods, including interim periods within those annual periods, beginning after December 15, 2018 with early adoption permitted in any interim period. The Company is currently evaluating the potential impact on its consolidated financial statements and related disclosures.

In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging, which applies targeted improvements to the hedge accounting guidance, including removing the requirement to record the ineffective portion of a hedging instrument in current period income. The guidance is effective for annual periods, including interim periods within those annual periods, beginning after December 15, 2018 with early adoption permitted in any interim period. Amendments from this ASU are to be applied prospectively, with a cumulative effect adjustment recorded to retained earnings. The Company is currently evaluating the potential impact on its consolidated financial statements and related disclosures.

In February 2016, the FASB issued ASU 2016-02, Leases (ASC Topic 842), which requires a lessee to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases with a lease term of more than twelve months. Leases will continue to be classified as either financing or operating, with classification affecting the recognition, measurement and presentation of expenses and cash flows arising from a lease. The new guidance is effective for the Company’s fiscal year that begins on December 1, 2019. The Company will elect the optional transition method to account for finance and operating leases existing at, or entered into after, December 1, 2019, and the Company will record a cumulative effect adjustment to retained earnings on the same date, if necessary. This optional transition method will not require any prior period restatements. We have completed aggregating our worldwide lease contracts, extracted lease data into a centralized database, established implementation controls, and are implementing a new lease accounting system to support the accounting and disclosure requirements of this ASU. The Company continues to evaluate certain practical expedients available and implement controls to support recognition and disclosure under ASC 842. As the implementation project progresses, the Company will determine the extent of the impact on its consolidated financial statements and related disclosures.

Note B – Revenue Recognition

The Company recognizes revenues when control of the promised goods is transferred to customers, in an amount that reflects the consideration expected to be received in exchange for those goods in accordance with ASC 606. When recognizing revenue, the Company applies the following five-step approach: 1) identify the contract with a customer, 2) identify the performance obligations, 3) determine the transaction price, 4) allocate the transaction price to the performance obligations in the contract, and 5) recognize revenue when a performance obligation is satisfied.

The Company considers confirmed customer purchase orders, which are typically governed by master sales agreements, to be the contracts, from an accounting perspective, with its customers. Under the Company's standard contract terms and conditions, the only performance obligation is the delivery of products and the performance obligation is satisfied at a point in time when the Company transfers control of the products to its customers. The Company may receive orders for products to be delivered over multiple dates that may extend across several reporting periods. The Company invoices its customers for each order and recognizes revenue for each distinct product upon shipment, once transfer of control has occurred. Payment terms used are standard for the industry and jurisdictions in which the Company operates. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment, to determine the net consideration to which the Company expects to receive. Discounts or rebates are specifically stated in customer contracts or invoices, and are recorded as a reduction of revenue in the period the related revenue is recognized. Rebates are estimated based on sales terms and past experience and typically are credited to customers based on achieving certain defined volume levels. The product price, as specified on the customer confirmed orders, is considered the standalone selling price. The Company allocates the transaction price to each distinct product based on its relative standalone selling price. The Company reviews material contracts to determine transfer of control based upon the business practices and legal requirements of each country.

The Company enters into various payment terms with its customers by the type and location of the customer and the products offered. Generally, the time between when revenue is recognized and when payment is due is not significant. The amount of shipping and handling fees invoiced to our customers at the time our product is shipped is included in net sales as we are the principal in those activities. Sales tax, valued-added tax, and other taxes collected from the Company's customers and remitted to governmental authorities, where applicable, are excluded from net sales. The Company records returns as a reduction to sales when incurred. Generally, customers do not have a unilateral right to return products. The Company primarily offers an assurance-type standard warranty that the product will conform to the specifications as designed for a period of time or period of usage after delivery. These warranties do not represent a separate performance obligation.

10

There were no changes in amounts previously reported in the Company’s consolidated financial statements due to the adoption of ASC 606.

The following table summarizes disaggregated net sales by geographic region and reportable segment for the three and nine months ended August 31, 2019:

	United States		Asia		Europe		Total
Three months ended August 31, 2019	(Dollars in millions)
Specialty Solutions	$	88.7	$	8.4	$	40.6	$	137.7
Performance Materials	33.1		10.9		10.7		54.7
Total net sales	$	121.8	$	19.3	$	51.3	$	192.4
Nine months ended August 31, 2019
Specialty Solutions	$	219.8	$	39.2	$	133.7	$	392.7
Performance Materials	110.4		42.4		21.5		174.3
Total net sales	$	330.2	$	81.6	$	155.2	$	567.0

Note C – Financial Instruments and Fair Value Measurements

Financial Risk Management Objectives and Policies

The Company is exposed primarily to credit, interest rate, and foreign currency rate risks, which arise in the normal course of business.

Credit Risk

Credit risk is the potential financial loss resulting from the failure of a customer or counterparty to settle its financial and contractual obligations with the Company as and when they fall due. The primary credit risk for the Company is its accounts receivable, which are generally unsecured. The Company has established credit limits for customers and monitors their balances to mitigate its risk of loss. Concentrations of credit risk with respect to accounts receivable are generally limited due to the wide variety of customers and markets using the Company's products. There was no single customer that represented more than 10% of the Company’s consolidated net sales during the three and nine month periods ending August 31, 2019 and 2018. There was no single customer who represented more than 10% of the Company’s net trade receivables at August 31, 2019 or November 30, 2018.

Interest Rate Risk

The Company’s exposure to the risk of changes in market interest rates relates primarily to the Company’s Term Loan B, Senior Secured Revolving Credit Facility, and various foreign subsidiary borrowings, all of which bear interest at variable rates, approximating market interest rates.

Foreign Currency Rate Risk

The Company incurs foreign currency rate risk on sales and purchases denominated in other than the functional currency. The currencies giving rise to this risk are primarily the Euro, Great Britain Pound Sterling, Renminbi, and Thai Baht.

Foreign currency exchange contracts are used by the Company to manage risks from the change in market exchange rates on cash payments by the Company's foreign subsidiaries and U.S. Dollar cash holdings in foreign locations. These forward contracts are used on a continuing basis for periods of approximately 30 days, consistent with the underlying hedged transactions. Hedging intends to offset the impact of foreign exchange rate movements on the Company’s operating results. The counterparties to these instruments are investment-grade financial institutions and the Company does not anticipate any non-performance. The Company maintains control over the size of positions entered into with any one counterparty and regularly monitors the credit rating of these institutions. Such instruments are not purchased or sold for trading purposes. These contracts are not designated as hedging instruments and changes in fair value of these instruments are recognized in earnings immediately. Foreign currency transaction gains and losses, including the impact of foreign currency contracts, that were recorded in the Consolidated Statements of Operations, as a component of other income (loss), was a loss of $0.1 million and a gain of $0.2 million for the nine-month periods ending August 31, 2019 and 2018, respectively.

11

Derivative Instruments

The Company recognizes the fair value of qualifying derivative instruments as either an asset or a liability within its Consolidated Balance Sheets. For derivative instruments not designated as hedges, the change in fair value of the derivative is recognized in earnings each reporting period. The Company defines fair value as the price that would be received to transfer an asset or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company uses a hierarchy of valuation inputs to measure fair value.

The hierarchy prioritizes the inputs into three broad levels:

Level 1 inputs—Quoted market prices in active markets for identical assets or liabilities.

Level 2 inputs—Observable market based inputs or unobservable inputs that are corroborated by market data.

Level 3 inputs—Unobservable inputs that are not corroborated by market data.

Fair Value Measurements

The Company uses the market approach and the income approach to value assets and liabilities as appropriate. The following financial assets and liabilities are measured and presented at fair value on a recurring basis as of August 31, 2019 and November 30, 2018:

	Notional Amount		Fair Value		Level 1		Level 2		Level 3
	(Dollars in millions)
Fair value measurements - August 31, 2019:
Financial liabilities
Foreign currency exchange contracts	$	17.3	$	.1	$	—	$	.1	$	—
Contingent consideration (1)	—		—		—		—		—
Total liabilities	$	17.3	$	.1	$	—	$	.1	$	—
Fair value measurements - November 30, 2018:
Financial assets
Foreign currency exchange contracts	$	16.5	$	.1	$	—	$	.1	$	—
Total assets	$	16.5	$	.1	$	—	$	.1	$	—
Financial liabilities
Contingent consideration (1)	$	—	$	.6	$	—	$	—	$	.6
Total liabilities	$	—	$	.6	$	—	$	—	$	.6

⁽¹⁾ Contingent consideration obligations arise from business or product line acquisitions. The fair values are based on a probability weighted discounted cash flow analysis reflecting an estimated achievement of specified performance measures of the acquired product lines. Contingent consideration is classified in the consolidated balance sheets as other current liabilities or other non-current liabilities based on contractual payment dates.

The changes in Level 3 assets and liabilities measured at fair value on a recurring basis during the first nine months of 2019 are summarized as follows:

	Contingent Consideration
	(Dollars in millions)
Balance at November 30, 2018	$	.6
Adjustments	(.6		)
Balance at August 31, 2019	$	—

There were no transfers into or out of Level 3 during the first nine months of 2019 or 2018. During the second quarter of fiscal 2019, the Company removed the contingent consideration liability based on its expected value. Changes in expected value are recognized in other income within the consolidated statements of operations.

The fair value of the Company’s Term Loan B at August 31, 2019 approximated $299.1 million, which is slightly less than its book value of $299.5 million as a result of prevailing market rates on the Company’s debt. The fair value of the Term

12

Loan B is based on market price information and is measured using the last available trade of the instrument on a secondary market in each respective period and therefore is considered a Level 2 measurement. The fair value is not indicative of the amount that the Company would have to pay to redeem these instruments since they are infrequently traded and are not callable at this value. The carrying value of the Senior Secured Revolving Credit Facility approximates fair value. The fair value of the Company's capital lease obligation approximates its carrying amount based on estimated borrowing rates to discount the future cash flows to their present value.

Note D - Restructuring and Severance

The following table is a summary of restructuring and severance charges for the three and nine months ended August 31, 2019 and 2018:

	Three Months Ended August 31,				Nine Months Ended August 31,
	2019		2018		2019		2018
	(Dollars in millions)
Severance Expense:
Specialty Solutions	$	.3	$	—	$	.3	$	.7
Performance Materials	.5		.4		2.2		.4
Corporate	—		—		.2		.7
Total Severance Costs	.8		.4		2.7		1.8
Facility Closure Costs:
Performance Materials	—		—		2.2		—
Total Restructuring and Severance Costs	$	.8	$	.4	$	4.9	$	1.8

Costs for restructuring plans are recognized as a component of restructuring and severance expense within the consolidated statements of operations. The Company initiated the following restructuring plans:

2018 Restructuring Plan

During the third quarter of fiscal 2018, the Company announced its plan to close its styrene butadiene manufacturing facility in Green Bay, Wisconsin, moving production to its Mogadore, Ohio facility. The Company recorded $4.2 million of restructuring and severance expenses in fiscal 2019 related to this plan. Total expense incurred to date for this plan is $6.0 million, all of which has been paid as of August 31, 2019. The Company sold the Green Bay, Wisconsin facility in May 2019 for $4.9 million, recognizing a gain of $4.4 million within the consolidated statement of operations. This gain is included in the Performance Materials segment operating results. This plan is complete.

2017 Restructuring Plan

The Company recorded $0.7 million of restructuring and severance expenses in the first nine months of 2019 related to the One OMNOVA initiative announced during the first quarter of 2017. This initiative was focused on improving functional excellence in marketing, sales, operations, supply chain and technology, as well as various corporate functions. The plan was designed to reduce complexity and drive consistency across the global enterprise through a standardized, integrated business system. Total expense incurred for this initiative was $5.9 million, all of which has been paid as of August 31, 2019. This plan is substantially complete.

The following table summarizes the Company's liabilities related to restructuring and severance activities:

	November 30, 2018		2019				August 31, 2019
			Provision		Payments
	(Dollars in millions)
Total	$	1.1	$	4.9	$	6.0	$	—

The Company may incur future costs related to its restructuring activities, as processes are continually evaluated to enhance the efficiency and cost effectiveness of its operations, and to ensure competitiveness across its businesses and across

13

geographic areas. Future costs could include costs related to closed facilities and restructuring plan implementation costs and these will be recognized as incurred.

Note E – Income Taxes

On December 22, 2017, U.S. federal tax legislation, commonly referred to as the Tax Cuts and Job Act (the “Tax Act”) was signed into law which, among other changes: reduced the U.S. corporate income tax rate effective January 1, 2018; imposed a one-time transition tax on foreign earnings; and beginning in fiscal 2019, creates a new minimum tax on certain foreign-sourced earnings known as global intangible low-tax income ("GILTI"). The Company will account for GILTI in the year the tax is incurred as a period cost. The Company completed the analysis of the impact of the transition tax in accordance with SAB 118 and the amount of $27.7 million is no longer considered provisional. The Company finalized the position to utilize existing net operating loss carryforwards ("NOLC's") to offset the income inclusion, and therefore will have no cash taxes or tax expense related to the transition tax.

The Company recorded income tax expense of $0.6 million and $2.3 million for the three months ended August 31, 2019 and 2018, respectively and income tax expense of $1.4 million and income tax benefit of $0.3 million for the nine months ended August 31, 2019 and 2018, respectively. The Company’s effective tax rate for the third quarters of both 2019 and 2018 were different than the U.S. federal statutory tax rate primarily due to losses in jurisdictions in which no tax benefit was recognized. The Company's effective tax rate for the first nine months of 2019 was different than the U.S. federal statutory tax rate primarily due to losses in jurisdictions in which no tax benefit was recognized. The Company’s effective tax rate for the first nine months of 2018 was different than its U.S. federal statutory tax rate primarily due to discrete items related to the Tax Act. These items included a $4.1 million income tax benefit related to the re-measurement of the U.S. deferred taxes as the U.S. federal tax rate was reduced from 35.0% to 21.0% and a $0.9 million income tax benefit associated with the reversal of the valuation allowance against the existing AMT credit carryforward as it is refundable under the Tax Act. In addition, during the first quarter of 2018, the Company recognized a $0.8 million income tax benefit related to the impact of a French tax rate change on the Company's deferred tax liabilities. The French tax rate was reduced to 25.0% beginning in 2022 and the Company's deferred tax liabilities were reduced to appropriately reflect this legislation as a current period tax benefit. These discrete tax benefits were partially offset by losses in jurisdictions in which no tax benefit was recognized.

As of August 31, 2019, the Company has $75.3 million of U.S. federal NOLC's, $8.1 million of U.S. federal capital loss carryforwards, $0.1 million of foreign tax credit carryforwards, $0.3 million of AMT credit carryforwards, and $78.9 million of state NOLC's. The $75.3 million of U.S. NOLC's reflects the net impact of the $11.7 million NOL generation for the year ended November 30, 2018 and the $27.7 million utilization for transition tax as part of U.S. tax reform. Due to the NOLC's, cash tax payments in the U.S. are expected to be minimal for the foreseeable future. The majority of the federal, state, and local NOLC's will expire in tax years 2024 through 2034 while the foreign tax credit carryforwards will expire in the tax years 2020 through 2022, and the capital loss carryforwards will expire beginning in tax year 2022. The Company has a valuation allowance against the U.S. federal and state NOLC's and the U.S. federal capital loss carryforward. As of August 31, 2019, the Company had approximately $51.7 million of foreign NOLC's of which $31.8 million have an indefinite carryforward period. The Company has recognized a valuation allowance against the $31.8 million foreign NOLC's which have an indefinite carryforward period as the Company does not anticipate utilizing these carryforwards.

The Company operates in numerous taxing jurisdictions and is subject to regular examinations by various tax authorities. With limited exceptions, the Company is no longer open to audits by U.S. and foreign jurisdictions for years prior to 2014.

Note F – Earnings Per Share

The following table summarizes the computation of earnings per common share and earnings per common share, assuming dilution:

14

	Three Months Ended August 31,					Nine Months Ended August 31,
	2019		2018			2019		2018
	(Dollars and shares in millions, except per share data)
Numerator:
Net income (loss)	$	.3	$	(1.9	)	$	1.3	$	13.7
Denominator:
Denominator for basic earnings (loss) per share - weighted average shares outstanding	44.8		44.5			44.8		44.6
Effect of dilutive securities	.9		—			.8		.2
Denominator for dilutive earnings (loss) per share - adjusted weighted average shares and assumed conversions	45.7		44.5			45.6		44.8
Net income (loss) per share - Basic and Diluted	$	.01	$	(.04	)	$	.03	$	.31

There are no anti-dilutive securities for the periods presented.

Note G – Accumulated Other Comprehensive Income (Loss)

The following tables reflect the changes in the components of accumulated other comprehensive income (loss), net of tax, for the three and nine months ended August 31, 2019 and 2018:

	Foreign Currency Items			Defined Benefit Plans			Accumulated Other Comprehensive (Income) Loss
Three months ended August 31, 2019 and 2018	(Dollars in millions)
Balance May 31, 2019	$	(34.3	)	$	(88.3	)	$	(122.6	)
Other comprehensive income (loss) before reclassifications	(2.5		)	—			(2.5		)
Amounts reclassified to earnings (a)	—			.6			.6
Balance August 31, 2019	$	(36.8	)	$	(87.7	)	$	(124.5	)
Balance May 31, 2018	$	(22.5	)	$	(100.0	)	$	(122.5	)
Other comprehensive income (loss) before reclassifications	(5.5		)	—			(5.5		)
Amounts reclassified to earnings (a)	—			1.2			1.2
Balance August 31, 2018	$	(28.0	)	$	(98.8	)	$	(126.8	)
Nine months ended August 31, 2019 and 2018
Balance November 30, 2018	$	(32.6	)	$	(89.8	)	$	(122.4	)
Other comprehensive income (loss) before reclassifications	(4.2		)	—			(4.2		)
Amounts reclassified to earnings (a)	—			2.1			2.1
Balance August 31, 2019	$	(36.8	)	$	(87.7	)	$	(124.5	)
Balance November 30, 2017	$	(23.1	)	$	(102.2	)	$	(125.3	)
Other comprehensive income (loss) before reclassifications	(4.9		)	—			(4.9		)
Amounts reclassified to earnings (a)	—			3.4			3.4
Balance August 31, 2018	$	(28.0	)	$	(98.8	)	$	(126.8	)

^(a) Amounts reclassified from accumulated other comprehensive income (loss) related to defined benefit plans were included in net periodic benefit expense.

Note H – Shareholders' Equity

15

The following tables reflect the changes in shareholders' equity for the nine months ended August 31, 2019 and 2018:

	Number of Common Shares Outstanding		Common Stock		Additional Contributed Capital			Retained Deficit			Treasury Stock			Accumulated Other Comprehensive Income (Loss)			Total Shareholders' Equity
	(Dollars and shares in millions)
Balance November 30, 2018	44.9		$	4.8	$	345.9		$	(145.4	)	$	(25.3	)	$	(122.4	)	$	57.6
Net income (loss)								(4.6		)							(4.6		)
Foreign currency translations														3.8			3.8
Adjustment for accounting change								(.5		)							(.5		)
Post-retirement benefit plans														.6			.6
Share-based compensation					.3												.3
Other	(.1	)									(.2		)				(.2		)
Balance February 28, 2019	44.8		$	4.8	$	346.2		$	(150.5	)	$	(25.5	)	$	(118.0	)	$	57.0
Net income (loss)								5.6									5.6
Foreign currency translations														(5.5		)	(5.5		)
Post-retirement benefit plans														.9			.9
Share-based compensation					1.5												1.5
Other					.3						(.1		)				.2
Balance May 31, 2019	44.8		$	4.8	$	348.0		$	(144.9	)	$	(25.6	)	$	(122.6	)	$	59.7
Net income (loss)								.3									.3
Foreign currency translations														(2.5		)	(2.5		)
Post-retirement benefit plans														.6			.6
Shared-based compensation					1.0												1.0
Other	.1				(.5		)				.1						(.4		)
Balance August 31, 2019	44.9		4.8		348.5			(144.6		)	(25.5		)	(124.5		)	58.7
Balance November 30, 2017	44.8		$	4.8	$	343.4		$	(159.2	)	$	(25.5	)	$	(125.3	)	$	38.2
Net income (loss)								7.3									7.3
Foreign currency translations														6.3			6.3
Adjustment for accounting change								(6.9		)							(6.9		)
Post-retirement benefit plans														1.1			1.1
Share-based compensation					.5												.5
Other					.5						(.5		)				—
Balance February 28, 2018	44.8		$	4.8	$	344.4		$	(158.8	)	$	(26.0	)	$	(117.9	)	$	46.5
Net income (loss)								8.4									8.4
Foreign currency translations														(5.7		)	(5.7		)
Post-retirement benefit plans														1.1			1.1
Share-based compensation					.4												.4
Other	.1				.3												.3
Balance May 31, 2018	44.9		$	4.8	$	345.1		$	(150.4	)	$	(26.0	)	$	(122.5	)	$	51.0
Net income (loss)								(1.9		)							(1.9		)
Foreign currency translations														(5.5		)	(5.5		)
Post-retirement benefit plans														1.2			1.2
Share-based compensation					1.2												1.2
Other					(.6		)										(.6		)
Balance August 31, 2018	44.9		4.8		345.7			(152.3		)	(26.0		)	(126.8		)	45.4

Note I – Inventories

Inventories are stated at lower of cost or net realizable value. U.S. inventories are valued using the last-in, first-out (“LIFO”) method and represented approximately $48.2 million, or 47.9%, and $47.6 million, or 45.9%, of gross inventories at August 31, 2019 and November 30, 2018, respectively. The remaining portion of inventories, which are located outside of the U.S., are valued using the first-in, first-out (“FIFO”) or an average cost method. Interim LIFO calculations are based on management’s estimates of expected year-end inventory levels and costs and are subject to final year-end LIFO inventory valuations. Inventory costs include material, labor, and overhead. Inventories, net, consisted of the following:

16

	August 31, 2019			November 30, 2018
	(Dollars in millions)
Raw materials and supplies	$	35.3		$	35.0
Work-in-process	5.2			5.3
Finished goods	60.1			63.5
Inventories, gross	100.6			103.8
LIFO reserve	(15.4		)	(18.1		)
Obsolescence reserve	(6.6		)	(6.9		)
Inventories, net	$	78.6		$	78.8

Note J – Debt and Credit Lines

Debt obligations due within the next twelve months consist of the following:

	August 31, 2019		November 30, 2018
	(Dollars in millions)
$350 million Term Loan B, due 2023, current portion (interest at 5.48% and 5.55%, respectively)	$	3.5	$	3.5
Capital lease obligations, current portion	.8		.7
Total	$	4.3	$	4.2

The Company’s long-term debt consists of the following:

	August 31, 2019			November 30, 2018
	(Dollars in millions)
$350 million Term Loan B, due 2023 (interest at 5.48% and 5.55%, respectively)	$	299.5		$	302.1
Senior Secured Revolving Credit, due 2021 (interest at 3.69% and 3.88%, respectively)	18.2			12.0
Capital lease obligations	15.1			15.6
Gross debt	332.8			329.7
Less: current portion	(4.3		)	(4.2		)
Unamortized original issue discount	(1.7		)	(2.1		)
Debt issuance costs	(4.0		)	(4.7		)
Total long-term debt, net of current portion	$	322.8		$	318.7

The weighted-average interest rate on the Company’s short-term debt was 5.61% and 5.27% during the third quarters of 2019 and 2018, respectively.

Term Loan B        

The Company's $350.0 million Term Loan B ("Term Loan B") matures on August 26, 2023 and is primarily secured by all real property, plant, and equipment of the Company's U.S. facilities and fully and unconditionally and jointly and severally guaranteed by the material U.S. subsidiaries of the Company. The Term Loan B contains affirmative and negative covenants, including a requirement to maintain a net debt leverage ratio of 5.0 to 1.0, limitations on additional debt, certain investments, and acquisitions outside of the Company’s line of business. The Company is in compliance with its Term Loan B covenants as of August 31, 2019.

The Company's Term Loan B has an interest rate of LIBOR plus 3.25%. The Term Loan B agreement permits the Company to request additional term loans or incremental equivalent debt borrowings (the “Additional Term Loans”) in a maximum aggregate amount equal to the greater of (a) $120.0 million and (b) an aggregate principal amount such that, on a pro forma basis (giving effect to any Additional Term Loans), the Company’s senior secured net debt leverage ratio will not exceed 4.0 to 1.0.

Senior Secured Revolving Credit Facility

The Company has a Senior Secured Revolving Credit Facility (the "Facility") which matures on August 26, 2021. The Facility is secured by U.S. accounts receivable, inventory, and intangible assets. The Facility contains affirmative and negative

17

covenants, similar to the Term Loan B, including limitations on additional debt, certain investments and acquisitions outside of the Company’s line of business. If the average excess availability of the Facility falls below $25.0 million during any fiscal quarter, the Company must then maintain a fixed charge coverage ratio greater than 1.1 to 1.0 as defined in the agreement. The Company was in compliance with this requirement at August 31, 2019. At August 31, 2019 there was a balance of $18.2 million borrowed under the Facility and the amount available for borrowing under the Facility was $46.5 million.

Eurodollar Revolving Loan

The Company amended its Eurodollar Revolving Loan ("Revolver") effective June 14, 2019. Total borrowing capacity of the Revolver was increased from €16.0 million to €25.0 million. In addition, the Company has the ability to increase borrowing capacity through a €9.0 million expansion feature as needed. The Revolver is secured by European accounts receivable. All other material terms are unchanged and similar to the Company's U.S. Facility, including the maturity date of August 26, 2021. The Revolver provides additional liquidity and working capital flexibility in Europe. At August 31, 2019 there were no amounts borrowed under the Revolver and the amount available for borrowing under the Revolver was €19.3 million.

Other Debt

The Company has borrowing facilities at certain of its foreign subsidiaries, which consist of overdraft lines, working capital credit lines, and facilities for the issuance of letters of credit and short-term borrowing needs. Total borrowing capacity for these facilities was $11.9 million and $7.0 million as of August 31, 2019 and November 30, 2018, respectively. There were no amounts borrowed under these facilities at August 31, 2019 and November 30, 2018.

Capital Lease Obligations

At August 31, 2019, the Company had net assets under capital leases totaling $14.0 million, which are included in property, plant, and equipment in the accompanying Consolidated Balance Sheets.

The following is a schedule by year of future minimum lease payments under the Company's capital leases together with the present value of the net future minimum lease payments as of August 31, 2019:

Year Ending November 30:	(Dollars in millions)
2019	$	.4
2020	1.5
2021	1.5
2022	1.4
2023	1.4
Thereafter	15.2
Total minimum lease payments	21.4
Less: Amount representing estimated executory costs	(.5		)
Net minimum lease payments	20.9
Less: Amount representing interest	(5.8		)
Present value of minimum lease payments	$	15.1

Debt Issuance Costs and Original Issue Discounts

Debt issuance costs and original issue discounts incurred in connection with the issuance of the Company's debt are being amortized over the respective terms of the underlying debt, including any amendments. Total amortization expense of debt issuance costs and original issue discounts is included as a component of interest expense and was $0.4 million for both the three months ended August 31, 2019 and 2018, and $1.1 million and $1.0 million for the nine months ended August 31, 2019 and 2018, respectively.

During the quarter ended February 28, 2018, the Company made a $40.0 million prepayment and determined that this constituted a partial extinguishment of debt and as such, wrote-off $0.8 million of debt issuance costs and original issue discounts.

Note K – Share-Based Employee Compensation

The Company provides compensation benefits to employees under the OMNOVA Solutions 2017 Equity Incentive Plan (the “Plan”), which was approved by shareholders on March 22, 2017. The Plan permits the Company to grant to officers, key employees and non-employee directors of the Company incentives directly linked to the price of OMNOVA Solutions’ common shares. The Plan authorizes the issuance of Company common shares in the aggregate for (a) awards of options rights to purchase Company common shares, (b) performance shares and performance units, (c) restricted shares, (d) restricted share units, or (e) appreciation rights. Shares granted under the Plan may be either newly issued shares or treasury shares or both. As

18

of August 31, 2019, approximately 1.9 million Company common shares remained available for grants under the Plan. All options granted under the Plan are granted at exercise prices equal to the market value of the Company’s common shares on the date of grant. Additionally, the Plan provides that the term of any option granted under the Plan may not exceed 10 years. Prior to March 22, 2017, the Company granted equity compensation under the OMNOVA Solutions Third Amended and Restated 1999 Equity and Performance Incentive Plan, which had substantially similar features.

The Company grants Performance Share Units ("PSU's") to its executive officers. The PSU's provide recipients the right to receive the Company's common shares if specified performance goals, including a performance goal relative to peers, are met over a three fiscal year measurement period. Each grantee receives a target grant of PSU's, but may earn between 0% and 200% (or in the case of the Company's Chief Executive Officer, between 0% and 160% for awards granted prior to 2019, and between 0% and 143% for grants made in 2019) of the target grant depending on the Company's performance against the stated performance goals.

Share-based compensation is measured at the grant date, based on the calculated fair value of the award, and is recognized as an expense over the requisite service period (generally the vesting period). The fair value of Restricted Share Awards ("RSA's"), Restricted Share Units ("RSU's"), and PSU's are determined based on the closing market price of the Company’s ordinary shares at the date of grant. RSU's entitle the holder to receive one ordinary share for each RSU at vesting, generally over a three year period from the date of grant. Estimates of fair value are not intended to predict actual future events or the value ultimately realized by employees who receive equity awards, and subsequent events are not indicative of the reasonableness of the original estimates of fair value made by the Company.

Compensation expense for all share-based payments included in general and administrative expense was $2.8 million and $2.1 million for the first nine months of 2019 and 2018, respectively.

As of August 31, 2019, there was $4.6 million of unrecognized compensation cost related to non-vested share-based compensation arrangements.

A summary of the RSA, RSU, and PSU activity for 2019 follows:

	Share Awards & Units		Weighted-Average Grant Date Fair Value per Share
Nonvested at December 1, 2018	1,350,313		$	8.11
Granted	623,449		$	7.18
Vested	(226,646	)	$	6.50
Canceled and Forfeited	(30,587	)	$	7.92
Nonvested at August 31, 2019	1,716,529		$	7.99

The Company also provides eligible employees the opportunity to purchase Company common shares through payroll deductions under the OMNOVA Solutions Employee Share Purchase Plan (the "ESPP"). The purchase price for common shares purchased from the Company will be 85% of the closing price of the common shares on the New York Stock Exchange on the investment date. Participants may contribute funds to the ESPP, not to exceed twenty-five thousand dollars in any calendar year. If a participant terminates his or her employment with the Company or its subsidiaries, the participant's participation will immediately terminate, uncommitted funds will be applied to the purchase of common shares, and the participant's account will be converted to a regular brokerage account. As of August 31, 2019, there were approximately 47,000 shares purchased by eligible participants through the ESPP.

Note L – Employee Benefit Plans

The Company maintains a number of defined benefit and defined contribution plans to provide retirement benefits for employees. These plans are maintained and contributions are made in accordance with the Employee Retirement Income Security Act of 1974 (“ERISA”), local statutory law, or as determined by the Board of Directors. The plans generally provide benefits based upon years of service and compensation. Pension plans are funded except for a U.S. non-qualified pension plan for certain key employees and certain foreign plans. Future service benefits are frozen for all participants under the Company's U.S. defined benefit plan. All benefits earned by affected employees through the dates on which such benefits were frozen have become fully vested with the affected employees eligible to receive benefits upon retirement, as described in the Plan document.

Net periodic benefit cost (income) consisted of the following for the three and nine month periods ending August 31, 2019 and 2018:

19

	Pension Plans						Health Care Plans
	(Dollars in millions)
Three months ended August 31, 2019 and 2018	2019			2018			2019			2018
Service costs	$	.8		$	.6		$	—		$	—
Interest costs	2.5			2.2			.1			.1
Expected return on plan assets	(4.0		)	(3.9		)	—			—
Amortization of net actuarial (gain) loss	1.1			1.4			(.4		)	(.2		)
Net periodic cost (benefit)	$	.4		$	.3		$	(.3	)	$	(.1	)
	Pension Plans						Health Care Plans
	(Dollars in millions)
Nine months ended August 31, 2019 and 2018	2019			2018			2019			2018
Service costs	$	2.2		$	1.9		$	—		$	—
Interest costs	7.6			6.7			.2			.2
Expected return on plan assets	(11.8		)	(11.7		)	—			—
Amortization of net actuarial (gain) loss	3.4			4.1			(1.0		)	(.7		)
Net periodic cost (benefit)	$	1.4		$	1.0		$	(.8	)	$	(.5	)

Service cost is recorded in SG&A, while other components of net periodic pension costs are recorded in Other (Income) Expense. Service cost represents plan administration expenses. The Company expects to contribute approximately $6.4 million to its pension plans during fiscal 2019. There were $3.0 million contributions made during the first nine months of 2019.

The Company also sponsors a defined contribution 401(k) plan. Participation in this plan is voluntary and is available to substantially all U.S. salaried employees and to certain groups of U.S. hourly employees. Company contributions to this plan are based on either a percentage of employee contributions or on a specified amount per hour based on the provisions of the applicable collective bargaining agreement. Company contributions are made in cash. Expense for this plan was $0.6 million and $0.7 million for the third quarter of 2019 and 2018 respectively, and $2.0 million and $2.1 million for the first nine months of 2019 and 2018, respectively.

Note M – Contingencies

From time to time, the Company is subject to various claims, proceedings, and lawsuits related to products, services, contracts, employment, environmental, safety, intellectual property, and other matters. The ultimate resolution of such claims, proceedings, and lawsuits is inherently unpredictable and, as a result, the Company’s estimates of liability, if any, are subject to change. Actual results may materially differ from the Company’s estimates and an unfavorable resolution of any matter could have a material adverse effect on the financial condition, results of operations, and/or cash flows of the Company. However, subject to the above and taking into account such amounts, if any, as are accrued from time to time on the Company’s balance sheet, the Company does not believe, based on the information currently available to it, that the ultimate resolution of these matters will have a material effect on the consolidated financial condition, results of operations or cash flows of the Company.

Note N – Business Segment Information

The Company's two reporting segments are Specialty Solutions and Performance Materials. These two reporting segments were determined based on products and services provided as defined under ASC 280, Segment Reporting. Accounting policies of the segments are the same as the Company’s accounting policies. The Company’s reporting segments are strategic business units that offer different products and services. They are managed separately based on certain differences in their operations, technology, and marketing strategies.

Segment operating profit represents net sales less applicable costs, expenses and provisions for restructuring and severance costs, asset write-offs and acquisition and integration related expenses relating to operations. However, Management excludes restructuring and severance costs, asset write-offs, and acquisition and integration related costs when evaluating the results and allocating resources to the segments.

Segment operating profit excludes certain unallocated corporate headquarters expenses. Corporate headquarters expense includes the cost of providing and maintaining the corporate headquarters functions, including salaries, rent, travel and

20

entertainment expenses, depreciation, utility costs, outside services, amortization of deferred financing costs and Merger related costs.

The following table summarizes operations by segment and a reconciliation of segment sales to consolidated sales and segment operating profit to income (loss) before income taxes:

	Three Months Ended August 31,						Nine Months Ended August 31,
	2019			2018			2019			2018
	(Dollars in millions)
Net Sales:
Specialty Solutions	$	137.7		$	122.1		$	392.7		$	360.0
Performance Materials	54.7			71.5			174.3			218.5
Total Net Sales	$	192.4		$	193.6		$	567.0		$	578.5
Segment Operating Profit:
Specialty Solutions	$	20.0		$	19.5		$	49.3		$	55.0
Performance Materials	(4.4		)	(7.9		)	(6.4		)	(5.6		)
Total segment operating profit	15.6			11.6			42.9			49.4
Interest expense	(5.1		)	(4.7		)	(15.3		)	(14.4		)
Corporate expenses	(9.6		)	(6.5		)	(24.9		)	(21.6		)
Income (Loss) Before Income Taxes	$	.9		$	.4		$	2.7		$	13.4

Note O - Asset Impairment

During the third quarter of 2019, the Company recognized an impairment charge of $0.9 million within the Performance Materials segment. The impairment charge was based on estimated fair value utilizing the relief from royalty method of the Income Approach. Future reductions in forecasted revenues or royalty rates could result in additional trademark impairments.

During the third quarter of 2018, the Company approved a plan close the Green Bay, Wisconsin plant shifting styrene butadiene manufacturing to its production plant in Mogadore, Ohio. As a result, the Company determined that certain plant and equipment were impaired and recognized an impairment charge of $9.2 million, primarily in the Performance Materials segment, to write-down the asset group to fair value based on the market approach analysis.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

OMNOVA Solutions Inc. became an independent, publicly-traded company on October 1, 1999, when it was spun off by GenCorp Inc., its former parent company. OMNOVA Solutions is incorporated under the laws of the State of Ohio, and its headquarters is located at 25435 Harvard Road, Beachwood, Ohio 44122-6201.

OMNOVA Solutions is a global innovator of performance enhancing chemistries and surfaces for a variety of commercial, industrial and residential end uses. Our products provide a variety of important functional and aesthetic benefits to hundreds of products that people use daily. We hold leading positions in key market categories, which have been built through innovative products, customized product solutions, strong technical expertise, well-established distribution channels, recognized brands, and long-standing customer relationships. We have strategically located manufacturing, technical and other facilities globally to service our broad customer base.

OMNOVA operates two business segments: Specialty Solutions and Performance Materials. Financial information relating to the Company’s business segments is included in Note N to the Consolidated Financial Statements of this report.

Specialty Solutions – The Specialty Solutions segment consists of three business lines: Specialty Coatings & Ingredients, Oil & Gas, and Laminates & Films. The Specialty Solutions segment develops, designs, produces, and markets a broad line of specialty products for use in coatings, adhesives, sealants, elastomers, laminates, films, nonwovens, and oil & gas products. These products are used in numerous applications, including architectural and industrial coatings; nonwovens used in hygiene products, filtration and construction; drilling additives for oil and gas drilling, cementing and fracking;

21

elastomeric modification of plastic casings and hoses used in household and industrial products and automobiles; tapes and adhesives; sports surfaces; textile finishes; commercial building refurbishment; new construction; residential cabinets; flooring; ceiling tile; furnishings; manufactured housing; health care patient and common area furniture; and a variety of industrial films applications. The segment's products improve the performance of customers’ products, including stain, rust and aging resistance; surface modification; gloss; softness or hardness; dimensional stability; high heat and pressure tolerance; and binding and barrier (e.g. moisture, oil) properties.

Specialty Coatings & Ingredients. OMNOVA Specialty Coatings & Ingredients is a leading global supplier of polymers, waterborne and solvent borne dispersions, elastomers, and other specialty chemicals for a variety of product categories. Applications for our specialty polymers and chemicals include: specialty coatings; nonwovens (such as disposable hygiene products, engine filters, roofing mat, scrub pads); construction; adhesives; tape; floor care; textiles; graphic arts; home & personal care; and various other specialty applications. Our focus is on developing unique products for custom applications that address specific customer needs, including enhanced functionality, improved durability, high temperature, chemical and UV resistance, corrosion resistance, improved environmental performance, and improved processibility.

Oil & Gas. OMNOVA's Oil & Gas is a leading supplier of specialty wellbore chemicals used in demanding applications all over the world. We offer a wide range of solutions including fluid loss control and sealing, emulsifiers, lubricants, and rheological modifiers for drilling fluids. The business also offers flow control and properties enhancement in cementing operations, gel additives for hydraulic fracturing fluids, and strengthening agents. We design unique polymers that meet conventional and unconventional drilling and completion requirements.

Laminates & Films. OMNOVA's Laminates & Films business line is a leading supplier of vinyl, paper, and specialty laminates, and performance films. Our laminates are used as alternatives to wood, paint, stone, stainless steel, high pressure laminates, and thermally fused laminates in markets where durability, design, and cost are key requirements. We offer our customers a broad range of designs and textures, as well as proprietary coating technology that provides enhanced durability and scratch and stain resistance. Applications for our laminates include: kitchen and bath cabinets; manufactured housing and recreational vehicle interiors; flooring; commercial and residential furniture; retail display fixtures; home furnishings; consumer appliances; bath and spa surrounds; food service tables; wall protection; and architectural accents. Films applications include: luxury vinyl tile (LVT); awnings; tents; flooring; promotional graphics; medical products; movie screens; decking; ceiling tile; and shower pan liners. A key strength of our laminates business is our coating technology, including ultraviolet, melamine, urethane, and thermally cured coatings, which provide greater durability for high-wear applications. In addition, our laminates business has differentiated itself in the market as a single-source supplier through its harmony programTM of integrated vinyl and paper laminate designs for the furniture and cabinet industries by building a unique library of matched vinyl and paper laminate designs, with a variety of patterns and textures, and developing rapid make-to-order production capabilities. We also offer SURF(X)® 3D Laminates for multi-dimensional applications for the office and health care furniture and retail display fixture and food service markets. These laminates offer a cost effective alternative to high pressure laminates, thermally fused melamine and real wood veneers. They provide furniture makers with design flexibility in rounded surfaces, eliminating the need for unsightly and expensive edge-banding, and providing enhanced cleanability/disinfection and durability with increased chip and crack resistance.

Performance Materials – The Performance Materials segment serves mature markets including plastics, paper, carpet and coated fabrics with a broad range of polymers based primarily on styrene butadiene (SB), styrene butadiene acrylonitrile (SBA), styrene butadiene vinyl pyridine, high styrene pigments, polyvinyl acetate, acrylic, styrene acrylic, calcium stearate, glyoxal, and bio-based chemistries. Performance Materials' custom-formulated products are tailored latexes, resins, binders, antioxidants, hollow plastic pigment, coated fabrics, and rubber reinforcing which are used in tire cord, polymer stabilization, industrial rubbers, carpet, paper, and various other applications. Its products provide a variety of functional properties to enhance the Company’s customers’ products, including greater strength, adhesion, dimensional stability, ultraviolet resistance, improved processibility, and enhanced appearance.

Paper and Carpet. OMNOVA Solutions is an innovative supplier of custom-formulated SB and SBA latex and hollow plastic pigments for carpet, paper and paperboard coatings. Applications for our products include paper and paperboard coatings used in specialty papers, food cartons, household and other consumer and industrial packaging, magazines, catalogs, direct mail advertising, and brochures. Our products for the carpet industry secure carpet fibers to the carpet backing and adhere the primary backing to the secondary backing, while meeting the stringent manufacturing, environmental, odor, flammability, and flexible installation requirements of our customers. Our strong historical position in residential carpeting has been enhanced by new products to serve that market, as well as innovations in commercial carpet backing binders that provide moisture barrier and other properties, enabling the replacement of higher cost polyurethane binders.

Performance Additives. OMNOVA is also a leading global supplier of vinyl pyridine latex which is used in bonding fabric to rubber for tire and belting applications. In addition, the Company is a leading global supplier of antioxidants used in polymer stabilization and synthetic latex gloves.

22

Coated Fabrics. OMNOVA Solutions is a leading North American and Asian supplier of vinyl and urethane coated fabrics for transportation, marine, commercial, residential, and health care applications. Our durable coated fabrics are well-suited for demanding, high-use environments and offer a cost effective alternative to other surfacing materials, such as leather and textile fabrics. Applications for our coated fabrics include: transportation seating (automotive OEM, bus and other mass transit, marine, and motorcycle); automotive aftermarket applications; contract and health care furniture; residential applications; stadium and arena seating; and healthcare equipment. A key differentiator for our coated fabrics products is our PreFixx® protective coating, long recognized for delivering the industry's best-in-class performance.

The Company primarily sells its products directly to manufacturers, and has manufacturing facilities in the United States, France, Portugal, China, and Thailand. For additional information about the Company's business (other than the description of the Company's reporting segments), please refer to Item 1 Business of the Company’s 2018 Annual Report on Form 10-K.

The Company has historically experienced stronger sales and income in its second, third, and fourth quarters, comprised of the three-month periods ending May 31, August 31, and November 30. Performance in the first quarter (December through February) has historically been affected by generally lower levels of customer manufacturing, construction, and refurbishment activities during the holidays and cold weather months.

The Company’s chief operating decision maker ("CODM"), its CEO, evaluates performance and allocates resources by operating segment. Segment information has been prepared in accordance with authoritative guidance promulgated by the Financial Accounting Standards Board (“FASB”). The Company’s two operating segments were determined based on the products and services provided. Accounting policies of the segments are the same as those described in Note A of the Company’s Unaudited Interim Consolidated Financial Statements. For a reconciliation of the Company’s segment operating performance information, please refer to the Business Segment Information footnote of the Company’s Unaudited Interim Consolidated Financial Statements.

Raw Materials

A majority of the Company’s raw materials are derived from petrochemicals and chemical feedstocks, where prices can be cyclical and volatile. Styrene, a key raw material component, is generally available worldwide, and OMNOVA has supply contracts with several producers. OMNOVA believes there is adequate global capacity to serve demand. OMNOVA’s styrene purchases for 2018 and estimated purchases for 2019 and an estimated range of market prices are as follows:

	Pounds Purchased (in millions)	Market Price Range Per Pound
2019 (estimated)	84	$0.43 - $0.53
2018	102	$0.53 - $0.73

Butadiene, a key raw material component, is generally available worldwide. OMNOVA has supply contracts with several producers. At times, when the demand of butadiene exceeds supply, it is sold on an allocated basis. OMNOVA’s butadiene purchases for 2018 and estimated purchases for 2019 and an estimated range of market prices are as follows:

	Pounds Purchased (in millions)	Market Price Range Per Pound
2019 (estimated)	70	$0.36 - $0.54
2018	77	$0.36 - $0.79

The Company negotiates pricing with the majority of its customers based on the cost of the raw material components of the products being purchased and the value-added performance attributes of those products. The Company's pricing objective, which may or may not be met, is to recover raw material price increases for its non-indexed contracts within three months. OMNOVA also has sales price index contracts with customers that represents approximately 12% of its net sales.

Key Indicators

Key economic measures relevant to the Company include global economic growth rates, discretionary spending for durable goods, oil and gas consumption and drilling levels, U.S. commercial real estate occupancy rates, U.S. office furniture sales, manufactured housing shipments (including recreational vehicles), housing starts and sales of existing homes, and

23

forecasts of raw material pricing for certain petrochemical feed stocks. Key Original Equipment Manufacturer ("OEM") industries, which provide a general indication of demand drivers to the Company, include commercial and residential construction and refurbishment, automotive and tire production, furniture, flooring, and ABS manufacturing. These measures provide general information on trends relevant to the demand for the Company’s products, but the trend information does not necessarily directly correlate with demand levels in the markets which ultimately use the Company’s products in part because the Company's market share is relatively small in a number of specialty markets.

Key operating measures utilized by the business segments include: orders; sales and pricing; working capital days; inventory; productivity; plant utilization; new product vitality; cost of quality; order fill-rates, which provide key indicators of business trends; and safety and other internal metrics. These measures are reported on various cycles including daily, weekly and monthly, depending on the needs established by operating management.

Key financial measures utilized by Management to evaluate the results of its businesses and to understand the key variables impacting the current and future results of the Company include sales and pricing; gross profit; SG&A; adjusted operating profit (loss); adjusted net income (loss); consolidated earnings (loss) before interest, taxes, depreciation, and amortization (“EBITDA”) as set forth in the Net Leverage Ratio in the Company’s $350,000,000 Term Loan B agreement; Adjusted EBITDA, working capital; operating cash flows; capital expenditures; cash interest expense; adjusted earnings per share; and applicable ratios, such as inventory turnover; working capital turnover; return on sales and assets; and leverage ratios. These measures, as well as objectives established by the Company's Board of Directors, are reviewed at monthly, quarterly, and annual intervals and compared with historical periods.

Results of Operations for the Three months ended August 31, 2019 Compared to the Three months ended August 31, 2018

The Company's net sales in the third quarter of 2019 of $192.4 million were flat compared to $193.6 million in the third quarter of 2018. The acquisition of OMNOVA Portugal during the fourth quarter of 2018 accounted for $15.0 million of current quarter sales. The Specialty Solutions business segment revenue increased $15.6 million, or 12.8%, and the Performance Materials business revenue decreased by $16.8 million, or 23.5%.

Gross profit in the third quarter of 2019 was $46.3 million with a gross profit margin of 24.1%, compared to gross profit of $49.1 million and a gross profit margin of 25.4% in the third quarter of 2018. The decrease in gross profit dollars resulted primarily from unfavorable foreign currency exchange.

SG&A in the third quarter of 2019 was $26.6 million, flat compared to $26.3 million in the third quarter of 2018.

Interest expense in the third quarter of 2019 was $5.1 million, compared to $4.7 million in the third quarter of 2018. The increase of $0.4 million, or 8.5%, was primarily attributed to a higher average outstanding debt balance.

The Company recorded income tax expense of $0.6 million and $2.3 million for the three months ended August 31, 2019 and 2018, respectively. The Company’s effective tax rate for the third quarters of both 2019 and 2018 were different than the U.S. federal statutory tax rate primarily due to losses in jurisdictions in which no tax benefit was recognized.

Net income for the third quarter of 2019 was $0.3 million, or $0.01 per diluted share, compared to net loss of $1.9 million, or $0.04 per diluted share, during the same quarter in the prior year.

Segment Discussion

The following Segment Discussion presents information used by the Company in assessing the results of operations by business segment. The Company believes that this presentation is useful for providing the investor with an understanding of the Company’s business and operating performance because these measures are used by the CODM in evaluating performance and allocating resources.

The following table reconciles segment sales to consolidated net sales and segment operating profit to consolidated income (loss) before income taxes:

24

	Three Months Ended August 31,
	2019			2018
	(Dollars in millions)
Net Sales:
Specialty Solutions	$	137.7		$	122.1
Performance Materials	54.7			71.5
Consolidated Net Sales	$	192.4		$	193.6
Segment Operating Profit:
Specialty Solutions	$	20.0		$	19.5
Performance Materials	(4.4		)	(7.9		)
Total Segment Operating Profit	15.6			11.6
Interest expense	(5.1		)	(4.7		)
Corporate expense	(9.6		)	(6.5		)
Consolidated Income (Loss) Before Income Taxes	$	.9		$	.4

Specialty Solutions

Specialty Solutions' net sales increased $15.6 million, or 12.8%, to $137.7 million in the third quarter of 2019 from $122.1 million in the third quarter of 2018. The improvement was primarily driven by favorable volume of $13.9 million and price/mix of $2.9 million, partially offset by unfavorable foreign currency exchange of $1.1 million. Volumes were up in coatings, adhesives & sealants, and oil & gas. These volume increases were partially offset by declines in home & personal care, elastomeric modifiers, decorative laminates, and performance films when compared to the same quarter last year. Foreign currency exchange had an unfavorable impact across all markets.

Segment operating profit was $20.0 million for the third quarter of 2019 compared to $19.5 million for the third quarter of 2018. The increase of $0.5 million, or 2.6%, from the third quarter of 2018 was due to favorable volume and price/mix, primarily in oil & gas, which was partially offset by higher manufacturing costs. Segment operating profit includes items that Management excludes when evaluating the results of the Company's segments. Those items for the third quarter of 2019 included a $0.2 million favorable adjustment to acquisition and integration expenses and $0.3 million for restructuring and severance. Those items for the third quarter of 2018 were $0.2 million of asset impairment, facility and other closure costs.

Performance Materials

Performance Materials net sales decreased $16.8 million, or 23.5%, to $54.7 million during the third quarter of 2019, compared to $71.5 million during the third quarter of 2018. The decrease was primarily driven by unfavorable volume of $13.3 million, price/mix of $3.1 million, and unfavorable foreign currency exchange of $0.4 million compared to the same quarter last year. Volumes were down in paper, carpet, tire cord and antioxidants, which were partially offset by increases in coated fabrics and contract manufacturing, when compared to the same quarter last year.

Segment operating loss was $4.4 million for the third quarter of 2019 compared to an operating loss of $7.9 million in the third quarter of 2018. Segment operating loss includes items that Management excludes when evaluating the results of the Company's segments. Those items for the third quarter of 2019 primarily consisted of $0.5 million of restructuring and severance and $1.6 million of asset impairment, facility and other closure costs. Those items for 2018 included $0.4 million of restructuring and severance and $9.6 million of asset impairment, facility and other closure costs.

Corporate

Corporate expenses were $9.6 million in the third quarter of 2019, compared to $6.5 million in the third quarter of 2018. SG&A expenses were higher during the current year primarily due to Merger related costs.

Results of Operations for the Nine Months Ended August 31, 2019 Compared to the Nine Months Ended August 31, 2018

25

The Company's net sales in the first nine months of 2019 were $567.0 million, compared to $578.5 million in the first nine months of 2018. The acquisition of OMNOVA Portugal during the fourth quarter of 2018 accounted for $43.5 million of current year sales. The Specialty Solutions business segment sales increased $32.7 million, or 9.1%, and Performance Materials business segment sales decreased by $44.2 million, or 20.2%. Contributing to the net sales decrease in 2019 were lower volumes of $5.4 million, primarily in paper and carpet, and unfavorable foreign currency exchange of $8.4 million, which were partially offset by favorable price/mix of $2.3 million.

Gross profit in the first nine months of 2019 was $132.3 million with a gross profit margin of 23.3%, compared to $147.2 million and 25.4% in the first nine months of 2018. The decrease from the comparable first nine months period resulted from unfavorable foreign currency exchange for both Specialty Solutions and Performance Materials, unfavorable price/mix and volume for Performance Materials, which were partially offset by favorable volume and price/mix within Specialty Solutions.

SG&A in the first nine months of 2019 was $85.6 million, or 15.1% of net sales, compared to $83.4 million, or 14.4% of net sales, in the first nine months of 2018. The $2.2 million increase in expense for the first nine months of 2019 reflects increased costs related to personnel, outside services, OMNOVA Portugal, and Merger related costs.

Interest expense was $15.3 million in the first nine months of 2019, compared to $14.4 million for the first nine months of 2018. The increase in the current year is primarily due to a higher average outstanding debt balance.

The Company recorded income tax expense of $1.4 million and an income tax benefit of $0.3 million for the nine months ended August 31, 2019 and 2018, respectively. The Company’s effective tax rate for the first nine months of 2019 was different than its U.S. federal statutory tax rate primarily due to losses in jurisdictions in which no tax benefit was recognized. The Company's effective tax rate for the first nine months of 2018 was different than its U.S. federal statutory rate primarily due to discrete items related to the Tax Act that were recorded in the first quarter of 2018. These items included a $4.1 million income tax benefit related to the re-measurement of the U.S. deferred taxes as the U.S. federal tax rate was reduced from 35% to 21% and a $0.9 million income tax benefit associated with the reversal of the valuation allowance against the existing AMT credit carryforward as it is refundable under the Tax Act. In addition, during the first quarter of 2018, the Company recognized a $0.8 million income tax benefit related to the impact of a French tax rate change on the Company’s deferred tax liabilities. These discrete tax benefits were partially offset by losses in jurisdictions in which no tax benefit was recognized.

The Company generated net income of $1.3 million, or $0.03 per diluted share, in the first nine months of 2019, compared to net income of $13.7 million, or $0.31 per diluted share, in the first nine months of 2018.

Segment Discussion

The following table reconciles segment sales to consolidated net sales and segment operating profit to consolidated income (loss) before income taxes:

	Nine Months Ended August 31,
	2019			2018
	(Dollars in millions)
Net Sales:
Specialty Solutions	$	392.7		$	360.0
Performance Materials	174.3			218.5
Consolidated Net Sales	$	567.0		$	578.5
Segment Operating Profit:
Specialty Solutions	$	49.3		55.0
Performance Materials	(6.4		)	(5.6		)
Total Segment Operating Profit	42.9			49.4
Interest expense	(15.3		)	(14.4		)
Corporate expense	(24.9		)	(21.6		)
Consolidated Income (Loss) Before Income Taxes	$	2.7		$	13.4

Specialty Solutions

Specialty Solutions net sales increased $32.7 million, or 9.1%, to $392.7 million in the first nine months of 2019 from $360.0 million in the first nine months of 2018. The improvement was driven by increased volume of $29.8 million and favorable price/mix of $8.4 million, partially offset by unfavorable foreign currency exchange of $5.5 million compared to the

26

first nine months of 2018. Volumes were favorable in coatings, adhesives & sealants, and oil & gas, but down in performance films, elastomeric modifiers, home & personal care compared to the first nine months of 2018.

Segment operating profit was $49.3 million for the first nine months of 2019, compared to $55.0 million for the first nine months of 2018. Segment operating profit decreased $5.7 million, or 10.4%, in the first nine months of 2019 as a result of unfavorable manufacturing and raw material costs, which were partially offset by favorable volume and price/mix. Segment operating profit includes items which management excludes when evaluating the results of the Company's segments. Those items for the first nine months of 2019 consisted of $0.3 million of restructuring and severance charges. Those items for 2018 included $0.7 million of restructuring and severance and $0.8 million of asset impairment, facility, and other closure costs.

Performance Materials

Performance Materials' net sales decreased $44.2 million, or 20.2%, to $174.3 million during the first nine months of 2019, compared to $218.5 million during the first nine months of 2018. The decrease was driven primarily from lower volumes of $36.4, unfavorable foreign currency exchange of $2.9 million and unfavorable price/mix of $5.1 million. Volumes increased within coated fabrics and contract manufacturing, but decreased in paper, carpet, tire cord, and reinforcing resins compared to the first nine months of 2018.

This segment generated an operating loss of $6.4 million in the first nine months of 2019 compared to operating loss of $5.6 million in the first nine months of 2018. Segment operating loss includes items which management excludes when evaluating the results of the Company's segments. Those items for the first nine months of 2019 primarily consisted of $2.2 million of restructuring and severance charges, $3.6 million of asset impairment, facility, and other closure costs, $1.0 million of accelerated depreciation on production transfer, $0.4 million of acquisition and integration related charges, and $4.4 million gain on sale of assets. Those items for the first nine months of 2018 included $10.0 million of asset impairment, facility, and other closure costs, accelerated depreciation on product transfer of $0.4 million, and $0.4 million of restructuring and severance charges.

Corporate

Corporate expenses were $24.9 million in the first nine months of 2019, compared to $21.6 million in the first nine months of 2018 primarily as a result of Merger related costs.

Financial Resources

	Nine Months Ended August 31,
	2019			2018			Change
	(Dollars in millions)
Net cash provided by (used in) operating activities	$	3.5		$	37.1		$	(33.6	)
Net cash provided by (used in) investing activities	$	(23.2	)	$	(13.3	)	$	(9.9	)
Net cash provided by (used in) financing activities	$	2.6		$	(44.6	)	$	47.2
Net increase (decrease) in cash and cash equivalents	$	(17.3	)	$	(21.8	)	$	4.5

Cash provided by operating activities was $3.5 million during the first nine months of 2019 compared to $37.1 million for the first nine months of 2018. The decrease in cash provided by operating activities is generally due to lower operating income and higher working capital.

Cash used in investing activities was $23.2 million during the first nine months of 2019 compared to $13.3 million in the first nine months of 2018. Cash use in both 2019 and 2018 was primarily for ongoing capital expenditures and business acquisitions. The Company expects approximately $35.0 million of capital expenditures during 2019, primarily for the transfer of production from Green Bay, Wisconsin to Mogadore, Ohio. Generally, capital expenditures are planned for asset replacement, new production capability, cost reduction, safety and productivity improvements and environmental protection. The Company expects to fund remaining capital expenditures with cash flow generated from operations.

Cash provided by financing activities was $2.6 million during the first nine months of 2019 compared to cash used in financing activities of $44.6 million during the first nine months of 2018, primarily as a result of a $40.0 million debt prepayment made during 2018.

The Company’s cash balance of $36.8 million as of August 31, 2019 consists of $2.0 million in the U.S., $22.6 million in Asia, and $12.2 million in Europe. The Company is not aware of any restrictions regarding the repatriation of its non-U.S. cash,

27

however, repatriation of cash from certain countries may have certain tax consequences and may not be able to be completed in a timely manner.

The Company believes that its cash flows from operations, together with existing credit facilities and cash on hand will be adequate to fund its cash requirements for at least the next twelve months.

Share Repurchase Program

During the fourth quarter of 2018, the Company's Board of Directors authorized the repurchase of up to $20.0 million of the Company's common stock. The Company may use various methods to make the repurchases, including open market repurchases, negotiated block transactions, or open market solicitations for shares, all or some of which may be effected through Rule 10b5-1 plans. The timing of repurchases will depend upon several factors including market and business conditions, and repurchases may be discontinued at any time. No repurchases have been made under this authorization as of August 31, 2019.

Debt

Information regarding the Company's debt is disclosed in the Debt and Credit Lines footnote to the Company's Unaudited Interim Consolidated Financial Statements.

Non-GAAP Financial Measures for Periods Ended August 31, 2019 and August 31, 2018

The following discussion includes Non-GAAP financial measures. An explanation of managements reasons for reviewing and presenting these Non-GAAP measures, and a reconciliation of the Non-GAAP financial measures to GAAP is provided below under the heading "GAAP to Non-GAAP Reconciliations."

Consolidated Results

For the third quarter of 2019, segment operating profit was $6.0 million compared to $5.1 million last year. Segment operating profit for the third quarter of 2019 included $7.9 million of items primarily related to merger transaction costs, severance and restructuring, and asset impairment costs. Segment operating profit for the third quarter of 2018 included $10.4 million of items primarily related to asset impairment charges and costs for the closure of the Company’s Green Bay, Wisconsin facility. Adjusted Segment Operating Profit, which excludes those items, was $8.8 million for the third quarter of 2019 compared to $10.8 million for the third quarter of 2018, with Specialty Solutions Adjusted Segment Operating Profit up 4.1% to $20.5 million, offset by a decline in Performance Materials Adjusted Segment Operating Profit (See Tables A and B). Adjusted Diluted Earnings per Share, which also excludes those items, were $0.15 for the third quarter of 2019, compared to $0.18 last year. The decline was primarily due to weakness in the laminates & films business and in Performance Materials, partially offset by improvements in the oil & gas and adhesives & sealants businesses.

For the nine months ended August 2019, segment operating profit was $18.0 million, compared to $27.8 million in the prior year. The 2019 results included $9.8 million of items primarily related to merger transaction costs, severance and restructuring, accelerated depreciation, and asset impairment costs. The 2018 results included $14.5 million of items primarily related to asset impairments and costs for the closure of the Company’s Green Bay, Wisconsin facility. Adjusted Segment Operating Profit, excluding those items, was $12.5 million for the nine months ended August 2019 compared to $27.9 million for the nine months ended August 2018 (See Tables C and D). Adjusted Diluted Earnings per Share were $0.21 for the year to date period, compared to $0.47 for the same period last year. The period-to-period decline in nine-month Adjusted Diluted Earnings Per Share primarily occurred during the first and second quarters of 2019.

Trailing Twelve Month Adjusted Segment EBITDA was $72.3 million compared to $83.2 million last year. While Trailing Twelve Month Adjusted Segment EBITDA was relatively flat for Specialty Solutions, at $86.7 million compared to $87.9 million, the Trailing Twelve Month Adjusted Segment EBITDA for Performance Materials declined $11.3 million, from $19.7 million at the end of August 2018 to $8.4 million at the end of August 2019. (See Tables E and F.)

During the third quarter of 2019, the Company experienced broad economic pressures in Asia, affecting several key end markets including construction, automotive and tires.

Specialty Solutions Segment Results

For the third quarter of 2019, Specialty Solutions operating profit was $20.0 million, compared with $19.5 million last year. Adjusted Segment Operating Profit for Specialty Solutions was $20.5 million, or 14.9% of net sales, compared to $19.7

28

million, or 16.1% of net sales, last year. (See Tables A and B.) The Company’s oil & gas business again demonstrated strong growth in revenue and profit during the quarter, as the Company’s differentiated offerings continue to find traction with end users. The growth in the oil & gas business, together with new product success in the Company’s adhesive & sealants business, and above-plan performance by the Company’s Portuguese business (acquired in September 2018), was partially offset by declines in the Company’s laminates & films business. The laminates & films business, which faced a comparison to a particularly strong quarter last year, continues to see challenging conditions in its end markets (particularly in recreational vehicles).

For the nine months ended August 2019, Specialty Solutions operating profit was $49.3 million, compared with $55.0 million last year. Adjusted Segment Operating Profit for the period was $49.6 million, or 12.6% of net sales, compared to $56.5 million, or 15.7% of net sales, for the comparable period last year. (See Tables C and D.) The period to period decline was the result of a slow start to the year in nonwovens and overall weakness in laminates & films (in particular, the recreational vehicle end market), compared against a historically strong first nine months of 2018. The contribution to profitability by the oil & gas business was up by approximately 50% from the prior period, but this was not sufficient to offset the declines in nonwovens and laminates & films.

Year-to-date, the Company’s vitality index (sales from new products introduced over the last five years as a percentage of total sales) for Specialty Solutions is 20.2%, up from 18.9% last year, and the profitability of the Company’s new product portfolio in Specialty Solutions has increased by 370 basis points.

Performance Materials Segment Results

Performance Materials’ segment operating loss for the quarter was $4.4 million, compared with a loss of $7.9 million last year. Adjusted Segment Operating Loss for Performance Materials was $2.3 million, compared to earnings of $2.2 million last year. (See Tables A and B.) The primary drivers of the year-over-year decline include the Company’s exit from the commodity paper market, volume reductions in the commodity carpet market, and increased competitive intensity in tire cord markets. These declines were partially offset by the benefits of closing the Company’s Green Bay, Wisconsin plant, which are expected to yield annual benefits of $7 million to $8 million by the second half of 2020, primarily benefiting the Performance Materials segment.

Performance Materials’ segment operating loss for the nine months ended August 2019 was $6.4 million, compared with a loss of $5.6 million for the same period last year. Adjusted Segment Operating Loss in the period was $3.6 million, compared to earnings of $5.1 million in the prior year period. (See Tables C and D.) The primary drivers of the decline are consistent with those of the quarter, and were partially offset by the benefits of closing the Company’s Green Bay, Wisconsin plant.

The challenges in commodity-based markets like tire cord continue to mask the performance of the Company’s smaller but more profitable Performance Material’s businesses, including the coated fabrics, reinforcing resins, and antioxidants businesses. The segment is continuing to execute its strategy of growing the profitable business while reducing exposure to the least profitable businesses through repurposing assets and reducing sales and investments in the most commoditized end markets.

GAAP to Non-GAAP Reconciliations

Adjusted Segment Operating Profit, Adjusted Income, Adjusted Diluted Earnings Per Share, and Adjusted EBITDA are non-GAAP financial measures as defined by the Securities and Exchange Commission. Management reviews adjusted financial measures in assessing the performance of the business segments and in making decisions regarding the allocation of resources to the business segments. Management believes that the adjusted information is useful for providing investors with an understanding of the Company’s business and operating performance. Management excludes the items shown in the tables below because Management does not consider them to be reflective of normal operations. These adjusted financial measurements are not measurements of financial performance under GAAP and such financial measures should not be considered as an alternative to Segment Operating Profit, Net Income, Diluted Earnings Per Share or other measures of financial performance determined in accordance with GAAP. These non-GAAP financial measures may not be comparable to similarly titled measures reported by other companies. The tables below provide the reconciliation of these financial measures to the comparable GAAP financial measures.

29

Non-GAAP and other Financial Matters
Three Months Ended August 31, 2019
													Table A
(In millions except per share data)	Specialty Solutions			Performance Materials			Combined Segments			Corporate			Consolidated
Net Sales	$	137.7		$	54.7		$	192.4		$	—		$	192.4
Segment Operating Profit / Corporate Expense	$	20.0		$	(4.4	)	$	15.6		$	(9.6	)	$	6.0
Interest expense	—			—			—			(5.1		)	(5.1		)
Income (Loss) Before Income Taxes	$	20.0		$	(4.4	)	$	15.6		$	(14.7	)	$	.9
Management Excluded Items
Restructuring and severance	.3			.5			.8			—			.8
Operational Improvements costs	—			—			—			(.4		)	(.4		)
Asset impairment, facility closure costs and other	—			1.6			1.6			(.2		)	1.4
Deferred financing fees written-off	—			—			—			.2			.2
Merger transaction costs	—			—			—			5.7			5.7
Acquisition and integration related expense	.2			—			.2			—			.2
Subtotal for management excluded Items	.5			2.1			2.6			5.3			7.9
Adjusted Segment Operating Profit / Corporate Expense Before Income Taxes	$	20.5		$	(2.3	)	$	18.2		$	(9.4	)	$	8.8
Income tax expense (25% rate)*													(2.2		)
Adjusted Income (Loss)													$	6.6
Adjusted Diluted Earnings Per Share from Adjusted Income													$	0.15
*Income Tax rate is based on the Company's estimated normalized annual effective tax rate
Adjusted Segment Operating Profit as a % of Sales	14.9		%	(4.2		)%	9.5		%
Segment / Corporate Capital Expenditures	$	5.0		$	1.6		$	6.6		$	.6		$	7.2
Adjusted Segment Operating Profit / Corporate Expense Before Income Taxes	$	20.5		$	(2.3	)	$	18.2		$	(9.4	)	$	8.8
Unallocated corporate interest expense	—			—			—			5.1			5.1
Segment / Consolidated Adjusted EBIT	20.5			(2.3		)	18.2			(4.3		)	13.9
Depreciation and amortization	4.8			2.7			7.5			.1			7.6
Segment / Consolidated Adjusted EBITDA	$	25.3		$	0.4		$	25.7		$	(4.2	)	$	21.5
Adjusted EBITDA as a % of sales	18.4		%	0.7		%	13.4		%				11.2		%

30

Non-GAAP and other Financial Matters (Continued)
Three Months Ended August 31, 2018
													Table B
(In millions except per share data)	Specialty Solutions			Performance Materials			Combined Segments			Corporate			Consolidated
Net Sales	$	122.1		$	71.5		$	193.6		$	—		$	193.6
Segment Operating Profit / Corporate Expense	$	19.5		$	(7.9	)	$	11.6		$	(6.5	)	$	5.1
Interest expense	—			—			—			(4.7		)	(4.7		)
Income (Loss) Before Income Taxes	$	19.5		$	(7.9	)	$	11.6		$	(11.2	)	$	.4
Management Excluded Items
Restructuring and severance	—			.4			.4			—			.4
Accelerated depreciation on production transfer	—			.5			.5			—			.5
Acquisition and integration related expense	(.5		)	(.3		)	(.8		)	.1			(.7		)
Other financing costs	(.1		)	(.1		)	(.2		)	—			(.2		)
Asset impairment, facility closure costs and other	.8			9.6			10.4			—			10.4
Subtotal for management excluded Items	.2			10.1			10.3			.1			10.4
Adjusted Segment Operating Profit / Corporate Expense Before Income Taxes	$	19.7		$	2.2		$	21.9		$	(11.1	)	$	10.8
Income tax expense (25% rate)*													(2.7		)
Adjusted Income (Loss)													$	8.1
Adjusted Diluted Earnings Per Share from Adjusted Income													$	0.18
*Income Tax rate is based on the Company's estimated normalized annual effective tax rate
Adjusted Segment Operating Profit as a % of Sales	16.1		%	3.1		%	11.3		%
Segment / Corporate Capital Expenditures	$	3.7		$	1.6		$	5.3		$	.4		$	5.7
Adjusted Segment Operating Profit / Corporate Expense Before Income Taxes	$	19.7		$	2.2		$	21.9		$	(11.1	)	$	10.8
Unallocated corporate interest expense	—			—			—			4.7			4.7
Segment / Consolidated Adjusted EBIT	19.7			2.2			21.9			(6.4		)	15.5
Depreciation and amortization	4.6			2.6			7.2			.1			7.3
Segment / Consolidated Adjusted EBITDA	$	24.3		$	4.8		$	29.1		$	(6.3	)	$	22.8
Adjusted EBITDA as a % of sales	19.9		%	6.7		%	15.0		%				11.8		%

31

Non-GAAP and other Financial Matters (Continued)
Nine Months Ended August 31, 2019
													Table C
(In millions except per share data)	Specialty Solutions			Performance Materials			Combined Segments			Corporate			Consolidated
Net Sales	$	392.7		$	174.3		$	567.0		$	—		$	567.0
Segment Operating Profit / Corporate Expense	$	49.3		$	(6.4	)	$	42.9		$	(24.9	)	$	18.0
Interest expense	—			—			—			(15.3		)	(15.3		)
Income (Loss) Before Income Taxes	$	49.3		$	(6.4	)	$	42.9		$	(40.2	)	$	2.7
Management Excluded Items
Restructuring and severance	.3			2.2			2.5			.2			2.7
Accelerated depreciation on production transfer	—			1.0			1.0			—			1.0
Operational Improvements costs	—			—			—			.3			.3
Asset impairment, facility closure costs and other	—			3.6			3.6			.1			3.7
(Gain) loss on sale of assets	—			(4.4		)	(4.4		)	.2			(4.2		)
Deferred financing fees written-off	—			—			—			.2			.2
Merger transaction costs	—			—			—			5.4			5.4
Acquisition and integration related expense	—			.4			.4			.3			.7
Subtotal for management excluded items	.3			2.8			3.1			6.7			9.8
Adjusted Segment Operating Profit / Corporate Expense before Income Taxes	$	49.6		$	(3.6	)	$	46.0		$	(33.5	)	$	12.5
Tax expense (25% rate)*													(3.1		)
Adjusted Income (Loss)													$	9.4
Adjusted Diluted Earnings Per Share from Adjusted Income													$	0.21
*Tax rate is based on the Company's estimated normalized annual effective tax rate
Adjusted Segment Operating Profit As A % Of Sales	12.6		%	(2.1		)%	8.1		%
Segment / Corporate Capital Expenditures	$	17.3		$	6.9		$	24.2		$	1.7		$	25.9
Adjusted Segment Operating Profit / Corporate Expense Before Income Taxes	$	49.6		$	(3.6	)	$	46.0		$	(33.5	)	$	12.5
Unallocated corporate interest expense	—			—			—			15.3			15.3
Segment / Consolidated Adjusted EBIT	49.6			(3.6		)	46.0			(18.2		)	27.8
Depreciation and amortization	14.7			7.5			22.2			.2			22.4
Segment / Consolidated Adjusted EBITDA	$	64.3		$	3.9		$	68.2		$	(18.0	)	$	50.2
Adjusted EBITDA as a % of sales	16.4		%	2.2		%	12.0		%				8.9		%

32

Non-GAAP and other Financial Matters (Continued)
Nine Months Ended August 31, 2018
													Table D
(In millions except per share data)	Specialty Solutions			Performance Materials			Combined Segments			Corporate			Consolidated
Net Sales	$	360.0		$	218.5		$	578.5		$	—		$	578.5
Segment Operating Profit / Corporate Expense	$	55.0		$	(5.6	)	$	49.4		$	(21.6	)	$	27.8
Interest expense	—			—			—			(14.4		)	(14.4		)
Income (Loss) Before Income Taxes	55.0			(5.6		)	49.4			(36.0		)	13.4
Management Excluded Items
Restructuring and severance	.7			.4			1.1			.7			1.8
Accelerated depreciation on production transfer	.1			.4			.5			—			.5
Asset impairment, facility closure costs and other	.9			10.0			10.9			.1			11.0
Environmental costs	—			.2			.2			—			.2
Deferred financing fees written-off	—			—			—			.8			.8
Other financing costs	(.1		)	(.1		)	(.2		)	—			(.2		)
Acquisition and integration related expense	(.1		)	(.2		)	(.3		)	.7			.4
Subtotal for management excluded items	1.5			10.7			12.2			2.3			14.5
Adjusted Segment Operating Profit / Corporate Expense before Income Taxes	$	56.5		$	5.1		$	61.6		$	(33.7	)	$	27.9
Tax expense (25% rate)*													(7.0		)
Adjusted Income													$	20.9
Adjusted Diluted Earnings Per Share from Adjusted Income													$	0.47
*Tax rate is based on the Company's estimated normalized annual effective tax rate
Adjusted Segment Operating Profit As A % Of Sales	15.7		%	2.3		%	10.6		%
Segment / Corporate Capital Expenditures	$	8.7		$	3.4		$	12.1		$	.7		$	12.8
Adjusted Segment Operating Profit / Corporate Expense Before Income Taxes	$	56.5		$	5.1		$	61.6		$	(33.7	)	$	27.9
Unallocated corporate interest expense	—			—			—			14.4			14.4
Segment / Consolidated Adjusted EBIT	56.5			5.1			61.6			(19.3		)	42.3
Depreciation and amortization	12.9			8.7			21.6			.2			21.8
Segment / Consolidated Adjusted EBITDA	$	69.4		$	13.8		$	83.2		$	(19.1	)	$	64.1
Adjusted EBITDA as a % of sales	19.3		%	6.3		%	14.4		%				11.1		%

33

Non-GAAP and other Financial Matters (Continued)
Trailing Twelve Months Ended August 31, 2019
													Table E
(In millions except per share data)	Specialty Solutions			Performance Materials			Combined Segments			Corporate			Consolidated
Net Sales	$	520.2		$	238.1		$	758.3		$	—		$	758.3
Segment Operating Profit / Corporate Expense	$	65.0		$	(10.6	)	$	54.4		$	(30.5	)	$	23.9
Interest expense	—			—			—			(20.2		)	(20.2		)
Income (Loss) Before Income Taxes	$	65.0		$	(10.6	)	$	54.4		$	(50.7	)	$	3.7
Management Excluded Items
Restructuring and severance	.3			2.9			3.2			.4			3.6
Accelerated depreciation on production transfer	—			1.7			1.7			—			1.7
Operational Improvements costs	—			—			—			.3			.3
Asset impairment, facility closure costs and other	.2			8.1			8.3			.1			8.4
(Gain) loss on sale of assets	—			(4.4		)	(4.4		)	(.7		)	(5.1		)
Deferred financing fees written-off	—			—			—			.2			.2
Merger transaction costs	—			—			—			5.4			5.4
Acquisition and integration related expense	1.9			.6			2.5			1.8			4.3
Subtotal for management excluded items	2.4			8.9			11.3			7.5			18.8
Adjusted Segment Operating Profit / Corporate Expense Before Income Taxes	$	67.4		$	(1.7	)	$	65.7		$	(43.2	)	$	22.5
Income tax expense													(5.6		)
Adjusted Income (Loss)													$	16.9
Adjusted Diluted Earnings Per Share From Adjusted Income													$	0.37
Adjusted Segment Operating Profit as a % of Sales	13.0		%	(0.7		)%	8.7		%
Segment / Corporate Capital Expenditures	$	25.4		$	9.6		$	35.0		$	1.9		$	36.9
Adjusted Segment Operating Profit / Corporate Expense Before Income Taxes	$	67.4		$	(1.7	)	$	65.7		$	(43.2	)	$	22.5
Unallocated corporate interest	—			—			—			20.2			20.2
Segment / Consolidated Adjusted EBIT	67.4			(1.7		)	65.7			(23.0		)	42.7
Depreciation and amortization	19.3			10.1			29.4			.2			29.6
Segment / Consolidated Adjusted EBITDA	$	86.7		$	8.4		$	95.1		$	(22.8	)	$	72.3
Adjusted EBITDA as a % of sales	16.7		%	3.5		%	12.5		%				9.5		%
Net Leverage
Total short and long-term debt (excluding OID and deferred financing fees of $5.7M.)													$	332.8
Less cash													(36.8		)
Net Debt (Debt less Cash)													$	296.0
Net Leverage Ratio**													4.1x
** The above calculation is not intended to be used for purposes of calculating debt covenant compliance.

34

Non-GAAP and other Financial Matters (Continued)
Trailing Twelve Months Ended August 31, 2018
													Table F
(In millions except per share data)	Specialty Solutions			Performance Materials			Combined Segments			Corporate			Consolidated
Net Sales	$	471.1		$	293.5		$	764.6		$	—		$	764.6
Segment Operating Profit / Corporate Expense	$	69.3		$	(24.0	)	$	45.3		$	(28.1	)	$	17.2
Interest expense	—			—			—			(19.9		)	$	(19.9	)
Income (Loss) Before Income Taxes	$	69.3		$	(24.0	)	45.3			$	(48.0	)	$	(2.7	)
Management Excluded Items
Restructuring and severance	.7			.4			1.1			1.0			2.1
Accelerated depreciation on production transfer	.1			.4			.5			—			.5
Operational improvements costs	—			—			—			—			—
Asset impairment, facility closure costs and other	1.2			31.3			32.5			.5			33.0
Environmental costs	—			.4			.4			—			.4
Deferred financing fees written-off	—			—			—			.8			.8
Corporate headquarters relocation costs	—			—			—			—			—
Pension settlement	—			—			—			—			—
Pension settlement	(.1		)	(.1		)	(.2		)	—			(.2		)
Acquisition and integration related expense	(.1		)	(.2		)	(.3		)	.7			.4
Subtotal for management excluded items	1.8			32.2			34.0			3.0			37.0
Adjusted Segment Operating Profit / Corporate Expense before Income Taxes	$	71.1		$	8.2		79.3			$	(45.0	)	$	34.3
Income tax expense													(10.3		)
Adjusted Income (Loss)													$	24.0
Adjusted Diluted Earnings Per Share from Adjusted Income													$	0.54
Adjusted Segment Operating Profit as a % of Sales	15.1		%	2.8		%	10.4		%
Segment / Corporate Capital Expenditures	$	13.7		$	6.3		$	20.0		$	.9		$	20.9
Adjusted Segment Operating Profit / Corporate Expense Before Income Taxes	$	71.1		$	8.2		$	79.3		$	(45.0	)	$	34.3
Unallocated corporate interest expense	—			—			—			19.9			19.9
Segment / Consolidated Adjusted EBIT	71.1			8.2			79.3			(25.1		)	54.2
Depreciation and amortization	16.8			11.5			28.3			0.7			29.0
Segment / Consolidated Adjusted EBITDA	$	87.9		$	19.7		$	107.6		$	(24.4	)	$	83.2
Adjusted EBITDA as a % of sales	18.7		%	6.7		%	14.1		%				10.9		%
Net Leverage
Total short and long-term debt (excluding OID and deferred financing fees of $7.2M.)													$	318.8
Less cash													(66.2		)
Net Debt (Debt less Cash)													$	252.6
Net Leverage Ratio**													3.0 x
** The above calculation is not intended to be used for purposes of calculating debt covenant compliance.

Significant Accounting Policies and Management Judgments

The Company’s discussion and analysis of its results of operations, financial condition, and liquidity are based upon the Company’s consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires the Company to make estimates and judgments that affect the amounts of assets and liabilities, revenues, and expenses and disclosure of contingent assets and liabilities as of the date of the financial statements. The Company periodically reviews its estimates and judgments including those related to product returns, accounts receivable, inventories, litigation and environmental reserves, pensions, and income taxes. The

35

Company bases its estimates and judgments on historical experience and on various assumptions that it believes to be reasonable under the circumstances. Actual results may differ materially from these estimates and judgments under different assumptions.

Information with respect to the Company’s significant accounting policies and management judgments which the Company believes could have the most significant effect on the Company’s reported results and require subjective or complex judgments by management is contained in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the Company’s Annual Report on Form 10-K for the year ended November 30, 2018, as filed with the SEC. The Company has not made any changes in estimates or judgments that have had a significant effect on the reported amounts.

Environmental Matters

The Company’s policy is to conduct its businesses with due regard for the preservation and protection of the environment. The Company devotes significant resources and management attention to comply with environmental laws and regulations. The Company’s Consolidated Balance Sheet as of August 31, 2019 reflects reserves for environmental remediation of $1.4 million. The Company’s estimates are subject to change and actual results may materially differ from the Company’s estimates. Management believes, on the basis of presently available information, that resolution of known environmental matters will not materially affect liquidity, capital resources, or the consolidated financial condition of the Company.

Employee Matters

At August 31, 2019, the Company employed approximately 1,900 employees globally. Approximately 12% of the Company’s U.S. employees are covered by collective bargaining agreements in the United States. In addition, certain of our foreign employees are also covered by collective bargaining agreements.

New Accounting Pronouncements

New accounting pronouncements impacting the Company are disclosed in Note A to the Company’s Unaudited Consolidated Financial Statements.

Shareholder Communications Pending the Merger

Pending its merger with Synthomer plc, the Company has suspended the distribution of earnings releases and has discontinued earnings teleconferences, and the Company’s shareholders should not rely on the Company issuing any future forward-looking guidance or on any existing forward-looking guidance. The Company currently expects to obtain all regulatory, and other approvals that are required for the completion of the merger by late 2019 or early 2020. This timing, however, is an estimate and there can be no assurance when any such approvals will be obtained, or that they will be obtained at all. Please refer to the disclosures below concerning risk factors relating to the consummation of the Merger.

Forward-Looking Statements

This quarterly report on Form 10-Q includes descriptions of our current business, operations, assets and other matters affecting the Company as well as “forward-looking statements” as defined by federal securities laws. All forward-looking statements by the Company, including verbal statements, are intended to qualify for the protections afforded forward-looking statements under the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management’s current expectation, judgment, belief, assumption, estimate or forecast about future events, circumstances or results and may address business conditions and prospects, strategy, capital structure, debt and cash levels, sales, profits, earnings, markets, products, technology, operations, customers, raw materials, claims and litigation, financial condition, and accounting policies among other matters. Words such as, but not limited to, “will,” “may,” “should,” “projects,” “forecasts,” “seeks,” “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “targets,” “optimistic,” “likely,” “would,” “could,” “committed,” and similar expressions or phrases identify forward-looking statements.

All descriptions of our business, operations and assets, as well as all forward-looking statements, involve risks and uncertainties. Many risks and uncertainties are inherent in business generally and the markets in which the Company operates or proposes to operate. Other risks and uncertainties are more specific to the Company’s businesses including businesses the Company acquires. There also may be risks and uncertainties not currently known to us. The occurrence of any such risks and uncertainties and the impact of such occurrences is often not predictable or within the Company’s control. Such impacts could adversely affect the Company’s business, operations or assets as well as the Company's results and the value of your investment in OMNOVA and, in some cases, such effect could be material. Certain risks and uncertainties facing the Company are described below or elsewhere in this Form 10-Q.

36

All written and verbal descriptions of our business, operations and assets and all forward-looking statements attributable to the Company or any person acting on the Company’s behalf are expressly qualified in their entirety by the risks, uncertainties, and cautionary statements contained and referenced herein.

All such descriptions and any forward-looking statement speak only as of the date on which such description or statement is made, and the Company undertakes no obligation, and specifically declines any obligation, other than that imposed by law, to publicly update or revise any such description or forward-looking statements whether as a result of new information, future events or otherwise.

Risks and uncertainties that may adversely affect our business, operations, assets, or other matters affecting the Company and may cause actual results and the value of your investment in OMNOVA to materially differ from expectations include, but are not limited to: (1) the Company's exposure to general economic, business, and industry conditions; (2) changes in raw material prices and availability; (3) extraordinary events such as natural disasters, political disruptions, terrorist attacks and acts of war; (4) the risk of doing business in foreign countries and markets; (5) the highly competitive markets the Company serves and continued consolidations among its competitors and customer base; (6) extensive and increasing governmental regulation, including environmental, health and safety regulations; (7) the Company's inability to protect its intellectual property or successfully defend itself from intellectual property claims; (8) claims and litigation; (9) changes in accounting policies, standards, and interpretations; (10) the actions of activist shareholders; (11) risks inherent in the operation of manufacturing facilities; (12) the Company's inability to achieve or achieve in a timely manner the objectives and benefits of cost reduction initiatives; (13) the Company's ability to develop and commercialize new products that can be value priced; (14) the Company's ability to identify and complete strategic transactions; (15) the Company’s ability to successfully integrate acquired companies; (16) information system failures and breaches in security; (17) the Company's use of purchase orders rather than long-term contracts for most of its business; (18) the disproportionate impact of certain product lines on the Company's operating profitability; (19) customer credit risk; (20) continued increases in healthcare costs; (21) the Company's ability retain or attract key employees; (22) the Company's ability to renew collective bargaining agreements with employees on acceptable terms and the risk of work stoppages; (23) the Company's contribution obligations under its U.S. pension plan; (24) the Company's reliance on foreign financial institutions to hold some of its funds; (25) the effect of goodwill impairment charges; (26) the volatility in the market price of the Company’s common shares; (27) the Company's substantial debt position; (28) a decision to incur additional debt; (29) the operational and financial restrictions contained in the Company's debt agreements; (30) the effects of a default under the Company's term loan or revolving credit facility; (31) the Company's ability to generate sufficient cash to service its outstanding debt; and (32) potential changes in the LIBOR calculation method and the expected phase-out of LIBOR.

In relation to the proposed acquisition of the Company by Synthomer, the following uncertainties and other factors could cause actual outcomes to differ from those set forth in the forward-looking statements: (i) the risk that the contemplated transactions may not be consummated in a timely manner, if at all; (ii) the risk that the definitive merger agreement may be terminated in circumstances that require the Company to pay Synthomer a termination fee; (iii) risks related to the diversion of management’s attention from the Company’s ongoing business operations; (iv) the effect of the announcement of the proposed transaction on the Company’s business relationships (including, without limitation, customers and suppliers), operating results and business generally; (v) risks related to obtaining the requisite consents to the proposed transaction, including, without limitation, the receipt of approval from the Company’s shareholders and Synthomer’s shareholders, the timing (including possible delays) and receipt of regulatory clearance from governmental authorities (including any conditions, limitations or restrictions placed on these approvals) and the risk that one or more governmental authority may deny any such approval; and (vi) the conditions of the capital markets during the period covered by the forward-looking statements. Further risks that could cause actual results to differ materially from those matters expressed in or implied by such forward-looking statements are set forth under “Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended November 30, 2018, and its subsequent quarterly reports on Form 10-Q. The Company does not undertake, and hereby disclaims, any duty to update these forward-looking statements, although its situation and circumstances may change in the future.

We provide greater detail regarding these risks and uncertainties in our 2018 Form 10-K and subsequent filings, which are available online at www.omnova.com and www.sec.gov.

37

Item 3. Quantitative and Qualitative Disclosure About Market Risk

Quantitative and Qualitative Disclosure About Market Risk

The Company is exposed to market risk from changes in interest rates on its long-term debt obligations. As described in the Debt and Credit Lines note to the Unaudited Consolidated Financial Statements, the Company’s debt bears interest at variable rates. Total borrowings for the Company's variable rate debt were $317.7 million as of August 31, 2019. The weighted average effective interest rate of the Company’s outstanding debt was 5.36% as of August 31, 2019. A hypothetical increase or decrease of 100 basis points would impact the Company’s interest expense on its variable rate debt by $3.2 million annually.

The Company is subject to foreign currency exchange rate risk. The Company has an accumulated currency translation loss of $36.8 million as of August 31, 2019, which is included in accumulated other comprehensive loss.

The Company does not enter into derivatives or other financial instruments for trading or speculative purposes.

Item 4. Controls and Procedures

Controls and Procedures

Management of the Company, including the Chief Executive Officer and the Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a–15(e) under the Securities Exchange Act of 1934) as of August 31, 2019 and based on this evaluation, has determined that the Company’s disclosure controls and procedures are effective as of such date. There were no changes in the Company’s internal control over financial reporting during the quarter ended August 31, 2019 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Part II. Other Information

Item 1. Legal Proceedings

From time to time, the Company is subject to various claims, proceedings and lawsuits related to products, services, contracts, employment, environmental, safety, intellectual property, and other matters. The ultimate resolution of such claims, proceedings, and lawsuits is inherently unpredictable and, as a result, the Company’s estimates of liability, if any, are subject to change. Actual results may materially differ from the Company’s estimates and an unfavorable resolution of any matter could have a material adverse effect on the financial condition, results of operations, and/or cash flows of the Company. However, subject to the above and taking into account such amounts, if any, as are accrued from time to time on the Company’s balance sheet, the Company does not believe, based on the information currently available to it, that the ultimate resolution of these matters will have a material effect on the consolidated financial condition, results of operations, or cash flows of the Company.

Item 1A. Risk Factors

There have been no material changes to the risk factors previously disclosed in Item 1A of the Company’s Annual Report on Form 10-K for the year ended November 30, 2018. Those risk factors, in addition to the other information set forth in this report, could materially affect the Company’s consolidated financial condition, results of operations, or cash flows. Additional unrecognized risks and uncertainties may materially adversely affect the Company’s consolidated financial condition, results of operations, or cash flows.

In Item 1A of the Company’s Annual Report on Form 10-K for the year ended November 30, 2018, the Company disclosed risk factors and other information that could materially affect the Company’s consolidated financial condition, results of operations, or cash flows. Other risks associated with the proposed transaction between the Company and Synthomer plc ("Synthomer"), Spirit USA Holdings Inc., and Synthomer USA LLC are more fully discussed in the Company’s definitive proxy statement filed with the SEC on September 9, 2019 in connection with the proposed transaction. In addition to such previously disclosed risk factors and other information, the Company has identified additional material risks that could affect the Company’s consolidated financial condition, results of operations, or cash flows, which are disclosed below:

The list of factors presented here is, and the list of factors presented in the Company’s Form 10-K and proxy statement should not be considered to be a complete statement of all potential risks and uncertainties. In addition, risks and uncertainties not presently known to the Company or that it believes to be immaterial also may adversely affect the Company. Should any

38

known or unknown risks or uncertainties develop into actual events, or underlying assumptions prove inaccurate, these developments could have material adverse effects on the Company’s business, financial condition and results of operations. The Company is under no obligation, and expressly disclaims any obligation, to update, alter, or otherwise revise any forward-looking statements, whether written or oral, that may be made from time to time, whether as a result of new information, future events or otherwise.

Risks associated with the proposed merger of the Company with Synthomer

We may face business and operational impacts due to the announcement of our proposed merger with Synthomer and the pendency of the proposed merger.

On July 3, 2019, the Company announced it had entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Synthomer, Spirit USA Holdings Inc., and Synthomer USA LLC, pursuant to which Spirit USA Holdings Inc., a wholly-owned subsidiary of Synthomer, would merge with and into the Company, subject to shareholder and regulatory approvals and other customary conditions (the "Merger"). Uncertainty about the effect of the Merger on our employees, customers, suppliers, distributors and other parties may have a material adverse effect on our business. There can be no assurance that our employees, including key personnel, can be retained to the same extent that we have previously been able to attract and retain employees. In addition, we have diverted, and will continue to divert, significant management resources towards the completion of the Merger, which may limit the amount of time that can be focused on our business and operations by such persons. Parties with which we do business, including our suppliers and distributors, may experience uncertainty associated with the Merger, including with respect to current or future business relationships with us, with Synthomer, or with the combined enterprise if the Merger is consummated. In addition, costs, fees, expenses and charges related to the Merger Agreement, the Merger, or pending and future litigation and other legal proceedings, including any such proceedings related to the Merger and instituted against us and others, cannot be quantified. The Company is required to operate under certain restrictions on its business pursuant to the terms of the Merger Agreement, including, among other things, restrictions on the ability in certain cases to enter into contracts or to enter into contracts having certain terms, to acquire or dispose of assets, or to incur indebtedness or incur capital expenditures, until the Merger becomes effective or the Merger Agreement terminates. These restrictions may prevent us from taking actions with respect to our business that we may consider advantageous and result in our inability to respond effectively to competitive pressures and industry developments. Finally, the Company may experience a loss of business based on the expectation that Synthomer will own the Company following the closing of the Merger.

The proposed merger of the Company with Synthomer may not be completed on a timely basis, or at all, and the failure to complete or delays in completing the proposed merger could adversely affect our business, financial results and stock price.

Completion of the Merger with Synthomer is subject to several conditions outside of our or Synthomer’s control that may prevent or delay its completion, including approval of the Merger Agreement by the Company’s shareholders and certain regulatory approvals. If the Merger is not completed, the Company’s share price could decrease if and to the extent that the current market price for the Company’s common shares reflects an assumption that a transaction will be consummated. Additionally, the Merger Agreement contains certain termination rights and provides that, upon termination of the Merger Agreement under specified circumstances, including a change in the recommendation of the Company’s Board of Directors that shareholders approve the Merger Agreement or a termination of the Merger Agreement by the Company to enter into an agreement for a superior proposal, the Company will pay Synthomer a cash termination fee of $15.8 million. Further, a failed transaction may result in negative publicity and a negative impression of the Company in the capital markets and among the investment community. Finally, any disruption to our business resulting from the announcement and pendency of the Merger, including any adverse impact in our relationships with employees, distributors or suppliers could continue or accelerate in the event of a failed transaction.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

From time to time, the Company may seek to retire, repurchase, or exchange its outstanding debt or capital securities through various methods including open market repurchases, negotiated block transactions, or open market solicitations for shares, all or some of which may be effected through Rule 10b5-1 plans. Such transactions, if any, depend on prevailing market conditions, our liquidity and capital requirements, contractual restrictions, and other factors, and may involve material amounts.

39

The following table summarizes the Company’s activity related to its common shares for the three months ended August 31, 2019.

Month	Total Number of shares repurchased (a)	Average price paid per share	Total number of shares purchased as part of publicly announced plans or programs	Maximum dollar value of shares that may yet be purchased under the plans or programs
June 1 -30	25,697	$5.61	—	$	20,000,000
July 1 - 31	—	N/A	—	$	20,000,000
August 1 -31	—	N/A	—	$	20,000,000
Total	25,697	$5.61	—

(a) Share repurchases resulted from common shares deemed surrendered by employees in connection with the Company’s stock compensation and benefit plans to satisfy tax obligations.

40

Item 6. Exhibits

2.1	Agreement and Plan of Merger, dated July 3, 2019 among Synthomer plc, Spirit USA Holdings Inc., Synthomer USA LLC and OMNOVA Solutions Inc. (incorporated by reference to Exhibit 2.1 of the Company's Current Report filed July 3, 2019 (File No. 1-15147)).
31.1	Rule 13a-14(a) Certification of the Company's Chief Executive Officer.(x)
31.2	Rule 13a-14(a) Certification of the Company's Chief Financial Officer.(x)
32.1	Section 1350 Certification of the Company's Chief Executive Officer and Chief Financial Officer.(x)
101	The following financial information from our Quarterly Report on Form 10-Q for the third quarter of 2019, filed with the SEC on September 26, 2019, formatted in XBRL: (i) the Condensed Consolidated Statements of Operations for the three and nine months ended August 31, 2019 and 2018; (ii) the Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended August 31, 2019 and 2018; (iii) the Consolidated Balance Sheets at August 31, 2019 and November 30, 2018; (iv) the Consolidated Statements of Cash Flows for the nine months ended August 31, 2019 and 2018; and (v) the Notes to the Unaudited Interim Consolidated Financial Statements.

(x) Filed herewith.

41

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		OMNOVA Solutions Inc.
Date:	September 26, 2019	By	/s/ Paul F. DeSantis
			Paul F. DeSantis Senior Vice President and Chief Financial Officer; Treasurer (Principal Financial Officer)
Date:	September 26, 2019	By	/s/ Donald B. McMillan
			Donald B. McMillan Vice President, Chief Accounting Officer (Principal Accounting Officer)

42

INDEX TO EXHIBITS

Exhibit Number	Description
2.1	Agreement and Plan of Merger, dated July 3, 2019 among Synthomer plc, Spirit USA Holdings Inc., Synthomer USA LLC and OMNOVA Solutions Inc. (incorporated by reference to Exhibit 2.1 of the Company's Current Report filed July 3, 2019 (File No. 1-15147)).
31.1	Principal Executive Officer’s Certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Principal Financial Officer’s Certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101	The following financial information from our Quarterly Report on Form 10-Q for the third quarter of 2019, filed with the SEC on September 26, 2019, formatted in XBRL: (i) the Condensed Consolidated Statements of Operations for the three and nine months ended August 31, 2019 and 2018; (ii) the Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended August 31, 2019 and 2018; (iii) the Consolidated Balance Sheets at August 31, 2019 and November 30, 2018; (iv) the Consolidated Statements of Cash Flows for the nine months ended August 31, 2019 and 2018; and (v) the Notes to the Unaudited Interim Consolidated Financial Statements.

43

EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, Anne P. Noonan, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of OMNOVA Solutions Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	September 26, 2019	/s/ Anne P. Noonan
		Name: Anne P. Noonan
		Title: President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, Paul F. DeSantis, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of OMNOVA Solutions Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	September 26, 2019	/s/ Paul F. DeSantis
		Name: Paul F. DeSantis
		Title: Senior Vice President and Chief Financial Officer; Treasurer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of OMNOVA Solutions Inc. (the “Company”) on Form 10-Q for the quarter ended August 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to such officer’s knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.

Date:	September 26, 2019	/s/ Anne P. Noonan
		Name:	Anne P. Noonan
		Title:	President and Chief Executive Officer

/s/ Paul F. DeSantis
Name:	Paul F. DeSantis
Title:	Senior Vice President and Chief Financial Officer; Treasurer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Report or as a separate disclosure document.

XML

Shareholders' Equity (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended						9 Months Ended
	Aug. 31, 2019	May 31, 2019	Feb. 28, 2019	Aug. 31, 2018	May 31, 2018	Feb. 28, 2018	Aug. 31, 2019	Aug. 31, 2018
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity Attributable to Parent, beginning of period	$ 59.7	$ 57.0	$ 57.6	$ 51.0	$ 46.5	$ 38.2	$ 57.6	$ 38.2
Net income (loss)	0.3	5.6	(4.6)	(1.9)	8.4	7.3	1.3	13.7
Foreign currency translations	(2.5)	(5.5)	3.8	(5.5)	(5.7)	6.3	(4.2)	(4.9)
Adjustment for accounting change			(0.5)			(6.9)
Post-retirement benefit plans	0.6	0.9	0.6	1.2	1.1	1.1	2.1	3.4
Share-based compensation	1.0	1.5	0.3	1.2	0.4	0.5
Other	(0.4)	0.2	(0.2)	(0.6)	0.3	0.0
Stockholders' Equity Attributable to Parent, end of period	$ 58.7	$ 59.7	$ 57.0	$ 45.4	$ 51.0	$ 46.5	$ 58.7	$ 45.4
Common Stock [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares, Outstanding, beginning of period	44.8	44.8	44.9	44.9	44.8	44.8	44.9	44.8
Stockholders' Equity Attributable to Parent, beginning of period	$ 4.8	$ 4.8	$ 4.8	$ 4.8	$ 4.8	$ 4.8	$ 4.8	$ 4.8
Stock Issued During Period, Shares, Other	0.1		(0.1)		0.1
Shares, Outstanding, end of period	44.9	44.8	44.8	44.9	44.9	44.8	44.9	44.9
Stockholders' Equity Attributable to Parent, end of period	$ 4.8	$ 4.8	$ 4.8	$ 4.8	$ 4.8	$ 4.8	$ 4.8	$ 4.8
Additional Paid-in Capital [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity Attributable to Parent, beginning of period	348.0	346.2	345.9	345.1	344.4	343.4	345.9	343.4
Share-based compensation	1.0	1.5	0.3	1.2	0.4	0.5
Other	(0.5)	0.3		(0.6)	0.3	0.5
Stockholders' Equity Attributable to Parent, end of period	348.5	348.0	346.2	345.7	345.1	344.4	348.5	345.7
Retained Earnings [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity Attributable to Parent, beginning of period	(144.9)	(150.5)	(145.4)	(150.4)	(158.8)	(159.2)	(145.4)	(159.2)
Net income (loss)	0.3	5.6	(4.6)	(1.9)	8.4	7.3
Adjustment for accounting change			(0.5)			(6.9)
Stockholders' Equity Attributable to Parent, end of period	(144.6)	(144.9)	(150.5)	(152.3)	(150.4)	(158.8)	(144.6)	(152.3)
Treasury Stock [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity Attributable to Parent, beginning of period	(25.6)	(25.5)	(25.3)	(26.0)	(26.0)	(25.5)	(25.3)	(25.5)
Other	0.1	(0.1)	(0.2)			(0.5)
Stockholders' Equity Attributable to Parent, end of period	(25.5)	(25.6)	(25.5)	(26.0)	(26.0)	(26.0)	(25.5)	(26.0)
AOCI Attributable to Parent [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity Attributable to Parent, beginning of period	(122.6)	(118.0)	(122.4)	(122.5)	(117.9)	(125.3)	(122.4)	(125.3)
Foreign currency translations	(2.5)	(5.5)	3.8	(5.5)	(5.7)	6.3
Post-retirement benefit plans	0.6	0.9	0.6	1.2	1.1	1.1
Stockholders' Equity Attributable to Parent, end of period	$ (124.5)	$ (122.6)	$ (118.0)	$ (126.8)	$ (122.5)	$ (117.9)	$ (124.5)	$ (126.8)

XML

Restructuring and Severance (Details) - USD ($) $ in Millions	3 Months Ended			9 Months Ended
	Aug. 31, 2019	May 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018	Nov. 30, 2018
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 0.8		$ 0.4	$ 4.9	$ 1.8
Payments for Restructuring				6.0
Proceeds from Sale of Property, Plant, and Equipment				5.5	0.0
Gain (Loss) on Disposition of Property Plant Equipment	0.1		0.0	4.2	0.0
Restructuring Reserve	0.0			0.0		$ 1.1
Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0.8		0.4	2.7	1.8
Specialty Solutions [Member] | Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0.3		0.0	0.3	0.7
Performance Materials [Member] | Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0.5		0.4	2.2	0.4
Performance Materials [Member] | Facility Closing [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0.0		0.0	2.2	0.0
Corporate, Non-Segment [Member] | Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 0.0		$ 0.0	0.2	$ 0.7
2018 restructuring plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges				4.2
Proceeds from Sale of Property, Plant, and Equipment		$ 4.9
Gain (Loss) on Disposition of Property Plant Equipment		$ 4.4
2017 restructuring plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges				0.7
Project Life to Date [Member] | 2018 restructuring plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges				6.0
Project Life to Date [Member] | 2017 restructuring plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges				$ 5.9

XML

Debt and Credit Lines Capital Lease Schedule (Details) - USD ($) $ in Millions	Aug. 31, 2019	Nov. 30, 2018
Debt Disclosure [Abstract]
2019	$ 0.4
2020	1.5
2021	1.5
2022	1.4
2023	1.4
Thereafter	15.2
Total minimum lease payments	21.4
Less: Amount representing estimated executory costs	(0.5)
Net minimum lease payments	20.9
Less: Amount representing interest	(5.8)
Present value of minimum lease payments	$ 15.1	$ 15.6

XML

Restructuring and Severance (Tables)

9 Months Ended

Aug. 31, 2019

Restructuring and Related Activities [Abstract]

Restructuring and Related Costs [Table Text Block]

The following table is a summary of restructuring and severance charges for the three and nine months ended August 31, 2019 and 2018:

	Three Months Ended August 31,				Nine Months Ended August 31,
	2019		2018		2019		2018
	(Dollars in millions)
Severance Expense:
Specialty Solutions	$	.3	$	—	$	.3	$	.7
Performance Materials	.5		.4		2.2		.4
Corporate	—		—		.2		.7
Total Severance Costs	.8		.4		2.7		1.8
Facility Closure Costs:
Performance Materials	—		—		2.2		—
Total Restructuring and Severance Costs	$	.8	$	.4	$	4.9	$	1.8

Schedule of Restructuring Reserve by Type of Cost [Table Text Block]

The following table summarizes the Company's liabilities related to restructuring and severance activities:

	November 30, 2018		2019				August 31, 2019
			Provision		Payments
	(Dollars in millions)
Total	$	1.1	$	4.9	$	6.0	$	—

XML

Business Segment Information

9 Months Ended

Aug. 31, 2019

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

Business Segment Information

The Company's two reporting segments are Specialty Solutions and Performance Materials. These two reporting segments were determined based on products and services provided as defined under ASC 280, Segment Reporting. Accounting policies of the segments are the same as the Company’s accounting policies. The Company’s reporting segments are strategic business units that offer different products and services. They are managed separately based on certain differences in their operations, technology, and marketing strategies.

Segment operating profit represents net sales less applicable costs, expenses and provisions for restructuring and severance costs, asset write-offs and acquisition and integration related expenses relating to operations. However, Management excludes restructuring and severance costs, asset write-offs, and acquisition and integration related costs when evaluating the results and allocating resources to the segments.

Segment operating profit excludes certain unallocated corporate headquarters expenses. Corporate headquarters expense includes the cost of providing and maintaining the corporate headquarters functions, including salaries, rent, travel and

entertainment expenses, depreciation, utility costs, outside services, amortization of deferred financing costs and Merger related costs.

The following table summarizes operations by segment and a reconciliation of segment sales to consolidated sales and segment operating profit to income (loss) before income taxes:

	Three Months Ended August 31,						Nine Months Ended August 31,
	2019			2018			2019			2018
	(Dollars in millions)
Net Sales:
Specialty Solutions	$	137.7		$	122.1		$	392.7		$	360.0
Performance Materials	54.7			71.5			174.3			218.5
Total Net Sales	$	192.4		$	193.6		$	567.0		$	578.5
Segment Operating Profit:
Specialty Solutions	$	20.0		$	19.5		$	49.3		$	55.0
Performance Materials	(4.4		)	(7.9		)	(6.4		)	(5.6		)
Total segment operating profit	15.6			11.6			42.9			49.4
Interest expense	(5.1		)	(4.7		)	(15.3		)	(14.4		)
Corporate expenses	(9.6		)	(6.5		)	(24.9		)	(21.6		)
Income (Loss) Before Income Taxes	$	.9		$	.4		$	2.7		$	13.4

XML

Description of Business, Basis of Presentation, and New Accounting Standards Description of Business (Policies)

9 Months Ended

Aug. 31, 2019

Description of Business [Abstract]

Nature of Operations

Description of Business

The Company is an innovator of emulsion polymers, specialty chemicals, and engineered surfaces for a variety of commercial, industrial, and residential end uses. The Company's products provide a variety of important functional and aesthetic benefits to hundreds of products that people use daily. The Company holds leading positions in key market categories, which have been built through innovative products, customized product solutions, strong technical expertise, well-established distribution channels, recognized brands, and long-standing customer relationships. The Company utilizes strategically-located manufacturing, technical, and other facilities in North America, Europe, China, and Thailand to service a broad customer base. The Company has two business segments: Specialty Solutions, which is focused on the Company's higher growth specialty businesses, and Performance Materials, which is focused on the Company’s more mature businesses.

Specialty Solutions – The Specialty Solutions segment develops, designs, produces, and markets a broad line of specialty polymers for use in coatings, adhesives, sealants, elastomers, nonwovens, and oil & gas products, as well as laminates and films. These products are used in numerous applications, including architectural and industrial coatings; nonwovens used in hygiene products, filtration, and construction; drilling additives for oil and gas exploration and production; elastomeric modification of plastic casings and hoses used in household and industrial products and automobiles; tapes and adhesives; sports surfaces; textile finishes; commercial building refurbishment; new construction; residential cabinets; flooring; ceiling tile; furnishings; manufactured housing; health care patient and common area furniture; and a variety of industrial films applications. The segment's products enhance our customers’ products performance, including stain, rust and aging resistance; surface modification; gloss; softness or hardness; dimensional stability; high heat and pressure tolerance; and binding and barrier (e.g. moisture, oil) properties.

The Specialty Solutions segment consists of Specialty Coatings & Ingredients, Oil & Gas, and Laminates & Films. The Specialty Coatings & Ingredients business line encompasses products that have applications for specialty coatings, nonwovens (such as disposable hygiene products, engine filters, roofing mat, and scrub pads), construction, adhesives, sealants, tape, floor care, textiles, graphic arts, and various other specialty applications. Oil & Gas applications include drilling fluid additives, which provide fluid loss control and sealing to enhance wellbore integrity, as well as cement additives for gas migration and fluid loss. The Laminates & Films product line applications include kitchen and bath cabinets, wall surfacing, manufactured housing and recreational vehicle interiors, flooring, commercial and residential furniture, retail display fixtures, home furnishings, commercial appliances, and a variety of industrial film applications.

Performance Materials – The Performance Materials segment serves mature markets with a broad range of emulsion polymers based primarily on styrene butadiene (SB), styrene butadiene acrylonitrile (SBA), styrene butadiene vinyl pyridine, high styrene pigments, polyvinyl acetate, acrylic, styrene acrylic, calcium stearate, glyoxal, and bio-based chemistries. Performance Materials' custom-formulated products are tailored latexes, resins, binders, antioxidants, hollow plastic pigment, coated fabrics, and rubber reinforcing which are used in tire cord, polymer stabilization, industrial rubbers, carpet binders, paper coatings, and various other applications. Its products provide a variety of functional properties to enhance the Company’s

customers’ products, including greater strength, adhesion, dimensional stability, ultraviolet resistance, improved processibility, and enhanced appearance.

The Performance Materials segment encompasses performance additives, paper coatings, carpet binders, and coated fabrics. This segment includes products that have applications in the paper coatings, paperboard, carpet binders, polymer stabilization, industrial rubbers, and tire cord industries. Paper and paperboard coatings are used in magazines, catalogs, direct mail advertising, brochures, printed reports, food cartons, household, and other consumer and industrial packaging. Carpet binders are used to secure carpet fibers to carpet backing and meet stringent manufacturing, environmental, odor, flammability, and flexible installation requirements. Tire cord is used in automotive tires. The Coated Fabrics product line applications include upholstery used in refurbishment and new construction for the commercial office, hospitality, health care, retail, education and restaurant markets, marine and transportation seating, commercial and residential furniture, automotive soft tops, and automotive after-market applications.

XML

Financial Instruments and Fair Value Measurements

9 Months Ended

Aug. 31, 2019

Fair Value Disclosures [Abstract]

Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]

Financial Instruments and Fair Value Measurements

Financial Risk Management Objectives and Policies

The Company is exposed primarily to credit, interest rate, and foreign currency rate risks, which arise in the normal course of business.

Credit Risk

Credit risk is the potential financial loss resulting from the failure of a customer or counterparty to settle its financial and contractual obligations with the Company as and when they fall due. The primary credit risk for the Company is its accounts receivable, which are generally unsecured. The Company has established credit limits for customers and monitors their balances to mitigate its risk of loss. Concentrations of credit risk with respect to accounts receivable are generally limited due to the wide variety of customers and markets using the Company's products. There was no single customer that represented more than 10% of the Company’s consolidated net sales during the three and nine month periods ending August 31, 2019 and 2018. There was no single customer who represented more than 10% of the Company’s net trade receivables at August 31, 2019 or November 30, 2018.

Interest Rate Risk

The Company’s exposure to the risk of changes in market interest rates relates primarily to the Company’s Term Loan B, Senior Secured Revolving Credit Facility, and various foreign subsidiary borrowings, all of which bear interest at variable rates, approximating market interest rates.

Foreign Currency Rate Risk

The Company incurs foreign currency rate risk on sales and purchases denominated in other than the functional currency. The currencies giving rise to this risk are primarily the Euro, Great Britain Pound Sterling, Renminbi, and Thai Baht.

Foreign currency exchange contracts are used by the Company to manage risks from the change in market exchange rates on cash payments by the Company's foreign subsidiaries and U.S. Dollar cash holdings in foreign locations. These forward contracts are used on a continuing basis for periods of approximately 30 days, consistent with the underlying hedged transactions. Hedging intends to offset the impact of foreign exchange rate movements on the Company’s operating results. The counterparties to these instruments are investment-grade financial institutions and the Company does not anticipate any non-performance. The Company maintains control over the size of positions entered into with any one counterparty and regularly monitors the credit rating of these institutions. Such instruments are not purchased or sold for trading purposes. These contracts are not designated as hedging instruments and changes in fair value of these instruments are recognized in earnings immediately. Foreign currency transaction gains and losses, including the impact of foreign currency contracts, that were recorded in the Consolidated Statements of Operations, as a component of other income (loss), was a loss of $0.1 million and a gain of $0.2 million for the nine-month periods ending August 31, 2019 and 2018, respectively.

Derivative Instruments

The Company recognizes the fair value of qualifying derivative instruments as either an asset or a liability within its Consolidated Balance Sheets. For derivative instruments not designated as hedges, the change in fair value of the derivative is recognized in earnings each reporting period. The Company defines fair value as the price that would be received to transfer an asset or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company uses a hierarchy of valuation inputs to measure fair value.

The hierarchy prioritizes the inputs into three broad levels:

Level 1 inputs—Quoted market prices in active markets for identical assets or liabilities.

Level 2 inputs—Observable market based inputs or unobservable inputs that are corroborated by market data.

Level 3 inputs—Unobservable inputs that are not corroborated by market data.

Fair Value Measurements

The Company uses the market approach and the income approach to value assets and liabilities as appropriate. The following financial assets and liabilities are measured and presented at fair value on a recurring basis as of August 31, 2019 and November 30, 2018:

	Notional Amount		Fair Value		Level 1		Level 2		Level 3
	(Dollars in millions)
Fair value measurements - August 31, 2019:
Financial liabilities
Foreign currency exchange contracts	$	17.3	$	.1	$	—	$	.1	$	—
Contingent consideration (1)	—		—		—		—		—
Total liabilities	$	17.3	$	.1	$	—	$	.1	$	—
Fair value measurements - November 30, 2018:
Financial assets
Foreign currency exchange contracts	$	16.5	$	.1	$	—	$	.1	$	—
Total assets	$	16.5	$	.1	$	—	$	.1	$	—
Financial liabilities
Contingent consideration (1)	$	—	$	.6	$	—	$	—	$	.6
Total liabilities	$	—	$	.6	$	—	$	—	$	.6

⁽¹⁾ Contingent consideration obligations arise from business or product line acquisitions. The fair values are based on a probability weighted discounted cash flow analysis reflecting an estimated achievement of specified performance measures of the acquired product lines. Contingent consideration is classified in the consolidated balance sheets as other current liabilities or other non-current liabilities based on contractual payment dates.

The changes in Level 3 assets and liabilities measured at fair value on a recurring basis during the first nine months of 2019 are summarized as follows:

	Contingent Consideration
	(Dollars in millions)
Balance at November 30, 2018	$	.6
Adjustments	(.6		)
Balance at August 31, 2019	$	—

There were no transfers into or out of Level 3 during the first nine months of 2019 or 2018. During the second quarter of fiscal 2019, the Company removed the contingent consideration liability based on its expected value. Changes in expected value are recognized in other income within the consolidated statements of operations.

The fair value of the Company’s Term Loan B at August 31, 2019 approximated $299.1 million, which is slightly less than its book value of $299.5 million as a result of prevailing market rates on the Company’s debt. The fair value of the Term

Loan B is based on market price information and is measured using the last available trade of the instrument on a secondary market in each respective period and therefore is considered a Level 2 measurement. The fair value is not indicative of the amount that the Company would have to pay to redeem these instruments since they are infrequently traded and are not callable at this value. The carrying value of the Senior Secured Revolving Credit Facility approximates fair value. The fair value of the Company's capital lease obligation approximates its carrying amount based on estimated borrowing rates to discount the future cash flows to their present value.

XML

Consolidated Statements of Financial Position (Parenthetical) - $ / shares	Aug. 31, 2019	Nov. 30, 2018
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 1	$ 1
Preferred stock, shares authorized	15,000,000	15,000,000
Preferred stock, outstanding	0	0
Common stock, par value	$ 0.1	$ 0.10
Common stock, shares authorized	135,000,000	135,000,000
Common stock, shares issued	48,300,000	48,300,000
Treasury stock, shares	3,400,000	3,400,000
Common Stock, Shares, Outstanding	44,900,000	44,900,000

XML

Document and Entity Information	9 Months Ended
	Aug. 31, 2019 $ / shares shares
Document and Entity Information [Abstract]
Title of 12(b) Security	Common Stock
Entity Incorporation, State or Country Code	OH
Document Type	10-Q
Document Period End Date	Aug. 31, 2019
Entity File Number	1-15147
Entity Registrant Name	OMNOVA SOLUTIONS INC
Entity Address, Address Line One	25435 Harvard Road
Entity Address, City or Town	Beachwood
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	44122-6201
City Area Code	216
Local Phone Number	682-7000
Document Fiscal Year Focus	2019
Entity Common Stock, Shares Outstanding | shares	44,853,732
Entity Listing, Par Value Per Share | $ / shares	$ 0.10
Amendment Flag	false
Current Fiscal Year End Date	--11-30
Document Fiscal Period Focus	Q3
Entity Central Index Key	0001090061
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Shell Company	false
Entity Tax Identification Number	34-1897652
Trading Symbol	OMN
Security Exchange Name	NYSE
Document Quarterly Report	true
Document Transition Report	false

XML

Employee Benefit Plans (Tables)

9 Months Ended

Aug. 31, 2019

Retirement Benefits [Abstract]

Components of Net Periodic Benefit Costs

Net periodic benefit cost (income) consisted of the following for the three and nine month periods ending August 31, 2019 and 2018:

	Pension Plans						Health Care Plans
	(Dollars in millions)
Three months ended August 31, 2019 and 2018	2019			2018			2019			2018
Service costs	$	.8		$	.6		$	—		$	—
Interest costs	2.5			2.2			.1			.1
Expected return on plan assets	(4.0		)	(3.9		)	—			—
Amortization of net actuarial (gain) loss	1.1			1.4			(.4		)	(.2		)
Net periodic cost (benefit)	$	.4		$	.3		$	(.3	)	$	(.1	)
	Pension Plans						Health Care Plans
	(Dollars in millions)
Nine months ended August 31, 2019 and 2018	2019			2018			2019			2018
Service costs	$	2.2		$	1.9		$	—		$	—
Interest costs	7.6			6.7			.2			.2
Expected return on plan assets	(11.8		)	(11.7		)	—			—
Amortization of net actuarial (gain) loss	3.4			4.1			(1.0		)	(.7		)
Net periodic cost (benefit)	$	1.4		$	1.0		$	(.8	)	$	(.5	)

XML

Shareholders' Equity (Tables)

9 Months Ended

Aug. 31, 2019

Statement of Stockholders' Equity [Abstract]

Schedule of Stockholders Equity [Table Text Block]

The following tables reflect the changes in shareholders' equity for the nine months ended August 31, 2019 and 2018:

	Number of Common Shares Outstanding		Common Stock		Additional Contributed Capital			Retained Deficit			Treasury Stock			Accumulated Other Comprehensive Income (Loss)			Total Shareholders' Equity
	(Dollars and shares in millions)
Balance November 30, 2018	44.9		$	4.8	$	345.9		$	(145.4	)	$	(25.3	)	$	(122.4	)	$	57.6
Net income (loss)								(4.6		)							(4.6		)
Foreign currency translations														3.8			3.8
Adjustment for accounting change								(.5		)							(.5		)
Post-retirement benefit plans														.6			.6
Share-based compensation					.3												.3
Other	(.1	)									(.2		)				(.2		)
Balance February 28, 2019	44.8		$	4.8	$	346.2		$	(150.5	)	$	(25.5	)	$	(118.0	)	$	57.0
Net income (loss)								5.6									5.6
Foreign currency translations														(5.5		)	(5.5		)
Post-retirement benefit plans														.9			.9
Share-based compensation					1.5												1.5
Other					.3						(.1		)				.2
Balance May 31, 2019	44.8		$	4.8	$	348.0		$	(144.9	)	$	(25.6	)	$	(122.6	)	$	59.7
Net income (loss)								.3									.3
Foreign currency translations														(2.5		)	(2.5		)
Post-retirement benefit plans														.6			.6
Shared-based compensation					1.0												1.0
Other	.1				(.5		)				.1						(.4		)
Balance August 31, 2019	44.9		4.8		348.5			(144.6		)	(25.5		)	(124.5		)	58.7
Balance November 30, 2017	44.8		$	4.8	$	343.4		$	(159.2	)	$	(25.5	)	$	(125.3	)	$	38.2
Net income (loss)								7.3									7.3
Foreign currency translations														6.3			6.3
Adjustment for accounting change								(6.9		)							(6.9		)
Post-retirement benefit plans														1.1			1.1
Share-based compensation					.5												.5
Other					.5						(.5		)				—
Balance February 28, 2018	44.8		$	4.8	$	344.4		$	(158.8	)	$	(26.0	)	$	(117.9	)	$	46.5
Net income (loss)								8.4									8.4
Foreign currency translations														(5.7		)	(5.7		)
Post-retirement benefit plans														1.1			1.1
Share-based compensation					.4												.4
Other	.1				.3												.3
Balance May 31, 2018	44.9		$	4.8	$	345.1		$	(150.4	)	$	(26.0	)	$	(122.5	)	$	51.0
Net income (loss)								(1.9		)							(1.9		)
Foreign currency translations														(5.5		)	(5.5		)
Post-retirement benefit plans														1.2			1.2
Share-based compensation					1.2												1.2
Other					(.6		)										(.6		)
Balance August 31, 2018	44.9		4.8		345.7			(152.3		)	(26.0		)	(126.8		)	45.4

XML

Revenue Recognition (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018
Disaggregation of Revenue [Line Items]
Net sales	$ 192.4	$ 193.6	$ 567.0	$ 578.5
Americas [Member]
Disaggregation of Revenue [Line Items]
Net sales	121.8		330.2
Asia [Member]
Disaggregation of Revenue [Line Items]
Net sales	19.3		81.6
Europe [Member]
Disaggregation of Revenue [Line Items]
Net sales	51.3		155.2
Specialty Solutions [Member]
Disaggregation of Revenue [Line Items]
Net sales	137.7		392.7
Specialty Solutions [Member] | Americas [Member]
Disaggregation of Revenue [Line Items]
Net sales	88.7		219.8
Specialty Solutions [Member] | Asia [Member]
Disaggregation of Revenue [Line Items]
Net sales	8.4		39.2
Specialty Solutions [Member] | Europe [Member]
Disaggregation of Revenue [Line Items]
Net sales	40.6		133.7
Performance Materials [Member]
Disaggregation of Revenue [Line Items]
Net sales	54.7		174.3
Performance Materials [Member] | Americas [Member]
Disaggregation of Revenue [Line Items]
Net sales	33.1		110.4
Performance Materials [Member] | Asia [Member]
Disaggregation of Revenue [Line Items]
Net sales	10.9		42.4
Performance Materials [Member] | Europe [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 10.7		$ 21.5

XML

Earnings (Loss) Per Share

9 Months Ended

Aug. 31, 2019

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share

The following table summarizes the computation of earnings per common share and earnings per common share, assuming dilution:

	Three Months Ended August 31,					Nine Months Ended August 31,
	2019		2018			2019		2018
	(Dollars and shares in millions, except per share data)
Numerator:
Net income (loss)	$	.3	$	(1.9	)	$	1.3	$	13.7
Denominator:
Denominator for basic earnings (loss) per share - weighted average shares outstanding	44.8		44.5			44.8		44.6
Effect of dilutive securities	.9		—			.8		.2
Denominator for dilutive earnings (loss) per share - adjusted weighted average shares and assumed conversions	45.7		44.5			45.6		44.8
Net income (loss) per share - Basic and Diluted	$	.01	$	(.04	)	$	.03	$	.31

There are no anti-dilutive securities for the periods presented.

XML

Debt and Credit Lines

9 Months Ended

Aug. 31, 2019

Debt Disclosure [Abstract]

Debt and Credit Lines

Debt and Credit Lines

Debt obligations due within the next twelve months consist of the following:

	August 31, 2019		November 30, 2018
	(Dollars in millions)
$350 million Term Loan B, due 2023, current portion (interest at 5.48% and 5.55%, respectively)	$	3.5	$	3.5
Capital lease obligations, current portion	.8		.7
Total	$	4.3	$	4.2

The Company’s long-term debt consists of the following:

	August 31, 2019			November 30, 2018
	(Dollars in millions)
$350 million Term Loan B, due 2023 (interest at 5.48% and 5.55%, respectively)	$	299.5		$	302.1
Senior Secured Revolving Credit, due 2021 (interest at 3.69% and 3.88%, respectively)	18.2			12.0
Capital lease obligations	15.1			15.6
Gross debt	332.8			329.7
Less: current portion	(4.3		)	(4.2		)
Unamortized original issue discount	(1.7		)	(2.1		)
Debt issuance costs	(4.0		)	(4.7		)
Total long-term debt, net of current portion	$	322.8		$	318.7

The weighted-average interest rate on the Company’s short-term debt was 5.61% and 5.27% during the third quarters of 2019 and 2018, respectively.

Term Loan B        

The Company's $350.0 million Term Loan B ("Term Loan B") matures on August 26, 2023 and is primarily secured by all real property, plant, and equipment of the Company's U.S. facilities and fully and unconditionally and jointly and severally guaranteed by the material U.S. subsidiaries of the Company. The Term Loan B contains affirmative and negative covenants, including a requirement to maintain a net debt leverage ratio of 5.0 to 1.0, limitations on additional debt, certain investments, and acquisitions outside of the Company’s line of business. The Company is in compliance with its Term Loan B covenants as of August 31, 2019.

The Company's Term Loan B has an interest rate of LIBOR plus 3.25%. The Term Loan B agreement permits the Company to request additional term loans or incremental equivalent debt borrowings (the “Additional Term Loans”) in a maximum aggregate amount equal to the greater of (a) $120.0 million and (b) an aggregate principal amount such that, on a pro forma basis (giving effect to any Additional Term Loans), the Company’s senior secured net debt leverage ratio will not exceed 4.0 to 1.0.

Senior Secured Revolving Credit Facility

The Company has a Senior Secured Revolving Credit Facility (the "Facility") which matures on August 26, 2021. The Facility is secured by U.S. accounts receivable, inventory, and intangible assets. The Facility contains affirmative and negative

covenants, similar to the Term Loan B, including limitations on additional debt, certain investments and acquisitions outside of the Company’s line of business. If the average excess availability of the Facility falls below $25.0 million during any fiscal quarter, the Company must then maintain a fixed charge coverage ratio greater than 1.1 to 1.0 as defined in the agreement. The Company was in compliance with this requirement at August 31, 2019. At August 31, 2019 there was a balance of $18.2 million borrowed under the Facility and the amount available for borrowing under the Facility was $46.5 million.

Eurodollar Revolving Loan

The Company amended its Eurodollar Revolving Loan ("Revolver") effective June 14, 2019. Total borrowing capacity of the Revolver was increased from €16.0 million to €25.0 million. In addition, the Company has the ability to increase borrowing capacity through a €9.0 million expansion feature as needed. The Revolver is secured by European accounts receivable. All other material terms are unchanged and similar to the Company's U.S. Facility, including the maturity date of August 26, 2021. The Revolver provides additional liquidity and working capital flexibility in Europe. At August 31, 2019 there were no amounts borrowed under the Revolver and the amount available for borrowing under the Revolver was €19.3 million.

Other Debt

The Company has borrowing facilities at certain of its foreign subsidiaries, which consist of overdraft lines, working capital credit lines, and facilities for the issuance of letters of credit and short-term borrowing needs. Total borrowing capacity for these facilities was $11.9 million and $7.0 million as of August 31, 2019 and November 30, 2018, respectively. There were no amounts borrowed under these facilities at August 31, 2019 and November 30, 2018.

Capital Lease Obligations

At August 31, 2019, the Company had net assets under capital leases totaling $14.0 million, which are included in property, plant, and equipment in the accompanying Consolidated Balance Sheets.

The following is a schedule by year of future minimum lease payments under the Company's capital leases together with the present value of the net future minimum lease payments as of August 31, 2019:

Year Ending November 30:	(Dollars in millions)
2019	$	.4
2020	1.5
2021	1.5
2022	1.4
2023	1.4
Thereafter	15.2
Total minimum lease payments	21.4
Less: Amount representing estimated executory costs	(.5		)
Net minimum lease payments	20.9
Less: Amount representing interest	(5.8		)
Present value of minimum lease payments	$	15.1

Debt Issuance Costs and Original Issue Discounts

Debt issuance costs and original issue discounts incurred in connection with the issuance of the Company's debt are being amortized over the respective terms of the underlying debt, including any amendments. Total amortization expense of debt issuance costs and original issue discounts is included as a component of interest expense and was $0.4 million for both the three months ended August 31, 2019 and 2018, and $1.1 million and $1.0 million for the nine months ended August 31, 2019 and 2018, respectively.

During the quarter ended February 28, 2018, the Company made a $40.0 million prepayment and determined that this constituted a partial extinguishment of debt and as such, wrote-off $0.8 million of debt issuance costs and original issue discounts.

XML

Debt and Credit Lines Additional Information (Details) € in Millions	3 Months Ended			9 Months Ended
	Aug. 31, 2019 USD ($)	Aug. 31, 2018 USD ($)	Feb. 28, 2018 USD ($)	Aug. 31, 2019 USD ($)	Aug. 31, 2018 USD ($)	Aug. 31, 2019 EUR (€)	May 31, 2019 EUR (€)	Nov. 30, 2018 USD ($)	Nov. 30, 2018 EUR (€)
Debt Instrument [Line Items]
Short-term Debt, Weighted Average Interest Rate, over Time	5.61%	5.27%
Capital Leased Assets	$ 14,000,000.0			$ 14,000,000.0
Amortization of Debt Issuance Costs and Discounts	400,000	$ 400,000		1,100,000	$ 1,000,000.0
Debt issuance costs write-off	$ 200,000	$ 0	$ 800,000	$ 200,000	$ 800,000
Senior Secured Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Expiration Date				Aug. 26, 2021
Line of Credit Facility, Maximum Amount Outstanding During Period				$ 25,000,000.0
Fixed Charge Coverage Ratio Required by Debt Covenant	1.1			1.1		1.1
Long-term Line of Credit, Outstanding Borrowings	$ 18,200,000			$ 18,200,000
Line of Credit Facility, Remaining Borrowing Capacity	46,500,000			46,500,000
Eurodollar Revolver [Domain]
Debt Instrument [Line Items]
Line of Credit Facility, Expansion Feature | €						€ 9.0
Long-term Line of Credit, Outstanding Borrowings | €						0.0
Line of Credit Facility, Remaining Borrowing Capacity | €						19.3
Line of Credit Facility, Maximum Borrowing Capacity | €						25.0	€ 16.0
Foreign Line of Credit [Member]
Debt Instrument [Line Items]
Long-term Line of Credit, Outstanding Borrowings | €						€ 0.0			€ 0.0
Line of Credit Facility, Maximum Borrowing Capacity	11,900,000			11,900,000				$ 7,000,000.0
Term Loan B [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 350,000,000.0			$ 350,000,000.0
Net Leverage Ratio Required by Debt Covenant	5.0			5.0		5.0
Debt Instrument, Basis Spread on Variable Rate				3.25%
Line of Credit Facility, Expansion Feature	$ 120,000,000.0			$ 120,000,000.0
Repayments of Debt			$ 40,000,000.0

XML

Employee Benefit Plans Components of Net Periodic Benefit Cost (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018
Pension Plan [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service costs	$ 0.8	$ 0.6	$ 2.2	$ 1.9
Interest costs	2.5	2.2	7.6	6.7
Expected return on plan assets	(4.0)	(3.9)	(11.8)	(11.7)
Amortization of net actuarial (gain) loss	1.1	1.4	3.4	4.1
Net periodic cost (benefit)	0.4	0.3	1.4	1.0
Postretirement Health Coverage [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service costs	0.0	0.0	0.0	0.0
Interest costs	0.1	0.1	0.2	0.2
Expected return on plan assets	0.0	0.0	0.0	0.0
Amortization of net actuarial (gain) loss	(0.4)	(0.2)	(1.0)	(0.7)
Net periodic cost (benefit)	$ (0.3)	$ (0.1)	$ (0.8)	$ (0.5)

XML

Additional Information (Details) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended
	Aug. 31, 2019 USD ($) $ / shares	Aug. 31, 2018 USD ($)	Aug. 31, 2019 segment $ / shares	Aug. 31, 2019 $ / shares	Aug. 31, 2019 USD ($) $ / shares	Aug. 31, 2018 USD ($)	Feb. 28, 2019 USD ($)	Nov. 30, 2018 $ / shares	Feb. 28, 2018 USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Common stock, par value | $ / shares	$ 0.1		$ 0.1	$ 0.1	$ 0.1			$ 0.10
Number of Reportable Segments			2	2
Cumulative Effect of New Accounting Principle in Period of Adoption							$ (0.5)		$ (6.9)
Prior Period Reclassification Adjustment	$ 0.7	$ 0.4			$ 1.6	$ 1.4

XML

Share-Based Employee Compensation Share-Based Employee Compensation (Tables)

9 Months Ended

Aug. 31, 2019

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Share-based Compensation, Activity [Table Text Block]

A summary of the RSA, RSU, and PSU activity for 2019 follows:

	Share Awards & Units		Weighted-Average Grant Date Fair Value per Share
Nonvested at December 1, 2018	1,350,313		$	8.11
Granted	623,449		$	7.18
Vested	(226,646	)	$	6.50
Canceled and Forfeited	(30,587	)	$	7.92
Nonvested at August 31, 2019	1,716,529		$	7.99

XML

Accumulated Other Comprehensive Income (Loss) (Tables)

9 Months Ended

Aug. 31, 2019

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]

The following tables reflect the changes in the components of accumulated other comprehensive income (loss), net of tax, for the three and nine months ended August 31, 2019 and 2018:

	Foreign Currency Items			Defined Benefit Plans			Accumulated Other Comprehensive (Income) Loss
Three months ended August 31, 2019 and 2018	(Dollars in millions)
Balance May 31, 2019	$	(34.3	)	$	(88.3	)	$	(122.6	)
Other comprehensive income (loss) before reclassifications	(2.5		)	—			(2.5		)
Amounts reclassified to earnings (a)	—			.6			.6
Balance August 31, 2019	$	(36.8	)	$	(87.7	)	$	(124.5	)
Balance May 31, 2018	$	(22.5	)	$	(100.0	)	$	(122.5	)
Other comprehensive income (loss) before reclassifications	(5.5		)	—			(5.5		)
Amounts reclassified to earnings (a)	—			1.2			1.2
Balance August 31, 2018	$	(28.0	)	$	(98.8	)	$	(126.8	)
Nine months ended August 31, 2019 and 2018
Balance November 30, 2018	$	(32.6	)	$	(89.8	)	$	(122.4	)
Other comprehensive income (loss) before reclassifications	(4.2		)	—			(4.2		)
Amounts reclassified to earnings (a)	—			2.1			2.1
Balance August 31, 2019	$	(36.8	)	$	(87.7	)	$	(124.5	)
Balance November 30, 2017	$	(23.1	)	$	(102.2	)	$	(125.3	)
Other comprehensive income (loss) before reclassifications	(4.9		)	—			(4.9		)
Amounts reclassified to earnings (a)	—			3.4			3.4
Balance August 31, 2018	$	(28.0	)	$	(98.8	)	$	(126.8	)

^(a) Amounts reclassified from accumulated other comprehensive income (loss) related to defined benefit plans were included in net periodic benefit expense.

XML

Accumulated Other Comprehensive Income (Loss)

9 Months Ended

Aug. 31, 2019

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Comprehensive Income (Loss) Note [Text Block]

Accumulated Other Comprehensive Income (Loss)

The following tables reflect the changes in the components of accumulated other comprehensive income (loss), net of tax, for the three and nine months ended August 31, 2019 and 2018:

	Foreign Currency Items			Defined Benefit Plans			Accumulated Other Comprehensive (Income) Loss
Three months ended August 31, 2019 and 2018	(Dollars in millions)
Balance May 31, 2019	$	(34.3	)	$	(88.3	)	$	(122.6	)
Other comprehensive income (loss) before reclassifications	(2.5		)	—			(2.5		)
Amounts reclassified to earnings (a)	—			.6			.6
Balance August 31, 2019	$	(36.8	)	$	(87.7	)	$	(124.5	)
Balance May 31, 2018	$	(22.5	)	$	(100.0	)	$	(122.5	)
Other comprehensive income (loss) before reclassifications	(5.5		)	—			(5.5		)
Amounts reclassified to earnings (a)	—			1.2			1.2
Balance August 31, 2018	$	(28.0	)	$	(98.8	)	$	(126.8	)
Nine months ended August 31, 2019 and 2018
Balance November 30, 2018	$	(32.6	)	$	(89.8	)	$	(122.4	)
Other comprehensive income (loss) before reclassifications	(4.2		)	—			(4.2		)
Amounts reclassified to earnings (a)	—			2.1			2.1
Balance August 31, 2019	$	(36.8	)	$	(87.7	)	$	(124.5	)
Balance November 30, 2017	$	(23.1	)	$	(102.2	)	$	(125.3	)
Other comprehensive income (loss) before reclassifications	(4.9		)	—			(4.9		)
Amounts reclassified to earnings (a)	—			3.4			3.4
Balance August 31, 2018	$	(28.0	)	$	(98.8	)	$	(126.8	)

^(a) Amounts reclassified from accumulated other comprehensive income (loss) related to defined benefit plans were included in net periodic benefit expense.

XML

Share-Based Employee Compensation

9 Months Ended

Aug. 31, 2019

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Share-Based Employee Compensation

Share-Based Employee Compensation

The Company provides compensation benefits to employees under the OMNOVA Solutions 2017 Equity Incentive Plan (the “Plan”), which was approved by shareholders on March 22, 2017. The Plan permits the Company to grant to officers, key employees and non-employee directors of the Company incentives directly linked to the price of OMNOVA Solutions’ common shares. The Plan authorizes the issuance of Company common shares in the aggregate for (a) awards of options rights to purchase Company common shares, (b) performance shares and performance units, (c) restricted shares, (d) restricted share units, or (e) appreciation rights. Shares granted under the Plan may be either newly issued shares or treasury shares or both. As

of August 31, 2019, approximately 1.9 million Company common shares remained available for grants under the Plan. All options granted under the Plan are granted at exercise prices equal to the market value of the Company’s common shares on the date of grant. Additionally, the Plan provides that the term of any option granted under the Plan may not exceed 10 years. Prior to March 22, 2017, the Company granted equity compensation under the OMNOVA Solutions Third Amended and Restated 1999 Equity and Performance Incentive Plan, which had substantially similar features.

The Company grants Performance Share Units ("PSU's") to its executive officers. The PSU's provide recipients the right to receive the Company's common shares if specified performance goals, including a performance goal relative to peers, are met over a three fiscal year measurement period. Each grantee receives a target grant of PSU's, but may earn between 0% and 200% (or in the case of the Company's Chief Executive Officer, between 0% and 160% for awards granted prior to 2019, and between 0% and 143% for grants made in 2019) of the target grant depending on the Company's performance against the stated performance goals.

Share-based compensation is measured at the grant date, based on the calculated fair value of the award, and is recognized as an expense over the requisite service period (generally the vesting period). The fair value of Restricted Share Awards ("RSA's"), Restricted Share Units ("RSU's"), and PSU's are determined based on the closing market price of the Company’s ordinary shares at the date of grant. RSU's entitle the holder to receive one ordinary share for each RSU at vesting, generally over a three year period from the date of grant. Estimates of fair value are not intended to predict actual future events or the value ultimately realized by employees who receive equity awards, and subsequent events are not indicative of the reasonableness of the original estimates of fair value made by the Company.

Compensation expense for all share-based payments included in general and administrative expense was $2.8 million and $2.1 million for the first nine months of 2019 and 2018, respectively.

As of August 31, 2019, there was $4.6 million of unrecognized compensation cost related to non-vested share-based compensation arrangements.

A summary of the RSA, RSU, and PSU activity for 2019 follows:

	Share Awards & Units		Weighted-Average Grant Date Fair Value per Share
Nonvested at December 1, 2018	1,350,313		$	8.11
Granted	623,449		$	7.18
Vested	(226,646	)	$	6.50
Canceled and Forfeited	(30,587	)	$	7.92
Nonvested at August 31, 2019	1,716,529		$	7.99

The Company also provides eligible employees the opportunity to purchase Company common shares through payroll deductions under the OMNOVA Solutions Employee Share Purchase Plan (the "ESPP"). The purchase price for common shares purchased from the Company will be 85% of the closing price of the common shares on the New York Stock Exchange on the investment date. Participants may contribute funds to the ESPP, not to exceed twenty-five thousand dollars in any calendar year. If a participant terminates his or her employment with the Company or its subsidiaries, the participant's participation will immediately terminate, uncommitted funds will be applied to the purchase of common shares, and the participant's account will be converted to a regular brokerage account. As of August 31, 2019, there were approximately 47,000 shares purchased by eligible participants through the ESPP.

XML

Debt and Credit Lines Phantom (Details) € in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Aug. 31, 2019 USD ($)	Aug. 31, 2018 USD ($)	Aug. 31, 2019 USD ($)	Aug. 31, 2018 USD ($)	Aug. 31, 2019 EUR (€)	Nov. 30, 2018 EUR (€)
Debt Instrument [Line Items]
Amortization of Debt Issuance Costs and Discounts	$ 0.4	$ 0.4	$ 1.1	$ 1.0
Term Loan B [Member]
Debt Instrument [Line Items]
Debt, Weighted Average Interest Rate	5.48%		5.48%		5.48%	5.55%
Senior Secured Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Debt, Weighted Average Interest Rate	3.69%		3.69%		3.69%	3.88%
Long-term Line of Credit, Outstanding Borrowings	$ 18.2		$ 18.2
Foreign Line of Credit [Member]
Debt Instrument [Line Items]
Long-term Line of Credit, Outstanding Borrowings | €					€ 0.0	€ 0.0

XML

Employee Benefit Plans Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018
Retirement Benefits [Abstract]
Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year	$ 6.4		$ 6.4
Defined Benefit Plan, Plan Assets, Contributions by Employer			3.0
Defined Contribution Plan, Cost	$ 0.6	$ 0.7	$ 2.0	$ 2.1

XML

Debt and Credit Lines Schedule of Long-Term Debt (Details) - USD ($) $ in Millions	Aug. 31, 2019	Nov. 30, 2018
Debt Instrument [Line Items]
Capital lease obligations	$ 15.1	$ 15.6
Gross debt	332.8	329.7
Less: current portion	(4.3)	(4.2)
Unamortized original issue discount	(1.7)	(2.1)
Debt issuance costs	4.0	4.7
Total long-term debt, net of current portion	322.8	318.7
Term Loan B [Member]
Debt Instrument [Line Items]
$350 million Term Loan B, due 2023 (interest at 5.48% and 5.55%, respectively)	299.5	302.1
Senior Secured Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Senior Secured Revolving Credit, due 2021 (interest at 3.69% and 3.88%, respectively)	$ 18.2	$ 12.0

XML

Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Accumulated Other Comprehensive Income (Loss), Net of Tax, beginning of period		$ (122.6)	$ (122.5)	$ (122.4)	$ (125.3)
Other comprehensive income (loss) before reclassifications		(2.5)	(5.5)	(4.2)	(4.9)
Amounts reclassified to earnings (a)	[1]	0.6	1.2	2.1	3.4
Accumulated Other Comprehensive Income (Loss), Net of Tax, end of period		(124.5)	(126.8)	(124.5)	(126.8)
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Accumulated Other Comprehensive Income (Loss), Net of Tax, beginning of period		(34.3)	(22.5)	(32.6)	(23.1)
Other comprehensive income (loss) before reclassifications		(2.5)	(5.5)	(4.2)	(4.9)
Amounts reclassified to earnings (a)	[1]	0.0	0.0	0.0	0.0
Accumulated Other Comprehensive Income (Loss), Net of Tax, end of period		(36.8)	(28.0)	(36.8)	(28.0)
Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Accumulated Other Comprehensive Income (Loss), Net of Tax, beginning of period		(88.3)	(100.0)	(89.8)	(102.2)
Other comprehensive income (loss) before reclassifications		0.0	0.0	0.0	0.0
Amounts reclassified to earnings (a)	[1]	0.6	1.2	2.1	3.4
Accumulated Other Comprehensive Income (Loss), Net of Tax, end of period		$ (87.7)	$ (98.8)	$ (87.7)	$ (98.8)

[1] Amounts reclassified from accumulated other comprehensive income (loss) related to defined benefit plans were included in net periodic benefit expense.

XML

Financial Instruments and Fair Value Measurements (Details) - USD ($) $ in Millions		9 Months Ended
		Aug. 31, 2019	Aug. 31, 2018	Nov. 30, 2018
Fair Value of Financial Instruments [Line Items]
Derivative, Description of Terms		P30D
Foreign Currency Transaction Gain (Loss), before Tax		$ 0.1	$ 0.2
Derivative Liability, Notional Amount		17.3		$ 0.0
Foreign Currency Contracts, Liability, Fair Value Disclosure		0.1
Business Combination, Contingent Consideration, Liability	[1]	0.0		0.6
Financial Liabilities Fair Value Disclosure		$ 0.1		0.6
Derivative Asset, Notional Amount				16.5
Foreign Currency Contract, Asset, Fair Value Disclosure				0.1
Assets, Fair Value Disclosure				0.1
Sales [Member]
Fair Value of Financial Instruments [Line Items]
Concentration Risk, Percentage		10.00%
Term Loan B [Member]
Fair Value of Financial Instruments [Line Items]
Long-term Debt, Fair Value		$ 299.1
$350 million Term Loan B, due 2023 (interest at 5.48% and 5.55%, respectively)		299.5		302.1
Contingent Consideration [Member]
Fair Value of Financial Instruments [Line Items]
Derivative Liability, Notional Amount	[1]	0.0		0.0
Foreign Exchange Contract [Member]
Fair Value of Financial Instruments [Line Items]
Derivative Liability, Notional Amount		$ 17.3
Derivative Asset, Notional Amount				16.5
Accounts Receivable [Member]
Fair Value of Financial Instruments [Line Items]
Concentration Risk, Percentage		10.00%
Fair Value, Inputs, Level 1 [Member]
Fair Value of Financial Instruments [Line Items]
Foreign Currency Contracts, Liability, Fair Value Disclosure		$ 0.0
Business Combination, Contingent Consideration, Liability	[1]	0.0		0.0
Financial Liabilities Fair Value Disclosure		0.0		0.0
Foreign Currency Contract, Asset, Fair Value Disclosure				0.0
Assets, Fair Value Disclosure				0.0
Fair Value, Inputs, Level 2 [Member]
Fair Value of Financial Instruments [Line Items]
Foreign Currency Contracts, Liability, Fair Value Disclosure		0.1
Business Combination, Contingent Consideration, Liability	[1]	0.0		0.0
Financial Liabilities Fair Value Disclosure		0.1		0.0
Foreign Currency Contract, Asset, Fair Value Disclosure				0.1
Assets, Fair Value Disclosure				0.1
Fair Value, Inputs, Level 3 [Member]
Fair Value of Financial Instruments [Line Items]
Foreign Currency Contracts, Liability, Fair Value Disclosure		0.0
Business Combination, Contingent Consideration, Liability	[1]	0.0		0.6
Financial Liabilities Fair Value Disclosure		0.0		0.6
Foreign Currency Contract, Asset, Fair Value Disclosure				0.0
Assets, Fair Value Disclosure				$ 0.0
Fair Value, Inputs, Level 3 [Member] | Contingent Consideration [Member]
Fair Value of Financial Instruments [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3		$ (0.6)

[1] Contingent consideration obligations arise from business or product line acquisitions. The fair values are based on a probability weighted discounted cash flow analysis reflecting an estimated achievement of specified performance measures of the acquired product lines. Contingent consideration is classified in the consolidated balance sheets as other current liabilities or other non-current liabilities based on contractual payment dates.

XML

Asset Impairment

9 Months Ended

Aug. 31, 2019

Property, Plant and Equipment [Abstract]

Asset Impairment Charges [Text Block]

Asset Impairment

During the third quarter of 2019, the Company recognized an impairment charge of $0.9 million within the Performance Materials segment. The impairment charge was based on estimated fair value utilizing the relief from royalty method of the Income Approach. Future reductions in forecasted revenues or royalty rates could result in additional trademark impairments.

During the third quarter of 2018, the Company approved a plan close the Green Bay, Wisconsin plant shifting styrene butadiene manufacturing to its production plant in Mogadore, Ohio. As a result, the Company determined that certain plant and equipment were impaired and recognized an impairment charge of $9.2 million, primarily in the Performance Materials segment, to write-down the asset group to fair value based on the market approach analysis.

XML

Description of Business, Basis of Presentation, and New Accounting Standards Accounting Policies Adopted (Policies)

9 Months Ended

Aug. 31, 2019

Accounting Policies [Abstract]

New Accounting Pronouncements, Policy [Policy Text Block]

Accounting Standards Adopted in 2019

In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-09, Revenue from Contracts with Customers Accounting Standards Codification ("ASC") Topic 606, which clarified existing accounting literature relating to how and when a company recognizes revenue. This standard prescribes a five-step model for recognizing revenue, the application of which will require a certain amount of judgment. The provisions of this ASU may be applied retroactively or on a modified retrospective (cumulative effect) basis. The standard requires additional disclosures in the notes to the consolidated financial statements, including qualitative and quantitative disclosures identifying the nature, amount, timing and significant judgments impacting revenue from contracts with customers. The Company adopted ASU 2014-09 during the first quarter of fiscal year 2019 and utilized the modified retrospective approach and recorded a cumulative effect adjustment to retained earnings of $0.5 million for the accounting impact of certain previously capitalized contract costs as of December 1, 2018.

In March 2017, the FASB issued ASU 2017-07, Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost, which requires that an employer report the service cost component in the same line item or items as other compensation costs arising from services rendered by the pertinent employees during the period. The amendments in this ASU also allow only the service cost component to be eligible for capitalization when applicable. ASU 2017-07 must be applied retrospectively for the presentation of the service cost component and the other components of net periodic benefit cost in the income statement and prospectively, on and after the effective date, for the capitalization of the service cost component of net periodic benefit cost in assets. The Company adopted ASU 2017-17 during the first quarter of fiscal year 2019. The Company elected to use the practical expedient to use amounts disclosed in the 2018 consolidated financial statements as an estimate for applying the retrospective presentation requirements. As a result, selling, general, and administrative expense ("SG&A") increased with an offsetting increase to other (income) expense of $0.7 million and $0.4 million in the three months ended August 31, 2019 and 2018, respectively, and $1.6 million and $1.4 million in the nine months ended August 31, 2019 and 2018, respectively. Other than this reclassification, the adoption of ASU 2017-07 did not have an impact on the Company’s consolidated financial statements as of and for the periods ended August 31, 2019 and 2018.

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows - Classification of Certain Cash Receipts and Cash Payments, which clarifies existing guidance related to accounting for cash receipts and cash payments and classification on the statement of cash flows. The amendments in this ASU should be applied using a retrospective transition method to each period presented. The Company adopted the amendments of this ASU effective December 1, 2018, and this ASU did not have an impact on the Company's consolidated financial statements.

In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows - Restricted Cash, which requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash would be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The amendments in this ASU should be applied using a retrospective transition method to each period presented. The Company adopted the amendments of this ASU effective December 1, 2018, and this ASU did not have an impact on the Company's consolidated financial statements.

In January 2017, the FASB issued ASU No. 2017-01, Clarifying the Definition of a Business, which clarified existing guidance on the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The Company adopted the amendments of this ASU effective December 1, 2018, and this ASU did not have an impact on the Company's consolidated financial statements.

Description of New Accounting Pronouncements Not yet Adopted

Accounting Standards Not Yet Adopted

In February 2018, the FASB issued ASU 2018-02, Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (Loss), which allows a reclassification from accumulated other comprehensive income (loss) to retained earnings for standard tax effects resulting from the Tax Cuts and Jobs Act. ASU 2018-02 must be applied either in the period of adoption or retrospectively to each period in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act is recognized. This guidance is effective for annual periods, including interim periods within those annual periods, beginning after December 15, 2018 with early adoption permitted in any interim period. The Company is currently evaluating the potential impact on its consolidated financial statements and related disclosures.

In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging, which applies targeted improvements to the hedge accounting guidance, including removing the requirement to record the ineffective portion of a hedging instrument in current period income. The guidance is effective for annual periods, including interim periods within those annual periods, beginning after December 15, 2018 with early adoption permitted in any interim period. Amendments from this ASU are to be applied prospectively, with a cumulative effect adjustment recorded to retained earnings. The Company is currently evaluating the potential impact on its consolidated financial statements and related disclosures.

In February 2016, the FASB issued ASU 2016-02, Leases (ASC Topic 842), which requires a lessee to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases with a lease term of more than twelve months. Leases will continue to be classified as either financing or operating, with classification affecting the recognition, measurement and presentation of expenses and cash flows arising from a lease. The new guidance is effective for the Company’s fiscal year that begins on December 1, 2019. The Company will elect the optional transition method to account for finance and operating leases existing at, or entered into after, December 1, 2019, and the Company will record a cumulative effect adjustment to retained earnings on the same date, if necessary. This optional transition method will not require any prior period restatements. We have completed aggregating our worldwide lease contracts, extracted lease data into a centralized database, established implementation controls, and are implementing a new lease accounting system to support the accounting and disclosure requirements of this ASU. The Company continues to evaluate certain practical expedients available and implement controls to support recognition and disclosure under ASC 842. As the implementation project progresses, the Company will determine the extent of the impact on its consolidated financial statements and related disclosures.

XML

Earnings (Loss) Per Share (Tables)

9 Months Ended

Aug. 31, 2019

Earnings Per Share [Abstract]

Computation of Earnings Per Commin Share And Fully Diluted Earnings Per Common Share

The following table summarizes the computation of earnings per common share and earnings per common share, assuming dilution:

	Three Months Ended August 31,					Nine Months Ended August 31,
	2019		2018			2019		2018
	(Dollars and shares in millions, except per share data)
Numerator:
Net income (loss)	$	.3	$	(1.9	)	$	1.3	$	13.7
Denominator:
Denominator for basic earnings (loss) per share - weighted average shares outstanding	44.8		44.5			44.8		44.6
Effect of dilutive securities	.9		—			.8		.2
Denominator for dilutive earnings (loss) per share - adjusted weighted average shares and assumed conversions	45.7		44.5			45.6		44.8
Net income (loss) per share - Basic and Diluted	$	.01	$	(.04	)	$	.03	$	.31

XML

Consolidated Statements of Financial Position - USD ($) $ in Millions	Aug. 31, 2019	Nov. 30, 2018
Current Assets
Cash and cash equivalents	$ 36.8	$ 54.1
Accounts receivable, net	113.4	112.1
Inventories, net	78.6	78.8
Prepaid expenses and other	8.6	8.0
Total Current Assets	237.4	253.0
Property, plant and equipment, net	208.7	205.8
Intangible assets, net	48.9	53.5
Goodwill	69.5	70.9
Other non-current assets	5.7	6.0
Total Assets	570.2	589.2
Current Liabilities
Short-term debt	4.3	4.2
Accounts payable	88.8	101.1
Accrued payroll and personal property taxes	17.9	15.5
Employee benefits	3.3	2.9
Other current liabilities	5.4	10.1
Total Current Liabilities	119.7	133.8
Long-term debt	322.8	318.7
Post-retirement benefits other than pensions	5.0	5.3
Pension liabilities	46.0	51.6
Deferred income taxes	10.7	13.4
Other non-current liabilities	7.3	8.8
Total Liabilities	511.5	531.6
Shareholders' Equity
Preferred stock - $1.00 par value; 15.0 million shares authorized; none outstanding	0.0	0.0
Common stock - $0.10 par value; 135.0 million shares authorized; 48.3 million shares issued; 44.9 million shares outstanding as of August 31, 2019 and November 30, 2018, respectively	4.8	4.8
Additional contributed capital	348.5	345.9
Retained deficit	(144.6)	(145.4)
Treasury stock at cost - 3.4 million shares as of August 31, 2019 and November 30, 2018, respectively	(25.5)	(25.3)
Accumulated other comprehensive loss	(124.5)	(122.4)
Total Shareholders’ Equity	58.7	57.6
Total Liabilities and Shareholders’ Equity	$ 570.2	$ 589.2

XML

Revenue Recognition

9 Months Ended

Aug. 31, 2019

Revenue from Contract with Customer [Abstract]

Revenue from Contract with Customer [Text Block]

Revenue Recognition

The Company recognizes revenues when control of the promised goods is transferred to customers, in an amount that reflects the consideration expected to be received in exchange for those goods in accordance with ASC 606. When recognizing revenue, the Company applies the following five-step approach: 1) identify the contract with a customer, 2) identify the performance obligations, 3) determine the transaction price, 4) allocate the transaction price to the performance obligations in the contract, and 5) recognize revenue when a performance obligation is satisfied.

The Company considers confirmed customer purchase orders, which are typically governed by master sales agreements, to be the contracts, from an accounting perspective, with its customers. Under the Company's standard contract terms and conditions, the only performance obligation is the delivery of products and the performance obligation is satisfied at a point in time when the Company transfers control of the products to its customers. The Company may receive orders for products to be delivered over multiple dates that may extend across several reporting periods. The Company invoices its customers for each order and recognizes revenue for each distinct product upon shipment, once transfer of control has occurred. Payment terms used are standard for the industry and jurisdictions in which the Company operates. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment, to determine the net consideration to which the Company expects to receive. Discounts or rebates are specifically stated in customer contracts or invoices, and are recorded as a reduction of revenue in the period the related revenue is recognized. Rebates are estimated based on sales terms and past experience and typically are credited to customers based on achieving certain defined volume levels. The product price, as specified on the customer confirmed orders, is considered the standalone selling price. The Company allocates the transaction price to each distinct product based on its relative standalone selling price. The Company reviews material contracts to determine transfer of control based upon the business practices and legal requirements of each country.

The Company enters into various payment terms with its customers by the type and location of the customer and the products offered. Generally, the time between when revenue is recognized and when payment is due is not significant. The amount of shipping and handling fees invoiced to our customers at the time our product is shipped is included in net sales as we are the principal in those activities. Sales tax, valued-added tax, and other taxes collected from the Company's customers and remitted to governmental authorities, where applicable, are excluded from net sales. The Company records returns as a reduction to sales when incurred. Generally, customers do not have a unilateral right to return products. The Company primarily offers an assurance-type standard warranty that the product will conform to the specifications as designed for a period of time or period of usage after delivery. These warranties do not represent a separate performance obligation.

There were no changes in amounts previously reported in the Company’s consolidated financial statements due to the adoption of ASC 606.

The following table summarizes disaggregated net sales by geographic region and reportable segment for the three and nine months ended August 31, 2019:

	United States		Asia		Europe		Total
Three months ended August 31, 2019	(Dollars in millions)
Specialty Solutions	$	88.7	$	8.4	$	40.6	$	137.7
Performance Materials	33.1		10.9		10.7		54.7
Total net sales	$	121.8	$	19.3	$	51.3	$	192.4
Nine months ended August 31, 2019
Specialty Solutions	$	219.8	$	39.2	$	133.7	$	392.7
Performance Materials	110.4		42.4		21.5		174.3
Total net sales	$	330.2	$	81.6	$	155.2	$	567.0

XML

Contingencies

9 Months Ended

Aug. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Contingencies and Commitments

Contingencies

From time to time, the Company is subject to various claims, proceedings, and lawsuits related to products, services, contracts, employment, environmental, safety, intellectual property, and other matters. The ultimate resolution of such claims, proceedings, and lawsuits is inherently unpredictable and, as a result, the Company’s estimates of liability, if any, are subject to change. Actual results may materially differ from the Company’s estimates and an unfavorable resolution of any matter could have a material adverse effect on the financial condition, results of operations, and/or cash flows of the Company. However, subject to the above and taking into account such amounts, if any, as are accrued from time to time on the Company’s balance sheet, the Company does not believe, based on the information currently available to it, that the ultimate resolution of these matters will have a material effect on the consolidated financial condition, results of operations or cash flows of the Company.

XML

Income Taxes

9 Months Ended

Aug. 31, 2019

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

On December 22, 2017, U.S. federal tax legislation, commonly referred to as the Tax Cuts and Job Act (the “Tax Act”) was signed into law which, among other changes: reduced the U.S. corporate income tax rate effective January 1, 2018; imposed a one-time transition tax on foreign earnings; and beginning in fiscal 2019, creates a new minimum tax on certain foreign-sourced earnings known as global intangible low-tax income ("GILTI"). The Company will account for GILTI in the year the tax is incurred as a period cost. The Company completed the analysis of the impact of the transition tax in accordance with SAB 118 and the amount of $27.7 million is no longer considered provisional. The Company finalized the position to utilize existing net operating loss carryforwards ("NOLC's") to offset the income inclusion, and therefore will have no cash taxes or tax expense related to the transition tax.

The Company recorded income tax expense of $0.6 million and $2.3 million for the three months ended August 31, 2019 and 2018, respectively and income tax expense of $1.4 million and income tax benefit of $0.3 million for the nine months ended August 31, 2019 and 2018, respectively. The Company’s effective tax rate for the third quarters of both 2019 and 2018 were different than the U.S. federal statutory tax rate primarily due to losses in jurisdictions in which no tax benefit was recognized. The Company's effective tax rate for the first nine months of 2019 was different than the U.S. federal statutory tax rate primarily due to losses in jurisdictions in which no tax benefit was recognized. The Company’s effective tax rate for the first nine months of 2018 was different than its U.S. federal statutory tax rate primarily due to discrete items related to the Tax Act. These items included a $4.1 million income tax benefit related to the re-measurement of the U.S. deferred taxes as the U.S. federal tax rate was reduced from 35.0% to 21.0% and a $0.9 million income tax benefit associated with the reversal of the valuation allowance against the existing AMT credit carryforward as it is refundable under the Tax Act. In addition, during the first quarter of 2018, the Company recognized a $0.8 million income tax benefit related to the impact of a French tax rate change on the Company's deferred tax liabilities. The French tax rate was reduced to 25.0% beginning in 2022 and the Company's deferred tax liabilities were reduced to appropriately reflect this legislation as a current period tax benefit. These discrete tax benefits were partially offset by losses in jurisdictions in which no tax benefit was recognized.

As of August 31, 2019, the Company has $75.3 million of U.S. federal NOLC's, $8.1 million of U.S. federal capital loss carryforwards, $0.1 million of foreign tax credit carryforwards, $0.3 million of AMT credit carryforwards, and $78.9 million of state NOLC's. The $75.3 million of U.S. NOLC's reflects the net impact of the $11.7 million NOL generation for the year ended November 30, 2018 and the $27.7 million utilization for transition tax as part of U.S. tax reform. Due to the NOLC's, cash tax payments in the U.S. are expected to be minimal for the foreseeable future. The majority of the federal, state, and local NOLC's will expire in tax years 2024 through 2034 while the foreign tax credit carryforwards will expire in the tax years 2020 through 2022, and the capital loss carryforwards will expire beginning in tax year 2022. The Company has a valuation allowance against the U.S. federal and state NOLC's and the U.S. federal capital loss carryforward. As of August 31, 2019, the Company had approximately $51.7 million of foreign NOLC's of which $31.8 million have an indefinite carryforward period. The Company has recognized a valuation allowance against the $31.8 million foreign NOLC's which have an indefinite carryforward period as the Company does not anticipate utilizing these carryforwards.

The Company operates in numerous taxing jurisdictions and is subject to regular examinations by various tax authorities. With limited exceptions, the Company is no longer open to audits by U.S. and foreign jurisdictions for years prior to 2014.

XML

Inventories

9 Months Ended

Aug. 31, 2019

Inventory Disclosure [Abstract]

Inventories

Inventories

Inventories are stated at lower of cost or net realizable value. U.S. inventories are valued using the last-in, first-out (“LIFO”) method and represented approximately $48.2 million, or 47.9%, and $47.6 million, or 45.9%, of gross inventories at August 31, 2019 and November 30, 2018, respectively. The remaining portion of inventories, which are located outside of the U.S., are valued using the first-in, first-out (“FIFO”) or an average cost method. Interim LIFO calculations are based on management’s estimates of expected year-end inventory levels and costs and are subject to final year-end LIFO inventory valuations. Inventory costs include material, labor, and overhead. Inventories, net, consisted of the following:

	August 31, 2019			November 30, 2018
	(Dollars in millions)
Raw materials and supplies	$	35.3		$	35.0
Work-in-process	5.2			5.3
Finished goods	60.1			63.5
Inventories, gross	100.6			103.8
LIFO reserve	(15.4		)	(18.1		)
Obsolescence reserve	(6.6		)	(6.9		)
Inventories, net	$	78.6		$	78.8

XML

Business Segment Information (Tables)

9 Months Ended

Aug. 31, 2019

Segment Reporting [Abstract]

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]

The following table summarizes operations by segment and a reconciliation of segment sales to consolidated sales and segment operating profit to income (loss) before income taxes:

	Three Months Ended August 31,						Nine Months Ended August 31,
	2019			2018			2019			2018
	(Dollars in millions)
Net Sales:
Specialty Solutions	$	137.7		$	122.1		$	392.7		$	360.0
Performance Materials	54.7			71.5			174.3			218.5
Total Net Sales	$	192.4		$	193.6		$	567.0		$	578.5
Segment Operating Profit:
Specialty Solutions	$	20.0		$	19.5		$	49.3		$	55.0
Performance Materials	(4.4		)	(7.9		)	(6.4		)	(5.6		)
Total segment operating profit	15.6			11.6			42.9			49.4
Interest expense	(5.1		)	(4.7		)	(15.3		)	(14.4		)
Corporate expenses	(9.6		)	(6.5		)	(24.9		)	(21.6		)
Income (Loss) Before Income Taxes	$	.9		$	.4		$	2.7		$	13.4

XML

Inventories (Tables)

9 Months Ended

Aug. 31, 2019

Inventory Disclosure [Abstract]

Schedule of Inventory

Inventories, net, consisted of the following:

	August 31, 2019			November 30, 2018
	(Dollars in millions)
Raw materials and supplies	$	35.3		$	35.0
Work-in-process	5.2			5.3
Finished goods	60.1			63.5
Inventories, gross	100.6			103.8
LIFO reserve	(15.4		)	(18.1		)
Obsolescence reserve	(6.6		)	(6.9		)
Inventories, net	$	78.6		$	78.8

XML

Share-Based Employee Compensation Additional Information (Details) - USD ($) shares in Thousands, $ in Millions	9 Months Ended		12 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Nov. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	1,900
Share-based Compensation	$ 2.8	$ 2.1
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized	$ 4.6
Employee Stock Ownership Plan (ESOP), Shares in ESOP	47
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement By Share-based Payment Award, Options Outstanding, Contractual Term	10 years
Performance Shares [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	0.00%
Performance Shares [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	200.00%
CEO Performance Shares [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	0.00%		0.00%
CEO Performance Shares [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	143.00%		160.00%
Employee Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date	85.00%
Selling, General and Administrative Expenses [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation		$ 2.1

XML

Asset Impairment (Details) - USD ($) $ in Millions	3 Months Ended
	Aug. 31, 2019	Aug. 31, 2018
Property, Plant and Equipment [Abstract]
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)	$ 0.9
Asset Impairment Charges		$ 9.2

XML

Inventories (Details) - USD ($) $ in Millions	Aug. 31, 2019	Nov. 30, 2018
Inventory Disclosure [Abstract]
LIFO inventory amount	$ 48.2	$ 47.6
Percentage of LIFO inventory	47.90%	45.90%
Raw materials and supplies	$ 35.3	$ 35.0
Work-in-process	5.2	5.3
Finished goods	60.1	63.5
Inventories, gross	100.6	103.8
LIFO reserve	(15.4)	(18.1)
Obsolescence reserve	(6.6)	(6.9)
Inventories, net	$ 78.6	$ 78.8

XML

Income Taxes (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended				9 Months Ended		12 Months Ended
	Dec. 31, 2017	Aug. 31, 2019	Feb. 28, 2019	Aug. 31, 2018	Feb. 28, 2018	Aug. 31, 2019	Aug. 31, 2018	Nov. 30, 2018
Income Taxes [Line Items]
GILTI Transition Tax			$ 27.7
Income tax (benefit) expense		$ (0.6)		$ (2.3)		$ (1.4)	$ 0.3
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	35.00%					21.00%
Reversal of VA against AMT from Legislation							0.9
Deferred Foreign Income Tax Expense (Benefit)					$ (0.8)
Deferred Tax Assets, Tax Credit Carryforwards, Alternative Minimum Tax		0.3				$ 0.3
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest		0.9		$ 0.4		2.7	13.4
Deferred Tax Assets, Tax Credit Carryforwards, Foreign, Indefinite Carryforward Period		31.8				31.8
Domestic Tax Authority [Member]
Income Taxes [Line Items]
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount							$ 4.1
Operating Loss Carryforwards		75.3				75.3
Deferred Tax Assets, Capital Loss Carryforwards		8.1				8.1
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest								$ (11.7)
Foreign Tax Authority [Member]
Income Taxes [Line Items]
Operating Loss Carryforwards		51.7				51.7
Tax Credit Carryforward, Amount		0.1				0.1
State and Local Jurisdiction [Member]
Income Taxes [Line Items]
Operating Loss Carryforwards		$ 78.9				$ 78.9

XML

Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Aug. 31, 2019	Aug. 31, 2018
Operating Activities
Net income (loss)	$ 1.3	$ 13.7
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
(Gain) loss on asset sales	4.2	0.0
Depreciation and amortization	23.4	22.3
Impairment of long-lived assets	1.0	9.6
Amortization and write-off of deferred financing fees	1.1	1.8
Non-cash stock compensation expense	2.8	2.1
Provision for uncollectible accounts	0.5	0.4
Provision for obsolete inventories	(0.1)	1.3
Deferred income taxes	(0.9)	(6.6)
Changes in operating assets and liabilities:
Accounts receivable	4.7	3.8
Inventories	(0.8)	(3.1)
Other current assets	(2.4)	(5.3)
Current liabilities	(3.8)	1.4
Other non-current assets	(5.9)	1.2
Other non-current liabilities	(5.6)	(2.5)
Contributions to defined benefit plan	3.0	6.0
Net Cash Provided By (Used In) Operating Activities	3.5	37.1
Investing Activities
Capital expenditures	(25.9)	(12.8)
Proceeds from asset sales	5.5	0.0
Business acquisitions	2.8	0.5
Net Cash Provided By (Used In) Investing Activities	(23.2)	(13.3)
Financing Activities
Proceeds from borrowings	267.6	2.3
Repayment of debt obligations	(264.5)	(45.4)
Payments for debt refinancing	0.0	1.0
Employee tax withholdings related to redemption of common shares	(0.5)	(0.5)
Net Cash Provided By (Used In) Financing Activities	2.6	(44.6)
Effect of exchange rate changes on cash and cash equivalents	(0.2)	(1.0)
Net Increase (Decrease) In Cash And Cash Equivalents	(17.3)	(21.8)
Cash and cash equivalents at beginning of period	54.1	88.0
Cash and Cash Equivalents at End of Period	36.8	66.2
Cash paid for:
Interest	14.2	13.2
Income taxes	$ 6.2	$ 5.7

XML

Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018
Income Statement [Abstract]
Net sales	$ 192.4	$ 193.6	$ 567.0	$ 578.5
Cost of goods sold (exclusive of depreciation)	146.1	144.5	434.7	431.3
Gross profit	46.3	49.1	132.3	147.2
Selling, general and administrative	26.6	26.3	85.6	83.4
Depreciation and amortization	7.5	7.8	23.4	22.3
Asset impairments	1.0	9.2	1.0	9.6
(Gain) loss on asset sales	0.1	0.0	4.2	0.0
Restructuring and severance	0.8	0.4	4.9	1.8
Interest expense	5.1	4.7	15.3	14.4
Debt issuance costs write-off	0.2	0.0	0.2	0.8
Merger, acquisition, and integration related expense	5.9	(0.3)	6.1	0.7
Other (income) expense, net	(1.6)	0.6	(2.7)	0.8
Total other costs and expenses	45.4	48.7	129.6	133.8
Income (loss) before income taxes	0.9	0.4	2.7	13.4
Income tax (benefit) expense	0.6	2.3	1.4	(0.3)
Net income (loss)	$ 0.3	$ (1.9)	$ 1.3	$ 13.7
Earnings Per Share
Net income (loss) per share - Basic and Diluted	$ 0.01	$ (0.04)	$ 0.03	$ 0.31
Weighted average shares outstanding - Basic	44.8	44.5	44.8	44.6
Weighted average shares outstanding - Diluted	45.7	44.5	45.6	44.8

XML

Description of Business, Basis of Presentation, and New Accounting Standards Significant Accounting Policies (Policies)

9 Months Ended

Aug. 31, 2019

Significant Accounting Policies [Abstract]

Significant Accounting Policies

The consolidation method is followed to report investments in subsidiaries. The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Inter-company accounts and transactions are eliminated during the consolidation process of these accounts.

A detailed description of the Company’s significant accounting policies and Management judgments is located in the audited consolidated financial statements for the year ended November 30, 2018, included in the Company’s Form 10-K filed with the SEC.

XML

Financial Instruments and Fair Value Measurements (Tables)

9 Months Ended

Aug. 31, 2019

Fair Value Disclosures [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

The following financial assets and liabilities are measured and presented at fair value on a recurring basis as of August 31, 2019 and November 30, 2018:

	Notional Amount		Fair Value		Level 1		Level 2		Level 3
	(Dollars in millions)
Fair value measurements - August 31, 2019:
Financial liabilities
Foreign currency exchange contracts	$	17.3	$	.1	$	—	$	.1	$	—
Contingent consideration (1)	—		—		—		—		—
Total liabilities	$	17.3	$	.1	$	—	$	.1	$	—
Fair value measurements - November 30, 2018:
Financial assets
Foreign currency exchange contracts	$	16.5	$	.1	$	—	$	.1	$	—
Total assets	$	16.5	$	.1	$	—	$	.1	$	—
Financial liabilities
Contingent consideration (1)	$	—	$	.6	$	—	$	—	$	.6
Total liabilities	$	—	$	.6	$	—	$	—	$	.6

⁽¹⁾ Contingent consideration obligations arise from business or product line acquisitions. The fair values are based on a probability weighted discounted cash flow analysis reflecting an estimated achievement of specified performance measures of the acquired product lines. Contingent consideration is classified in the consolidated balance sheets as other current liabilities or other non-current liabilities based on contractual payment dates.

Schedule of Business Acquisitions by Acquisition, Contingent Consideration

The changes in Level 3 assets and liabilities measured at fair value on a recurring basis during the first nine months of 2019 are summarized as follows:

	Contingent Consideration
	(Dollars in millions)
Balance at November 30, 2018	$	.6
Adjustments	(.6		)
Balance at August 31, 2019	$	—

XML

Debt and Credit Lines Schedule of Short Term Debt (Details) - USD ($) $ in Millions	Aug. 31, 2019	Nov. 30, 2018
Short-term Debt [Line Items]
Capital lease obligations, current portion	$ 0.8	$ 0.7
Total	4.3	4.2
Term Loan B [Member]
Short-term Debt [Line Items]
$350 million Term Loan B, due 2023, current portion (interest at 5.48% and 5.55%, respectively)	$ 3.5	$ 3.5

XML

Earnings (Loss) Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended						9 Months Ended
	Aug. 31, 2019	May 31, 2019	Feb. 28, 2019	Aug. 31, 2018	May 31, 2018	Feb. 28, 2018	Aug. 31, 2019	Aug. 31, 2018
Earnings Per Share [Abstract]
Net income (loss)	$ 0.3	$ 5.6	$ (4.6)	$ (1.9)	$ 8.4	$ 7.3	$ 1.3	$ 13.7
Denominator for basic earnings (loss) per share - weighted average shares outstanding	44.8			44.5			44.8	44.6
Effect of dilutive securities	0.9			0.0			0.8	0.2
Denominator for dilutive earnings (loss) per share - adjusted weighted average shares and assumed conversions	45.7			44.5			45.6	44.8
Net income (loss) per share - Basic and Diluted	$ 0.01			$ (0.04)			$ 0.03	$ 0.31

XML

Description of Business, Basis of Presentation, and New Accounting Standards

9 Months Ended

Aug. 31, 2019

Accounting Policies [Abstract]

Business Description and Accounting Policies

Pending Merger

On July 3, 2019, OMNOVA Solutions Inc. (the "Company") announced that it entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Synthomer plc ("Synthomer"), Spirit USA Holdings Inc. ("Merger Sub"), and Synthomer USA LLC, pursuant to which Merger Sub, a wholly-owned subsidiary of Synthomer, would merge with and into the Company, subject to shareholder and regulatory approvals and other customary conditions (the "Merger").

Upon consummation of the Merger (the “Effective Time”), each common share, par value $0.10 per share, of the Company (“Company Common Shares”) issued and outstanding immediately prior to the Effective Time (other than dissenting shares, shares held in the treasury of the Company and shares held by Synthomer or any of its wholly owned subsidiaries) will be canceled and automatically converted into the right to receive $10.15 in cash, without interest and subject to any applicable withholding taxes (the “Per-Share Amount”).

Pursuant to the Merger Agreement, each unvested Company restricted share, restricted share unit, and performance share that is outstanding immediately prior to the Effective Time, will be canceled and converted into the right to receive an amount in cash equal to the Per-Share Amount. Each Company performance share will be considered to have vested at target achievement levels.

The Merger Agreement contains customary representations, warranties, and covenants, including, among others, covenants: (a) that each of the Company, Synthomer, and Merger Sub uses its reasonable best efforts to cause the proposed transactions to be consummated; (b) that require the Company, Synthomer and Merger Sub to take certain actions that may be necessary to obtain required antitrust approvals; (c) that require the Company (i) subject to certain restrictions, to operate in the ordinary course of business consistent with past practice until the Effective Time, (ii) not to initiate, solicit or knowingly facilitate or encourage the making of any inquiries or proposals relating to alternate transactions or, subject to certain exceptions, engage in any discussions or negotiations with respect thereto, and (iii) to convene a meeting of the Company’s shareholders and solicit proxies from its shareholders in favor of the adoption of the Merger Agreement; and (d) that require Synthomer (y) not to initiate, solicit or knowingly facilitate or encourage the making of any offers or proposals relating to certain acquisitions of Synthomer’s equity or assets or, subject to certain exceptions, engage or participate in any discussions or negotiations with respect thereto, and (z) to convene a meeting of Synthomer’s shareholders and solicit proxies from its shareholders in favor of approving the transactions and certain matters related thereto.

Subject to certain exceptions and limitations, either party may terminate the Merger Agreement if the proposed transactions are not consummated by nine (9) months after the date of the Merger Agreement, subject to an automatic extension for an additional period of three (3) months if necessary to obtain regulatory clearances. Consummation of the proposed transactions is not subject to any financing condition.

The Merger Agreement contains certain termination rights and provides that, upon termination of the Merger Agreement under specified circumstances, including, without limitation, (i) a change in the recommendation of the Company’s Board of Directors or a termination of the Merger Agreement by the Company to enter into an agreement for a “superior proposal,” the Company will pay Synthomer a cash termination fee equal to $15.8 million, and (ii) a change in recommendation of Synthomer’s Board of Directors or a termination of the Merger Agreement by the Company or Synthomer due to a failure in certain circumstances to obtain certain antitrust approvals with respect to the transactions, Synthomer will pay the Company a cash termination fee equal to $15.8 million.

The proposed Merger has been unanimously approved by the respective Boards of Synthomer and the Company, and at a special meeting of Synthomer’s shareholders on July 31, 2019, Synthomer received shareholder approval to, among other things, consummate the Merger. The closing of the Merger remains subject to the satisfaction of customary closing conditions, including approval of the Merger Agreement by the Company’s shareholders and receiving regulatory clearance for the transaction in certain non-U.S. jurisdictions. The Company's shareholders will have the opportunity to vote on a proposal to adopt the Merger Agreement at a special meeting of Company shareholders scheduled to occur on October 10, 2019. The Company and Synthomer continue to target closing the transaction in late 2019 or early 2020.

Basis of Presentation

The accompanying unaudited interim consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial statements and with the instructions to Form 10-Q and Article 10

of Regulation S-X and, therefore, do not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements. These interim consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the OMNOVA Solutions Inc. (“OMNOVA Solutions”, "OMNOVA", the “Company”, "we", "us" or "our") Annual Report on Form 10-K for the year ended November 30, 2018, previously filed with the Securities and Exchange Commission (“SEC”).

The consolidated financial statements as of August 31, 2019 have been derived from the unaudited interim consolidated financial statements at that date and do not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.

These interim consolidated financial statements reflect all adjustments that are, in the opinion of Management, necessary for a fair presentation of the results for the interim period and all such adjustments are of a normal recurring nature except as disclosed herein. The results of operations for the interim period are not necessarily indicative, if annualized, of those to be expected for the full year.

The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires Management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.

The consolidation method is followed to report investments in subsidiaries. The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Inter-company accounts and transactions are eliminated during the consolidation process of these accounts.

A detailed description of the Company’s significant accounting policies and Management judgments is located in the audited consolidated financial statements for the year ended November 30, 2018, included in the Company’s Form 10-K filed with the SEC.

Description of Business

The Company is an innovator of emulsion polymers, specialty chemicals, and engineered surfaces for a variety of commercial, industrial, and residential end uses. The Company's products provide a variety of important functional and aesthetic benefits to hundreds of products that people use daily. The Company holds leading positions in key market categories, which have been built through innovative products, customized product solutions, strong technical expertise, well-established distribution channels, recognized brands, and long-standing customer relationships. The Company utilizes strategically-located manufacturing, technical, and other facilities in North America, Europe, China, and Thailand to service a broad customer base. The Company has two business segments: Specialty Solutions, which is focused on the Company's higher growth specialty businesses, and Performance Materials, which is focused on the Company’s more mature businesses.

Specialty Solutions – The Specialty Solutions segment develops, designs, produces, and markets a broad line of specialty polymers for use in coatings, adhesives, sealants, elastomers, nonwovens, and oil & gas products, as well as laminates and films. These products are used in numerous applications, including architectural and industrial coatings; nonwovens used in hygiene products, filtration, and construction; drilling additives for oil and gas exploration and production; elastomeric modification of plastic casings and hoses used in household and industrial products and automobiles; tapes and adhesives; sports surfaces; textile finishes; commercial building refurbishment; new construction; residential cabinets; flooring; ceiling tile; furnishings; manufactured housing; health care patient and common area furniture; and a variety of industrial films applications. The segment's products enhance our customers’ products performance, including stain, rust and aging resistance; surface modification; gloss; softness or hardness; dimensional stability; high heat and pressure tolerance; and binding and barrier (e.g. moisture, oil) properties.

The Specialty Solutions segment consists of Specialty Coatings & Ingredients, Oil & Gas, and Laminates & Films. The Specialty Coatings & Ingredients business line encompasses products that have applications for specialty coatings, nonwovens (such as disposable hygiene products, engine filters, roofing mat, and scrub pads), construction, adhesives, sealants, tape, floor care, textiles, graphic arts, and various other specialty applications. Oil & Gas applications include drilling fluid additives, which provide fluid loss control and sealing to enhance wellbore integrity, as well as cement additives for gas migration and fluid loss. The Laminates & Films product line applications include kitchen and bath cabinets, wall surfacing, manufactured housing and recreational vehicle interiors, flooring, commercial and residential furniture, retail display fixtures, home furnishings, commercial appliances, and a variety of industrial film applications.

Performance Materials – The Performance Materials segment serves mature markets with a broad range of emulsion polymers based primarily on styrene butadiene (SB), styrene butadiene acrylonitrile (SBA), styrene butadiene vinyl pyridine, high styrene pigments, polyvinyl acetate, acrylic, styrene acrylic, calcium stearate, glyoxal, and bio-based chemistries. Performance Materials' custom-formulated products are tailored latexes, resins, binders, antioxidants, hollow plastic pigment, coated fabrics, and rubber reinforcing which are used in tire cord, polymer stabilization, industrial rubbers, carpet binders, paper coatings, and various other applications. Its products provide a variety of functional properties to enhance the Company’s

customers’ products, including greater strength, adhesion, dimensional stability, ultraviolet resistance, improved processibility, and enhanced appearance.

The Performance Materials segment encompasses performance additives, paper coatings, carpet binders, and coated fabrics. This segment includes products that have applications in the paper coatings, paperboard, carpet binders, polymer stabilization, industrial rubbers, and tire cord industries. Paper and paperboard coatings are used in magazines, catalogs, direct mail advertising, brochures, printed reports, food cartons, household, and other consumer and industrial packaging. Carpet binders are used to secure carpet fibers to carpet backing and meet stringent manufacturing, environmental, odor, flammability, and flexible installation requirements. Tire cord is used in automotive tires. The Coated Fabrics product line applications include upholstery used in refurbishment and new construction for the commercial office, hospitality, health care, retail, education and restaurant markets, marine and transportation seating, commercial and residential furniture, automotive soft tops, and automotive after-market applications.

Accounting Standards

Accounting Standards Adopted in 2019

In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-09, Revenue from Contracts with Customers Accounting Standards Codification ("ASC") Topic 606, which clarified existing accounting literature relating to how and when a company recognizes revenue. This standard prescribes a five-step model for recognizing revenue, the application of which will require a certain amount of judgment. The provisions of this ASU may be applied retroactively or on a modified retrospective (cumulative effect) basis. The standard requires additional disclosures in the notes to the consolidated financial statements, including qualitative and quantitative disclosures identifying the nature, amount, timing and significant judgments impacting revenue from contracts with customers. The Company adopted ASU 2014-09 during the first quarter of fiscal year 2019 and utilized the modified retrospective approach and recorded a cumulative effect adjustment to retained earnings of $0.5 million for the accounting impact of certain previously capitalized contract costs as of December 1, 2018.

In March 2017, the FASB issued ASU 2017-07, Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost, which requires that an employer report the service cost component in the same line item or items as other compensation costs arising from services rendered by the pertinent employees during the period. The amendments in this ASU also allow only the service cost component to be eligible for capitalization when applicable. ASU 2017-07 must be applied retrospectively for the presentation of the service cost component and the other components of net periodic benefit cost in the income statement and prospectively, on and after the effective date, for the capitalization of the service cost component of net periodic benefit cost in assets. The Company adopted ASU 2017-17 during the first quarter of fiscal year 2019. The Company elected to use the practical expedient to use amounts disclosed in the 2018 consolidated financial statements as an estimate for applying the retrospective presentation requirements. As a result, selling, general, and administrative expense ("SG&A") increased with an offsetting increase to other (income) expense of $0.7 million and $0.4 million in the three months ended August 31, 2019 and 2018, respectively, and $1.6 million and $1.4 million in the nine months ended August 31, 2019 and 2018, respectively. Other than this reclassification, the adoption of ASU 2017-07 did not have an impact on the Company’s consolidated financial statements as of and for the periods ended August 31, 2019 and 2018.

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows - Classification of Certain Cash Receipts and Cash Payments, which clarifies existing guidance related to accounting for cash receipts and cash payments and classification on the statement of cash flows. The amendments in this ASU should be applied using a retrospective transition method to each period presented. The Company adopted the amendments of this ASU effective December 1, 2018, and this ASU did not have an impact on the Company's consolidated financial statements.

In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows - Restricted Cash, which requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash would be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The amendments in this ASU should be applied using a retrospective transition method to each period presented. The Company adopted the amendments of this ASU effective December 1, 2018, and this ASU did not have an impact on the Company's consolidated financial statements.

In January 2017, the FASB issued ASU No. 2017-01, Clarifying the Definition of a Business, which clarified existing guidance on the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The Company adopted the amendments of this ASU effective December 1, 2018, and this ASU did not have an impact on the Company's consolidated financial statements.

Accounting Standards Not Yet Adopted

In February 2018, the FASB issued ASU 2018-02, Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (Loss), which allows a reclassification from accumulated other comprehensive income (loss) to retained earnings for standard tax effects resulting from the Tax Cuts and Jobs Act. ASU 2018-02 must be applied either in the period of adoption or retrospectively to each period in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act is recognized. This guidance is effective for annual periods, including interim periods within those annual periods, beginning after December 15, 2018 with early adoption permitted in any interim period. The Company is currently evaluating the potential impact on its consolidated financial statements and related disclosures.

In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging, which applies targeted improvements to the hedge accounting guidance, including removing the requirement to record the ineffective portion of a hedging instrument in current period income. The guidance is effective for annual periods, including interim periods within those annual periods, beginning after December 15, 2018 with early adoption permitted in any interim period. Amendments from this ASU are to be applied prospectively, with a cumulative effect adjustment recorded to retained earnings. The Company is currently evaluating the potential impact on its consolidated financial statements and related disclosures.

In February 2016, the FASB issued ASU 2016-02, Leases (ASC Topic 842), which requires a lessee to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases with a lease term of more than twelve months. Leases will continue to be classified as either financing or operating, with classification affecting the recognition, measurement and presentation of expenses and cash flows arising from a lease. The new guidance is effective for the Company’s fiscal year that begins on December 1, 2019. The Company will elect the optional transition method to account for finance and operating leases existing at, or entered into after, December 1, 2019, and the Company will record a cumulative effect adjustment to retained earnings on the same date, if necessary. This optional transition method will not require any prior period restatements. We have completed aggregating our worldwide lease contracts, extracted lease data into a centralized database, established implementation controls, and are implementing a new lease accounting system to support the accounting and disclosure requirements of this ASU. The Company continues to evaluate certain practical expedients available and implement controls to support recognition and disclosure under ASC 842. As the implementation project progresses, the Company will determine the extent of the impact on its consolidated financial statements and related disclosures.

XML

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 0.3	$ (1.9)	$ 1.3	$ 13.7
Foreign currency translations:
Unrealized net change during the period	(2.3)	(5.4)	(3.6)	(4.4)
Unrealized net change on intercompany foreign debt during the period	(0.2)	(0.1)	(0.6)	(0.4)
Tax effect	0.0	0.0	0.0	0.1
Foreign currency translations, net of tax	(2.5)	(5.5)	(4.2)	(4.9)
Post retirement benefit plans:
Amortization of net loss included in net periodic benefit cost	0.8	1.2	2.5	3.4
Tax effect	(0.2)	0.0	(0.4)	0.0
Post-retirement benefit plans, net of tax	0.6	1.2	2.1	3.4
Other comprehensive income (loss), net of tax	(1.9)	(4.3)	(2.1)	(1.5)
Comprehensive income (loss)	$ (1.6)	$ (6.2)	$ (0.8)	$ 12.2

XML

Description of Business, Basis of Presentation, and New Accounting Standards Use of Estimates (Policies)

9 Months Ended

Aug. 31, 2019

Accounting Policies [Abstract]

Basis of Accounting

The accompanying unaudited interim consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial statements and with the instructions to Form 10-Q and Article 10

of Regulation S-X and, therefore, do not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements. These interim consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the OMNOVA Solutions Inc. (“OMNOVA Solutions”, "OMNOVA", the “Company”, "we", "us" or "our") Annual Report on Form 10-K for the year ended November 30, 2018, previously filed with the Securities and Exchange Commission (“SEC”).

The consolidated financial statements as of August 31, 2019 have been derived from the unaudited interim consolidated financial statements at that date and do not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.

These interim consolidated financial statements reflect all adjustments that are, in the opinion of Management, necessary for a fair presentation of the results for the interim period and all such adjustments are of a normal recurring nature except as disclosed herein. The results of operations for the interim period are not necessarily indicative, if annualized, of those to be expected for the full year.

Use of Estimates, Policy

The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires Management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.

XML

Revenue Recognition (Tables)

9 Months Ended

Aug. 31, 2019

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue [Table Text Block]

The following table summarizes disaggregated net sales by geographic region and reportable segment for the three and nine months ended August 31, 2019:

	United States		Asia		Europe		Total
Three months ended August 31, 2019	(Dollars in millions)
Specialty Solutions	$	88.7	$	8.4	$	40.6	$	137.7
Performance Materials	33.1		10.9		10.7		54.7
Total net sales	$	121.8	$	19.3	$	51.3	$	192.4
Nine months ended August 31, 2019
Specialty Solutions	$	219.8	$	39.2	$	133.7	$	392.7
Performance Materials	110.4		42.4		21.5		174.3
Total net sales	$	330.2	$	81.6	$	155.2	$	567.0

XML

Restructuring and Severance

9 Months Ended

Aug. 31, 2019

Restructuring and Related Activities [Abstract]

Restructuring and Related Activities Disclosure

Restructuring and Severance

The following table is a summary of restructuring and severance charges for the three and nine months ended August 31, 2019 and 2018:

	Three Months Ended August 31,				Nine Months Ended August 31,
	2019		2018		2019		2018
	(Dollars in millions)
Severance Expense:
Specialty Solutions	$	.3	$	—	$	.3	$	.7
Performance Materials	.5		.4		2.2		.4
Corporate	—		—		.2		.7
Total Severance Costs	.8		.4		2.7		1.8
Facility Closure Costs:
Performance Materials	—		—		2.2		—
Total Restructuring and Severance Costs	$	.8	$	.4	$	4.9	$	1.8

Costs for restructuring plans are recognized as a component of restructuring and severance expense within the consolidated statements of operations. The Company initiated the following restructuring plans:

2018 Restructuring Plan

During the third quarter of fiscal 2018, the Company announced its plan to close its styrene butadiene manufacturing facility in Green Bay, Wisconsin, moving production to its Mogadore, Ohio facility. The Company recorded $4.2 million of restructuring and severance expenses in fiscal 2019 related to this plan. Total expense incurred to date for this plan is $6.0 million, all of which has been paid as of August 31, 2019. The Company sold the Green Bay, Wisconsin facility in May 2019 for $4.9 million, recognizing a gain of $4.4 million within the consolidated statement of operations. This gain is included in the Performance Materials segment operating results. This plan is complete.

2017 Restructuring Plan

The Company recorded $0.7 million of restructuring and severance expenses in the first nine months of 2019 related to the One OMNOVA initiative announced during the first quarter of 2017. This initiative was focused on improving functional excellence in marketing, sales, operations, supply chain and technology, as well as various corporate functions. The plan was designed to reduce complexity and drive consistency across the global enterprise through a standardized, integrated business system. Total expense incurred for this initiative was $5.9 million, all of which has been paid as of August 31, 2019. This plan is substantially complete.

The following table summarizes the Company's liabilities related to restructuring and severance activities:

	November 30, 2018		2019				August 31, 2019
			Provision		Payments
	(Dollars in millions)
Total	$	1.1	$	4.9	$	6.0	$	—

The Company may incur future costs related to its restructuring activities, as processes are continually evaluated to enhance the efficiency and cost effectiveness of its operations, and to ensure competitiveness across its businesses and across

geographic areas. Future costs could include costs related to closed facilities and restructuring plan implementation costs and these will be recognized as incurred.

XML

Shareholders' Equity

9 Months Ended

Aug. 31, 2019

Statement of Stockholders' Equity [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

Shareholders' Equity

The following tables reflect the changes in shareholders' equity for the nine months ended August 31, 2019 and 2018:

	Number of Common Shares Outstanding		Common Stock		Additional Contributed Capital			Retained Deficit			Treasury Stock			Accumulated Other Comprehensive Income (Loss)			Total Shareholders' Equity
	(Dollars and shares in millions)
Balance November 30, 2018	44.9		$	4.8	$	345.9		$	(145.4	)	$	(25.3	)	$	(122.4	)	$	57.6
Net income (loss)								(4.6		)							(4.6		)
Foreign currency translations														3.8			3.8
Adjustment for accounting change								(.5		)							(.5		)
Post-retirement benefit plans														.6			.6
Share-based compensation					.3												.3
Other	(.1	)									(.2		)				(.2		)
Balance February 28, 2019	44.8		$	4.8	$	346.2		$	(150.5	)	$	(25.5	)	$	(118.0	)	$	57.0
Net income (loss)								5.6									5.6
Foreign currency translations														(5.5		)	(5.5		)
Post-retirement benefit plans														.9			.9
Share-based compensation					1.5												1.5
Other					.3						(.1		)				.2
Balance May 31, 2019	44.8		$	4.8	$	348.0		$	(144.9	)	$	(25.6	)	$	(122.6	)	$	59.7
Net income (loss)								.3									.3
Foreign currency translations														(2.5		)	(2.5		)
Post-retirement benefit plans														.6			.6
Shared-based compensation					1.0												1.0
Other	.1				(.5		)				.1						(.4		)
Balance August 31, 2019	44.9		4.8		348.5			(144.6		)	(25.5		)	(124.5		)	58.7
Balance November 30, 2017	44.8		$	4.8	$	343.4		$	(159.2	)	$	(25.5	)	$	(125.3	)	$	38.2
Net income (loss)								7.3									7.3
Foreign currency translations														6.3			6.3
Adjustment for accounting change								(6.9		)							(6.9		)
Post-retirement benefit plans														1.1			1.1
Share-based compensation					.5												.5
Other					.5						(.5		)				—
Balance February 28, 2018	44.8		$	4.8	$	344.4		$	(158.8	)	$	(26.0	)	$	(117.9	)	$	46.5
Net income (loss)								8.4									8.4
Foreign currency translations														(5.7		)	(5.7		)
Post-retirement benefit plans														1.1			1.1
Share-based compensation					.4												.4
Other	.1				.3												.3
Balance May 31, 2018	44.9		$	4.8	$	345.1		$	(150.4	)	$	(26.0	)	$	(122.5	)	$	51.0
Net income (loss)								(1.9		)							(1.9		)
Foreign currency translations														(5.5		)	(5.5		)
Post-retirement benefit plans														1.2			1.2
Share-based compensation					1.2												1.2
Other					(.6		)										(.6		)
Balance August 31, 2018	44.9		4.8		345.7			(152.3		)	(26.0		)	(126.8		)	45.4

XML

Employee Benefit Plans

9 Months Ended

Aug. 31, 2019

Retirement Benefits [Abstract]

Pension and Other Postretirement Benefits Disclosure

Employee Benefit Plans

The Company maintains a number of defined benefit and defined contribution plans to provide retirement benefits for employees. These plans are maintained and contributions are made in accordance with the Employee Retirement Income Security Act of 1974 (“ERISA”), local statutory law, or as determined by the Board of Directors. The plans generally provide benefits based upon years of service and compensation. Pension plans are funded except for a U.S. non-qualified pension plan for certain key employees and certain foreign plans. Future service benefits are frozen for all participants under the Company's U.S. defined benefit plan. All benefits earned by affected employees through the dates on which such benefits were frozen have become fully vested with the affected employees eligible to receive benefits upon retirement, as described in the Plan document.

Net periodic benefit cost (income) consisted of the following for the three and nine month periods ending August 31, 2019 and 2018:

	Pension Plans						Health Care Plans
	(Dollars in millions)
Three months ended August 31, 2019 and 2018	2019			2018			2019			2018
Service costs	$	.8		$	.6		$	—		$	—
Interest costs	2.5			2.2			.1			.1
Expected return on plan assets	(4.0		)	(3.9		)	—			—
Amortization of net actuarial (gain) loss	1.1			1.4			(.4		)	(.2		)
Net periodic cost (benefit)	$	.4		$	.3		$	(.3	)	$	(.1	)
	Pension Plans						Health Care Plans
	(Dollars in millions)
Nine months ended August 31, 2019 and 2018	2019			2018			2019			2018
Service costs	$	2.2		$	1.9		$	—		$	—
Interest costs	7.6			6.7			.2			.2
Expected return on plan assets	(11.8		)	(11.7		)	—			—
Amortization of net actuarial (gain) loss	3.4			4.1			(1.0		)	(.7		)
Net periodic cost (benefit)	$	1.4		$	1.0		$	(.8	)	$	(.5	)

Service cost is recorded in SG&A, while other components of net periodic pension costs are recorded in Other (Income) Expense. Service cost represents plan administration expenses. The Company expects to contribute approximately $6.4 million to its pension plans during fiscal 2019. There were $3.0 million contributions made during the first nine months of 2019.

The Company also sponsors a defined contribution 401(k) plan. Participation in this plan is voluntary and is available to substantially all U.S. salaried employees and to certain groups of U.S. hourly employees. Company contributions to this plan are based on either a percentage of employee contributions or on a specified amount per hour based on the provisions of the applicable collective bargaining agreement. Company contributions are made in cash. Expense for this plan was $0.6 million and $0.7 million for the third quarter of 2019 and 2018 respectively, and $2.0 million and $2.1 million for the first nine months of 2019 and 2018, respectively.

XML

Description of Business, Basis of Presentation, and New Accounting Standards Merger (Details) - Synthomer and OMNOVA Merger [Member] $ / shares in Units, $ in Millions	9 Months Ended
	Aug. 31, 2019 USD ($) $ / shares
Business Acquisition [Line Items]
Business Acquisition, Share Price | $ / shares	$ 10.15
Merger Termination Fee | $	$ 15.8

XML

Debt and Credit Lines (Tables)

9 Months Ended

Aug. 31, 2019

Debt Disclosure [Abstract]

Schedule of Short-term Debt

Debt obligations due within the next twelve months consist of the following:

	August 31, 2019		November 30, 2018
	(Dollars in millions)
$350 million Term Loan B, due 2023, current portion (interest at 5.48% and 5.55%, respectively)	$	3.5	$	3.5
Capital lease obligations, current portion	.8		.7
Total	$	4.3	$	4.2

Schedule of Long-Term Debt

The Company’s long-term debt consists of the following:

	August 31, 2019			November 30, 2018
	(Dollars in millions)
$350 million Term Loan B, due 2023 (interest at 5.48% and 5.55%, respectively)	$	299.5		$	302.1
Senior Secured Revolving Credit, due 2021 (interest at 3.69% and 3.88%, respectively)	18.2			12.0
Capital lease obligations	15.1			15.6
Gross debt	332.8			329.7
Less: current portion	(4.3		)	(4.2		)
Unamortized original issue discount	(1.7		)	(2.1		)
Debt issuance costs	(4.0		)	(4.7		)
Total long-term debt, net of current portion	$	322.8		$	318.7

Schedule of Future Minimum Lease Payments for Capital Leases

The following is a schedule by year of future minimum lease payments under the Company's capital leases together with the present value of the net future minimum lease payments as of August 31, 2019:

Year Ending November 30:	(Dollars in millions)
2019	$	.4
2020	1.5
2021	1.5
2022	1.4
2023	1.4
Thereafter	15.2
Total minimum lease payments	21.4
Less: Amount representing estimated executory costs	(.5		)
Net minimum lease payments	20.9
Less: Amount representing interest	(5.8		)
Present value of minimum lease payments	$	15.1

XML

Share-Based Employee Compensation Restricted Share Rollforward (Details) - $ / shares	9 Months Ended
	Aug. 31, 2019	Nov. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Nonvested at December 1, 2018	1,350,313
Granted	623,449
Vested	226,646
Canceled and Forfeited	30,587
Nonvested at August 31, 2019	1,716,529
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 7.99	$ 8.11
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	7.18
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value	6.50
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value	$ 7.92

XML

Business Segment Information (Details) $ in Millions	3 Months Ended		9 Months Ended
	Aug. 31, 2019 USD ($)	Aug. 31, 2018 USD ($)	Aug. 31, 2019 segment	Aug. 31, 2019	Aug. 31, 2019 USD ($)	Aug. 31, 2018 USD ($)
Segment Reporting Information [Line Items]
Number of Reportable Segments			2	2
Net sales	$ 192.4	$ 193.6			$ 567.0	$ 578.5
Interest expense	(5.1)	(4.7)			(15.3)	(14.4)
Income (loss) before income taxes	0.9	0.4			2.7	13.4
Specialty Solutions [Member]
Segment Reporting Information [Line Items]
Net sales	137.7				392.7
Performance Materials [Member]
Segment Reporting Information [Line Items]
Net sales	54.7				174.3
Operating Segments [Member]
Segment Reporting Information [Line Items]
Operating Income (Loss)	15.6	11.6			42.9	49.4
Operating Segments [Member] | Specialty Solutions [Member]
Segment Reporting Information [Line Items]
Net sales	137.7	122.1			392.7	360.0
Operating Income (Loss)	20.0	19.5			49.3	55.0
Operating Segments [Member] | Performance Materials [Member]
Segment Reporting Information [Line Items]
Net sales	54.7	71.5			174.3	218.5
Operating Income (Loss)	(4.4)	(7.9)			(6.4)	(5.6)
Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Interest expense	(5.1)	(4.7)			(15.3)	(14.4)
Corporate, Non-Segment [Member]
Segment Reporting Information [Line Items]
Corporate expenses	$ (9.6)	$ (6.5)			$ (24.9)	$ (21.6)